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Sickle Cell Disease Erythrocyte Stiffness and Cytoadhesion Investigated
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Jamie Lynn Maciaszek, PhD
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The biomechanical properties of red blood cells (RBCs), including increased stiffness and
abnormal cytoadherence, are integral components in the cascade of events resulting to
vasoocclusive episodes (VOEs) in sickle cell disease (SCD). VOEs are the main cause of
morbidity in SCD and sickle cell trait (SCT). Using experimental techniques based on atomic
force microscopy (AFM), we studied the stiffness and adhesion of RBCs from SCD patients and
from subjects with SCT. We found that SCD and SCT RBCs are three-fold stiffer than normal
RBCs. Further, a ten-fold increase in the stiffness of sickled RBCs was measured upon
deoxygenation. In an effort to rectify the increased stiffness of sickle RBCs, mice were fed a diet
supplemented with docosahexanoic acid (DHA), an omega-3 fatty acid. A decrease in RBC
stiffness was measured suggesting therapeutic benefits of DHA. Cytoadherence of RBCs to
subendothelial laminin via the basal cell adhesion molecule/Lutheran (BCAM/Lu) is implicated in
vasculopathy, a common condition in SCD patients. We established the in vitro technique of
single-molecule force spectroscopy (SMFS) which enables detection of single BCAM/Lu
proteins on the RBC surface via measurement of the unbinding force with laminin. It was shown
that epinephrine, acting through the cyclic adenosine monophosphate (cAMP) signaling
pathway, increases the population of active BCAM/Lu receptors on SCT RBCs, suggesting a
role in exercise-induced VOEs. The sensitivity of the SMFS system was validated in a neuronal
system to quantitatively map SK channels and then employed to investigate the effects of cAMP
pathway targeting on BCAM/Lu receptor expression on normal and SCD RBCs. We illustrated
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that A-kinase anchoring proteins are crucial for BCAM/Lu receptor activation. To examine the
relevance of results based on SMFS in the cytoadhesion of entire RBCs, single-cell force
spectroscopy (SCFS) was established to measure the adhesion of whole cells with a
functionalized substrate. We established a correspondence between the SMFS and SCFS
results. Both techniques were able to detect significant changes in the adhesive response of
RBCs to cAMP pathway modulation and variability was measured amongst human subjects,
suggesting that RBCs maintain diverse intracellular levels of tonic protein kinase A.

Sickle Cell Disease Erythrocyte Stiffness and Cytoadhesion Investigated
via Atomic Force Microscopy

Jamie Lynn Maciaszek

B.S., Lehigh University, 2009
M.S., University of Connecticut, 2012

A Dissertation
Submitted in Partial Fulfillment of the
Requirements for the Degree of
Doctor of Philosophy
at the
University of Connecticut

2013

iii

Approval Page

Copyright by
Jamie Lynn Maciaszek

2013

iv

APPROVAL PAGE

Doctor of Philosophy Dissertation

Sickle Cell Disease Erythrocyte Stiffness and Cytoadhesion Investigated via Atomic Force
Microscopy

Presented by
Jamie Lynn Maciaszek, B.S., M.S.

Major Advisor ______________________________________________________________
George Lykotrafitis

Associate Advisor ___________________________________________________________
Anastasios V. Tzingounis

Associate Advisor ___________________________________________________________
Biree Andemariam

Associate Advisor ___________________________________________________________
Tai-Hsi Fan

Associate Advisor ___________________________________________________________
Wei Sun

University of Connecticut
2013

v

Acknowledgment
It is amazing how quickly the past four and a half years have flown by, years filled with some of
my greatest memories as well as some of the toughest challenges. The completion of my
doctoral degree has been an extremely enriching experience, both personally and
professionally. All of this would not have been possible without the guidance and help of several
individuals who contributed and extended their valuable assistance in the completion of this
research, and more importantly have provided me support throughout these years.
First and foremost, it is with immense gratitude that I acknowledge the invaluable support and
mentorship of my Major Advisor, Dr. George Lykotrafitis. I am sincerely appreciative of his
unparalleled guidance and unwavering belief in me and in my growth as a researcher over the
past four years.
I would like to thank Dr. Biree Andemariam at the University of Connecticut Health Center for
providing me with her expertise on sickle cell disease. I am very grateful to Dr. Anastasios
Tzingounis for his expertise on pathway signaling and valuable perspective on my experimental
results. I would also like to thank my associate advisors Dr. Wei Sun and Dr. Tai-Hsi Fan for
their mentorship and support on my fellowship applications and dissertation studies. Thank you
to my fellow Cell Mechanics Lab members for their support, assistance, and always being there
to listen. I would also like to appreciatively acknowledge the Departments of Biomedical
Engineering and Mechanical Engineering for their continued support of my research. I am also
very grateful for the financial support of the American Heart Association Founder’s Affiliate
Predoctoral Fellowship (11PRE7280009).
Thanks are due to many others, particularly Drs. Nancy Wandersee and Madelyn Hanson of the
Blood Center of Wisconsin for collaborating with us on the murine erythrocyte stiffness project. I
have greatly learned from their knowledge of sickle cell disease and experimental planning

vi

which will certainly benefit me in my career. In addition, I would like to thank Harriet Zawistowski
of the Clinical Research Center at the University of Connecticut Health Center who took the time
recruit and enroll subjects for the study. I would also like to thank Dr. William Zempsky and
James Santanelli at Connecticut Children’s Medical Center for providing me with blood samples
to fulfill my American Heart Association predoctoral fellowship study.
Last but certainly not least, I would like to thank my family and friends, who have provided me
with encouragement, support, and an infinite amount of necessary laughter. I am blessed to
have such wonderful friends in my life, and would like to especially thank my BFFs – Rachel,
Shana, Gina, and Jill – for countless phone calls, text messages, and keeping me grounded.
Most importantly, to my mom, dad, and brother: I am forever grateful for your unwavering
support and commitment to my accomplishments. Thank you for your unconditional love
through the many challenges that I have encountered. This journey would not have been
possible without you. I love you.

vii

Table of Contents

Title Page .................................................................................................................................. iii
Approval Page .......................................................................................................................... iv
Acknowledgment ..................................................................................................................... vi
List of Figures .......................................................................................................................... xi
List of Tables .......................................................................................................................... xiv
Chapter 1. Introduction............................................................................................................. 1
1.1. Sickle cell disease ........................................................................................................... 1
1.2. Objectives ........................................................................................................................ 7
1.3. Rationale ........................................................................................................................11
Chapter 2. Atomic Force Microscopy .................................................................................... 13
Chapter 3. Microelasticity of Red Blood Cells in Sickle Cell Disease ................................. 26
3.1. Abstract ..........................................................................................................................26
3.2. Introduction .....................................................................................................................26
3.3. Sickle Cell Disease .........................................................................................................27
3.4. Atomic Force Microscopy Probing of Cell Elasticity.........................................................28
3.5. Methods..........................................................................................................................35
3.6. Results ...........................................................................................................................37
3.7. Discussion ......................................................................................................................42
Chapter 4. Sickle Cell Trait Human Erythrocytes Show a Significant Increase in their
Stiffness Compared to Erythrocytes from Healthy Individuals ........................................... 45
4.1. Abstract ..........................................................................................................................45
4.2. Introduction .....................................................................................................................45
4.3. Methods..........................................................................................................................49
4.4. Results ...........................................................................................................................52
4.5. Discussion ......................................................................................................................54

viii

Chapter 5. Dietary Supplementation with Docosohexanoic Acid (DHA) Increases Red
Blood Cell Membrane Flexibility in Mice with Sickle Cell Disease ...................................... 56
5.1. Abstract ..........................................................................................................................56
5.2. Introduction .....................................................................................................................56
5.3. Methods..........................................................................................................................57
5.4. Results ...........................................................................................................................62
5.5. Discussion ......................................................................................................................66
Chapter 6. Epinephrine Modulates BCAM/Lu and ICAM-4 Expression on the Sickle Cell
Trait Red Blood Cell Membrane ............................................................................................. 70
6.1. Abstract ..........................................................................................................................70
6.2. Introduction .....................................................................................................................70
6.3. Design and Methods .......................................................................................................72
6.4. Results ...........................................................................................................................76
6.5. Discussion ......................................................................................................................83
6.6. Conclusions ....................................................................................................................85
Chapter 7. Establishing the Sensitivity of Force Nanoscopy in the Detection of Native SK
Channels in Living Neurons ................................................................................................... 86
7.1. Abstract ..........................................................................................................................86
7.2. Introduction .....................................................................................................................86
7.3. Materials and Methods ...................................................................................................88
7.4. Results ...........................................................................................................................90
7.5. Discussion ......................................................................................................................97
Chapter 8. AKAP-Dependent Modulation of BCAM/Lu Adhesion on Normal and Sickle
Cell Disease RBCs Revealed by Force Nanoscopy ............................................................ 100
8.1. Abstract ........................................................................................................................100
8.2. Introduction ...................................................................................................................100
8.3. Methods........................................................................................................................103
8.4. Experimental Validation ................................................................................................107
8.5. Results .........................................................................................................................110

ix

8.6. Discussion ....................................................................................................................119
Chapter 9. Single-Cell Force Spectroscopy as a Technique to Quantify Human Red Blood
Cell Adhesion to Subendothelial Laminin ........................................................................... 123
9.1. Abstract ........................................................................................................................123
9.2. Introduction ...................................................................................................................123
9.3. Methods........................................................................................................................126
9.4. Results and Discussion ................................................................................................131
9.5. Conclusion ....................................................................................................................143
Chapter 10. Epilogue ............................................................................................................ 145
Chapter 11. References ........................................................................................................ 150
Chapter 12. List of Conference or Journal Publications .................................................... 168
12.1. Journal Publications....................................................................................................168
12.2. Personal Presentations At Conferences .....................................................................169
12.3. Conference Proceedings ............................................................................................170
12.4. Conference Abstracts .................................................................................................171

x

List of Figures
Figure 1.1.1. Human red blood cell surface adhesion receptors. ................................................ 3
Figure 1.1.2. Red blood cell surface adhesion receptors for endothelial ligands......................... 4
Figure 1.1.3. Vasculopathy of sickle cell disease. ...................................................................... 5
Figure 1.1.4. Beta adrenergic pathway. ...................................................................................... 7
Figure 2.1. Atomic force microscope. ........................................................................................13
Figure 2.2. Force curve regions. ...............................................................................................16
Figure 2.3. The general indentation problem for a smooth, rigid, frictionless punch. .................17
Figure 3.4.1. The general indentation problem for a smooth, rigid, frictionless punch................29
Figure 3.4.2. Force-distance curves obtained during the retraction cycle of the indention. ........33
Figure 3.6.1. Three-dimensional topographical images of SCD erythrocytes obtained via AFM 38
Figure 3.6.2. Theoretical models for a pyramid indenter and a parabolic indenter fitted to the
experimental data for clinical SCD erythrocytes obtained via AFM. ........................................40
Figure 3.6.3. Experimental data for Young’s modulus. ..............................................................41
Figure 3.6.4. Histograms of the Young’s modulus determined for sickle cell disease RBCs
maintained in oxygenated and deoxygenated environments. .................................................42
Figure 4.3.1. Three-dimensional topographical images of RBCs ...............................................50
Figure 4.4.1. Theoretical model for a pyramidal shaped indenter fitted to the experimental data
for normal and SCT erythrocytes obtained via AFM ...............................................................51
Figure 4.4.2. Histograms of the Young’s modulus determined for RBCs ...................................53
Figure 5.4.1. Dietary supplementation with DHA decreases RBC stiffness in SS mice..............63
Figure 5.4.2. Dietary supplementation with DHA increases RBC deformability in SS mice. .......65
Figure 5.4.3. Dietary supplementation with DHA does not affect in vitro adhesion to TSP but
decreases irreversibly sickled RBCs in SS mice. ...................................................................67
Figure 6.4.1. Strategy for measuring the BCAM/Lu-laminin binding force at the single-molecule
level using AFM. ....................................................................................................................75

xi

Figure 6.4.2. Measurement of the binding force of the BCAM/Lu-laminin and ICAM-4-αvβ3
complexes. ............................................................................................................................77
Figure 6.4.3. AFM topographic image of a SCT erythrocyte ......................................................78
Figure 6.4.4. Measurement of the binding force of the BCAM/Lu-laminin and ICAM-4-αvβ3
complexes on erythrocytes. ...................................................................................................79
Figure 6.4.5. Measurement of the physiologic implications of epinephrine-stimulated adhesion.
..............................................................................................................................................80
Figure 6.4.6. Validation of the specificity of the BCAM/Lu-laminin interaction on wild-type RBCs.
..............................................................................................................................................81
Figure 6.4.7. Distribution of BCAM/Lu and ICAM-4 on the surface of wild-type RBCs and sickle
cell trait RBCs using different probes and cell preparations ...................................................82
Figure 7.4.1. Detection of SK2 channels on living cells using Atomic Force Microscopy (AFM).91
Figure 7.4.2. Counting SK2 channels in living cells. ..................................................................94
Figure 7.4.3. SK channels are polarized in pyramidal neurons. .................................................96
Figure 7.4.4. SK channel maps in pyramidal neurons are dynamic. ..........................................98
Figure 8.3.1. Measurement of the frequency of active BCAM/Lu surface receptors and the
unbinding force with LAMA5 on RBCs using AFM. ..............................................................106
Figure 8.4.1. Immunofluorescence following probe functionalization. ......................................108
Figure 8.4.2. Scan area size determination. ............................................................................109
Figure 8.4.3. Specificity of unbinding forces. ...........................................................................110
Figure 8.5.1. Distribution of BCAM/Lu on normal RBCs and unbinding force of BCAM/Lu to
LAMA5. ................................................................................................................................112
Figure 8.5.2. Distribution of BCAM/Lu on SS-RBCs and unbinding force of BCAM/Lu to LAMA5.
............................................................................................................................................114
Figure 8.5.3. Modulation of BCAM/Lu via AKAPs on the RBC membrane. ..............................116
Figure 8.5.4. Modulation of the collective frequency of BCAM/Lu receptors on SS-RBCs from

xii

HU-treated patients. .............................................................................................................118
Figure 9.3.1. Measurement of red blood cell adhesion to subendothelial matrix laminin using
single-cell force spectroscopy. .............................................................................................129
Figure 9.4.1. Determination of laminin solution concentration to be employed in SCFS assay 133
Figure 9.4.2. Human RBC adhesion to laminin substrates (50 µg/ml) at increasing contact times
............................................................................................................................................136
Figure 9.4.3. Correlation of single-cell measurements with traditional SMFS measurements ..139
Figure 9.4.4. Single-cell force spectroscopy can clearly detect significant changes in RBC
adhesion to laminin substrates (50 µg/ml) following treatment with biochemical agents
modulating the cAMP-dependent pathway ...........................................................................142

xiii

List of Tables
Table 5.3.1. Fatty acid composition ...........................................................................................58
Table 5.4.1. Red blood cell and reticulocyte measures. ............................................................64

xiv

Chapter 1. Introduction
1.1. Sickle cell disease
Sickle cell disease (SCD) is a multisystem disease characterized by extreme pain and episodes
of acute illness resulting from microvascular infarction [1-3]. The genotype for homozygous SCD
results in early mortality and high morbidity, while the heterozygous sickle cell trait (SCT)
occasionally can be associated with collapse and sudden death during physical exertion [1-4].
SCD occurs in over 100,000 individuals in the United States [4] and over 3 million individuals
worldwide [5-6]. Over 70% of sufferers live in Africa, where little is known about the disease [1,
4, 7-8]. The number of SCD cases is expected to increase about 30% by 2050, making it a
significant global health issue [5]. SCT occurs in approximately 300 million people worldwide,
with the highest prevalence of approximately 30% to 40% in sub-Saharan Africa where it offers
protection against severe malaria [9]. Recurrent vasoocclusive episodes (VOEs) and
inflammation result in progressive damage to most organs, including the brain, kidneys, lungs,
bones, and cardiovascular system, which becomes apparent with increasing age [1]. One of the
main problems of SCD in children is the increased occurrence of stroke [10-12], with overt
stroke estimated to occur in 11% of individuals under the age of 20, often resulting in permanent
neurological and cognitive impairment [11-19]. Silent cerebral infarcts, a relatively newly
recognized complication of SCD, occur in 22% of neurologically asymptomatic children and
correlate with neurophysiologic dysfunction and predisposition of overt stroke [12, 19-27].

SCD is an inherited blood disorder caused by a single point mutation in one of the genes
encoding hemoglobin [28-34]. Hemoglobin (Hb) is formed by four polypeptide chains, two of
type α and two of type β. In abnormal sickle hemoglobin (HbS), the normal sequence of Val-HisLeu-Thr-Pro-Glu-Glu-Lys is changed to Val-His-Leu-Thr-Pro-Val-Glu-Lys, with the amino acid
valine substituting for glutamic acid at the β6 site. The replacement of two charged groups with
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two hydrophobic groups leads to polymerization of deoxygenated Hb and to the formation of
long stiff rodlike fibers [33, 35-36], which force RBCs to assume a wide variety of irregular
shapes [37]. Other factors such as lowered pH, RBC dehydration and hyperthermia are also
known to prompt sickling [38]. The genetics and underlying biophysics of the disease related to
HbS have been extensively studied [1, 33, 35, 37, 39-42], however little remains known about
the onset and progression of VOEs, specifically cell-cell interactions and blood cell adhesion
events which are thought to be an integral component of VOEs. Therefore, clinical management
of SCD is still basic and, although some evidence lends support to the use of blood transfusion
and hydroxyurea in some circumstances, no drugs have been developed that specifically target
the pathophysiology of the disease.

SCT is marked by the presence of both HbS and HbA [43]. HbS comprises approximately 2046% of the total hemoglobin content in RBCs from persons with SCT [44], with most individuals
having 40-42% [45]. SCT has a very significant social impact because approximately it occurs in
approximately 300 million people worldwide and three million people in the United States,
making it 40 to 50 times more prevalent than SCD [46]. In comparison to the homozygous SCD,
the heterozygous SCT is traditionally regarded as a benign condition [28, 47-48]. During
strenuous exercise, individuals can develop a syndrome resembling SCD with VOEs resulting
from changes in the RBC morphology, viscoelasticity, and adhesion [38, 49-54]. These VOEs
can lead to organ damage and ischemic pain, and are occasionally associated with significant
morbidity and mortality, specifically in the case of physical training [55]. VOEs can also develop
in other extreme conditions such as hypoxia, acidosis, dehydration, hyperosmolarity, or elevated
erythrocyte 2,3-diphosphoglycerate (DPG) [46, 49-50, 56]. SCT is exclusively associated with
rare but often fatal renal medullary cancer. Other complications associated with SCT include
increased urinary tract infections in women, gross hematuria, complications of hyphema, splenic
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infarction with altitude hypoxia or exercise, and life-threatening complications of exercise,
exertional heat illness (exertional rhabdomyolysis, heat stroke, or renal failure) or idiopathic
sudden death [46, 53, 57].

Figure 1.1.1. Human red blood cell surface adhesion receptors. These receptors mediate
adhesion on healthy and pathological RBCs.

Healthy RBCs have a diameter of approximately 8-10 µm and a height of 2.5 µm. They are very
deformable and have the ability to deform to diameters as small as 1-3 μm to traverse narrow
capillaries and blood vessels during their approximately three-month life cycle [58]. Healthy
erythrocytes contain only soluble adult hemoglobin (HbA), a globular protein totaling 25-30% of
the cell, which transports oxygen from the lungs to tissues [33, 59]. These cells have a
characteristic biconcave shape which increases the surface area to facilitate the diffusion of O 2
and CO2 into and out of the cell [59-60]. This biconcave morphology is also associated with the
high compliance of the erythrocytes [61]. Although RBCs are generally considered to be
relatively inactive due to their lack of a nucleus and organelles, they express several surface
adhesion receptors (Figure 1.1.1) which modulate cellular physiology and function [62]. Many of
these receptors mediate cell-cell interactions, or adhesion, on both healthy and pathological
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RBCs. Membrane proteins known to be involved in mediating the interaction between RBCs and
the endothelium include: basal cell adhesion molecule and its isoform Lutheran (BCAM/Lu), a
high-affinity laminin receptor; ICAM-4 (LW glycoprotein), a receptor for a number of integrins;
CD47, a thrombospondin (TSP) receptor, as shown in Figure 1.1.2 [63].

Figure 1.1.2. Red blood cell surface adhesion receptors for endothelial ligands.

A cascade of events results in the onset and progression of painful VOEs, the hallmark of SCD,
which result from the blockage of small vessels in many different organs [31, 64-67]. The
development of vascular obstruction in SCD is complicated and likely involves many different
abnormalities of both circulating blood and the blood vessel wall (Figure 1.1.3). Endothelial cell
activation, cytoadherence, inflammation, and coagulation activation contribute to blood flow
obstruction and play a critical role in the pathophysiology of VOEs [64, 66, 68]. The
pathogenesis of complications in SCD begins with loss of RBC deformability and increased
cytoadherence of the RBCs. Loss of deformability and increased RBC rigidity occurs because
Hb fibers form noncovalent cross-links and create a gel. This gives RBCs their irregular shapes
and also alters their viscoelastic behavior and increases their cytoadherence [36, 69-70]. The
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abnormal morphologic, adhesive, and elastic properties of sickle RBCs then causes obstruction
of the microvasculature which ultimately results in stroke, VOEs, and organ damage.
Importantly, cytoadherence of RBCs to the vascular endothelium and subendothelial matrix is
thought to be a major contributor to and possibly the primary cause of vasculopathy in SCD [12,
64, 71].

Figure 1.1.3. Vasculopathy of sickle cell disease. The combination of abnormal cytoadherence
of the sickle RBC, the over-activity of the blood clotting system, and vessel wall damage
contribute importantly to blood vessel occlusion and crises in SCD. There are many other
factors involved in SCD vasculopathy including: sickle RBC adhesion, abnormal shear,
increased inflammation, oxidative endothelial cell damage (ROS), an increase in serum free Hb,
dysregulation of the nitric oxide pathway (NO/NOS), increases in cell adhesion molecule (CAM)
and tissue factor (TF) expression, loss of vasoregulation, intimal hyperplasia, platelet and
leukocyte adhesion, propagation of fibrin clot, and entrapment of rigid sickle RBCs.

On healthy and pathological RBCs, the activation of adhesion receptors can be modulated by
hormones such as epinephrine [30, 72], pharmaceutical drugs such as hydroxyurea [73], and
other biochemical stimuli. Hydroxyurea (HU) is currently the only pharmacologic treatment to
reduce the frequency of VOEs, yet only two-thirds of patients respond favorably to the drug [74].
Hydroxyurea stimulates an increase in fetal hemoglobin (HbF) [75-76], however clinical
improvement following HU treatment has been observed prior to measureable increases in HbF,
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suggesting the critical role of other mechanisms such as altered RBC signaling [73, 77-78].

Quantitative understanding of RBC cytoadherence mediated by the second messenger cyclic
adenosine monophosphate (cAMP) is necessary to fully elucidate the mechanism of RBC
adhesion and signaling, and to guide advances in SCD pharmacotherapy. The current work will
focus in part on subcellular targeting of the cAMP-dependent protein kinase A (PKA), a
tetrameric holoenzyme consisting of two catalytic and two regulatory subunits [79]. Because
SCD patients have extensive endothelial damage [80] and elevated plasma levels of laminin
[81], RBC adhesion studies have focused on the specific interaction between BCAM/Lu and the
α5 chain of laminin (LAMA5), a component of the subendothelial matrix [82-83]. Importantly, by
using a flow adhesion assay, Hines et al [72] previously demonstrated that the interaction
between BCAM/Lu and laminin is mediated by cAMP, an upstream effector of the PKA pathway
[84]. In RBCs, stimulation of the β2-adrenergic receptor (β2-AR) [85-86] activates the G-protein
coupled receptor Gαs, which stimulates adenylyl cyclase (AC) [87]. AC then catalyzes the
conversion of adenosine triphosphate (ATP) to cAMP, which results in PKA activation and
resultant BCAM/Lu-laminin adhesion (Figure 1.1.4). It was previously reported that levels of
cAMP are significantly higher in sickle RBCs than RBCs from healthy subjects [72-73]. Contrary
to the established mechanism of the PKA pathway, studies have also shown that healthy RBCs
have little response to stimulation by epinephrine or forskolin [72]. Further, it is currently
unknown if scaffold or anchoring proteins, such as A-kinase anchoring proteins (AKAPs), which
compartmentalize PKA [88], play a role in BCAM/Lu receptor activation. Subsequent chapters of
this work will investigated these subcellular targets and their specific effects on the population of
active BCAM/Lu receptors. In addition, we will investigate the effect of epinephrine on the
population of active BCAM/Lu and ICAM-4 receptors on normal and SCT erythrocytes.
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Figure 1.1.4. Beta adrenergic pathway. The beta adrenergic pathway is a cAMP-dependent
signaling pathway which modulates the activation of adhesion receptors on human RBCs.

1.2. Objectives
The objectives for subsequent chapters are outlined below.

Chapter 2. Atomic Force Microscopy
Atomic force microscopy (AFM) is appropriate for measuring the biomechanical and adhesive
properties of living cells due to its high force sensitivity and its ability to measure local and
overall properties of individual cells under physiological conditions. This chapter aims to
describe the principles of AFM with respect to biological applications.

Chapter 3. Microelasticity of Red Blood Cells in Sickle Cell Disease
A systematic force-displacement curve analysis is reported on the quantification of material
stiffness via AFM using two theoretical models derived from the Hertz model. We determined
the model for a four-sided pyramidal indenter to be the best fit for our application as compared
to the model for a parabolic indenter. This analysis was applied to red blood cells from patients
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with sickle cell disease to determine the Young’s modulus of these cells in the oxygenated and
deoxygenated state. Our findings conclude that deoxygenation and therapeutic treatment have
a significant impact on the stiffness. This analysis presents a new approach to addressing
medical disorders.

Chapter 4. Sickle Cell Trait Human Erythrocytes Show a Significant Increase in their Stiffness
Compared to Erythrocytes from Healthy Individuals
The force-displacement curve analysis established in Chapter 3 was employed to measure the
stiffness of abnormal human RBCs from patients with the genotype for SCT. The determined
Young’s modulus was compared with measurements of erythrocytes from healthy subjects. The
results showed that the Young’s modulus of SCT erythrocytes was approximately three times
higher than in normal cells. Observed differences indicate the effect of the polymerization of
hemoglobin S as well as possible changes in the organization of the cell cytoskeleton
associated with the sickle cell trait.

Chapter 5. Dietary Supplementation with Docosohexanoic Acid (DHA) Increases Red Blood Cell
Membrane Flexibility in Mice with Sickle Cell Disease
In an effort to rectify the increased stiffness of sickle RBCs determined in Chapter 3, mice were
fed a diet supplemented with docosahexanoic acid (DHA), an omega-3 fatty acid, and
measurements were recorded via AFM. Murine RBCs were examined for: 1) stiffness, as
measured by AFM using the force-displacement curve analysis established in Chapter 3; 2)
deformability, as measured by ektacytometry; and 3) percent irreversibly sickled RBCs on
peripheral blood smears. Using AFM, stiffness is increased and deformability decreased in
RBCs from SS mice fed CTRL diet compared to wild-type mice. In contrast, RBCs from SS mice
fed DHA diet had markedly decreased stiffness and increased deformability compared to RBCs
from SS mice fed CTRL diet. Furthermore, examination of peripheral blood smears revealed
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less irreversibly sickled RBCs in SS mice fed DHA diet as compared to CTRL diet. In summary,
our findings indicate that DHA supplementation improves RBC flexibility and reduces irreversibly
sickled cells in SS mice. These results point to potential therapeutic benefits of dietary omega-3
fatty acids in SCD. changes

Chapter 6. Epinephrine Modulates BCAM/Lu and ICAM-4 Expression on the Sickle Cell Trait
Red Blood Cell Membrane
The in vitro technique of single-molecule force spectroscopy was established using RBCs from
subjects with SCT. We report that epinephrine, a hormone secreted under stress and strenuous
exercise, increases both the frequency and strength of adhesion events between BCAM/Lu and
subendothelial laminin, and between ICAM-4 and endothelial integrin αvβ3, compared to nonstimulated SCT erythrocytes. Increases in adhesion frequency present significant evidence of
the role of epinephrine in BCAM/Lu-laminin and ICAM-4-αvβ3 bonding, and suggest
mechanisms of vaso-occlusion during physical exertion in SCT.

Chapter 7. Topography of Native SK Channels Revealed by Force Nanoscopy in Living
Neurons
As a proof of principle, we demonstrate that integration of pharmacology with single molecule
AFM allows for the high-resolution mapping of native potassium channels in living neurons. By
linking apamin, a toxin that specifically binds to SK channels, to the tip of an AFM cantilever, we
are able to detect binding events between the apamin and SK channels. We find that native SK
channels from rat hippocampal neurons reside primarily in dendrites as single entities and in
pairs. To establish the sensitivity of the assay, we also show that SK channel dendritic
distribution is dynamic and under the control of protein kinase A.

9

Chapter 8. AKAP-Dependent Modulation of BCAM/Lu Adhesion on Normal and Sickle Cell
Disease RBCs Revealed by Force Nanoscopy
SMFS was employed to investigate the effects of subcellular cAMP pathway targeting on
BCAM/Lu receptor expression on normal and SCD RBCs. Human normal and sickle RBCs
adhere with high affinity to laminin via the BCAM/Lu receptor which is implicated in VOEs in
SCD and activated through the cAMP signaling pathway. We measured the unbinding force
between BCAM/Lu on the RBC and laminin attached to the AFM probe. We showed that the
expression of active BCAM/Lu receptors is higher in homozygous sickle RBCs (SS-RBCs) than
normal RBCs and that it is critically dependent on the cAMP signaling pathway on both normal
and SS-RBCs. Importantly, we illustrated that A-kinase anchoring proteins (AKAPs) are crucial
for BCAM/Lu receptor activation. Furthermore, we found that SS-RBCs from hydroxyureatreated patients show a lower expression of active BCAM/Lu receptors, a lower unbinding force
to laminin, and insignificant stimulation by epinephrine as compared to SS-RBCs from untreated
patients. These findings may lead to novel anti-adhesive targets for VOEs in SCD.

Chapter 9. Single-Cell Force Spectroscopy as a Technique to Quantify Human Red Blood Cell
Adhesion to Subendothelial Laminin
To examine the relevance of results based on SMFS in the cytoadhesion of entire RBCs, singlecell force spectroscopy (SCFS) was established to measure the adhesion of whole cells with a
functionalized substrate. Adhesion forces were recorded as RBCs attached to AFM cantilevers
were pulled-off of substrates coated with laminin protein. We established a correspondence
between the SMFS and SCFS results. In particular, it was found that elevated overall cell
adhesion measured via SCFS coincided with a rise in the resultant total force measured on 1
µm2 areas of the RBC membrane at baseline via SMFS. Both techniques were able to detect
significant changes in the adhesive response of RBCs to cAMP pathway modulation and
variability was measured amongst human subjects, suggesting that RBCs maintain diverse
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intracellular levels of tonic protein kinase A. By using single-cell measurements, we established
a powerful new method for the quantitative measurement of the adhesion of single RBCs with
specific receptor-mediated binding.

1.3. Rationale
Multiple biological processes contribute to the pathogenesis of vasculopathy in SCD including
red cell sickling, inflammation and adhesion biology, coagulation activation, stasis, deficient
bioavailability and excessive consumption of NO, excessive oxidation, and reperfusion injury
physiology. The biomechanical properties of RBCs, including increased stiffness and abnormal
cytoadherence, are integral components in the cascade of events resulting to vasculopathy in
SCD and SCT [1, 9, 28]. The hemoglobin biophysics and genetics underlying the disease have
been extensively studied, however despite substantial evidence underlining the importance of
RBC stiffness and hetero-cellular interactions in the onset and progression of VOEs, the exact
mechanism is not known. Thus, clinical management of SCD is still basic and although some
evidence supports the use of blood transfusion therapy and hydroxyurea to reduce the
frequency of VOEs, no drugs have been developed that specifically target the pathophysiology
of the disease. Therefore, substantial work must be performed to better understand RBC
biophysics in SCD, namely stiffness and adhesion, in an effort to develop better
therapeutic methods for the prevention and treatment of VOEs.

Human normal and sickle RBCs adhere with high affinity to laminin via the BCAM/Lu receptor
which is activated through the cAMP signaling pathway. The adhesion of single RBCs and the
effect of cAMP signaling at the single-molecule and single-cell level are central to disease
pathology and anti-adhesive drug development. We established two in vitro techniques, based
on AFM, to study human RBC adhesion in physiological conditions. The first, SMFS enables
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detection of single BCAM/Lu proteins on the RBC surface and measures the exact unbinding
force between BCAM/Lu and laminin. The second, SCFS enables quantitative study of RBC
adhesion while maintaining the native state of surface receptors. By studying RBC adhesion
using SMFS in conjunction with SCFS, we expect a significant impact on identifying potential
targets for anti-adhesive drug therapies to prevent and treat VOEs in SCD.
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Chapter 2. Atomic Force Microscopy

Atomic force microscopy (AFM; Figure 2.1) [89] has opened a wide range of novel possibilities
for imaging and manipulating biological systems in their native environment [90-91]. It allows for
measurements of native biological samples in physiological conditions [30, 92-93] while
avoiding complex sample preparation procedures and the artifacts connected with such
procedures. The mild experimental conditions used in AFM allow for dynamic studies of cellular
morphology, elasticity, and molecular interactions at the single-molecule and single-cell level
[30, 90, 94]. In particular, functionalization of the AFM cantilever tip with ligands has allowed for
mapping the distribution of complementary receptors on model or cellular surfaces [90-91, 9498] with high resolution.

Figure 2.1. Atomic force microscope. Labeled components of the Asylum Research MFP-3DBIO AFM atop a Zeiss optical inverted microscope. Image edited from Asylum Research MFP3D-BIO brochure [99].

The AFM works by scanning, in a raster fashion, a very tiny tip mounted at the end of a flexible
cantilever in gentle touch with the sample. This relative motion is performed with sub-Angstrom
accuracy by a piezoelectric actuator. Interacting with the sample, the cantilever deflects and the
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tip-sample interaction can be monitored with high resolution exploiting a laser beam impinging
on the back of the cantilever [89, 92]. The beam is reflected towards a split photodetector
configuring an optical lever which amplifies cantilever deflections. Connected to the cantilever
deflection sensor is a feedback circuit that keeps interactions between the cantilever tip and the
sample at a fixed value by controlling the distance between the cantilever tip and the sample.
AFM cantilever probes utilized in biological applications are generally composed of thin silicon
nitride with a tiny pyramid tip at the end of the probe. Typical spring constants for these AFM
cantilevers range from 0.01 N/m to 100 N/m, enabling a minimum force sensitivity of
approximately 10-11 N.

A typical force-distance curve (Figure 2.2) can be divided into several regions. Starting from the
right (region I) the AFM tip is far from the sample and no interaction is detected. Moving towards
the left side of the plot (dotted curve), the tip is approaching the sample and no interaction is
detected until the cantilever deflects downwards towards the sample as a result of van der
Waals forces (region II). At this point, these van der Waals forces cause the cantilever tip to
snap into contact with the sample. The ‘jump to contact’ point corresponds to the position where
the gradient of the interaction force exceeds the cantilever spring constant. At each position in
the force curve, the cantilever is deflected until the restoring force is equal to the interaction
force with the sample, thus causing the system to be always at equilibrium. After the contact, as
the tip continues its approach cycle and moves closer to the surface, a positive deflection of the
cantilever arises (region III) due to repulsive forces. This is the contact region of the force curve
where elastic properties of the sample can be measured [93, 100-103]. The cantilever moves
toward the sample until a preset force threshold is reached. At this time, the movement direction
is inverted and the cantilever starts moving away from the sample (solid curve). Initially, the
behavior of the cantilever during withdrawal equals that described for the approach, but due to
adhesion between the functionalized cantilever tip and the sample, the cantilever starts to
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deflect negatively (region IV) until the adhesion force is overcome by the cantilever restoring
force and the contact breaks. The resulting breakage of contact is referred to as the rupture
force and is used to determine the bond magnitude of a protein-protein interaction, or any
interaction between a molecule functionalized on the cantilever tip and a receptor on the
sample.

In a force-curve cycle the cantilever deflection is measured and can be converted to force using
Hooke’s law:

where

is the force,

is the spring constant of the cantilever and

is the cantilever deflection.

By using a cantilever with a very small spring constant, a resolution of 10 pN can be obtained in
the measurement of forces [92].

The retraction component of the force curve quantifies the exact detachment force, denoting the
adhesive force, of the cell-cell or cell-protein interaction [30, 91]. If on the sample surface there
is a molecule or a cell and the tip is functionalized in order to expose a partner suitable to
specific interaction with it off its surface, the ligand-receptor interaction can be measured by
exploiting the detachment force in the retraction portion of the force-distance curve. When the
tip and sample are brought into contact, the molecules/cells present on the tip and surface
interact and form bonds. Upon cantilever retraction, the bonds previously formed are disrupted
and the typical detachment force is measured. To analyze the collected data, usually a
distribution of the number of detachment events as a function of the detachment force is
obtained. In SMFS, the presence of a detachment force is the indication that a single-molecule
interaction is measured, the multiples of the unbinding force being the result of coincident
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breakage of several bonds. Moreover, when a retraction curve presents several detachment
events, the last one most likely represents a single bond breakage [92, 104]. In SCFS, the
detachment forces are characteristic of the breakage of many receptor-ligand bond formations
and are typically higher than those recorded in SMFS.

Figure 2.2. Force curve regions. Force curve illustration with the different regions of the
approach and withdrawal portions highlighted. Region I demonstrates no interaction between
the tip and the sample, region II shows the cantilever deflecting downward towards the sample
as a result of van der Waals forces, region III shows the positive deflection of the cantilever due
to repulsive forces, and region IV demonstrates the negative deflection of the cantilever tip as a
result of adhesion forces between the tip and the sample. The different regions are discussed
thoroughly in the text.

Contact problems
The general theory of elasticity has been applied to AFM measurements based on the contact
theory of Hertz and Sneddon [105-107]. AFM stiffness measurement is modeled as indentation
of an elastic half-space,

< 0, by a frictionless rigid punch [108], as shown in Figure 2.3. The

profile of the punch is described by the function

, and

is the normal deformation

of the indented elastic half-space surface. In this case, the half-space represents the indented
RBC.
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Figure 2.3. The general indentation problem for a smooth, rigid, frictionless punch.

The gap

between the punch and the half-space is defined as

.

(1)

When the shape of the employed indenter exhibits a two-fold symmetry (e.g. pyramidal or
parabolic) then the contact area
with the center of

preserves the same symmetry as the base of the indenter,

at the coordinate origin (

= 0,

normal to the surface and are compressive inside

= 0,

= 0). The contact tractions act

and zero exactly at the contact perimeter,

as well as outside .

The gap is zero within the contact region

and positive in the separation region

, since

interpenetration of material is prohibited. Therefore, we have two conditions

; in

(2)

; in .

(3)

The definition of the frictionless contact problem is completed by assuming that the tangential
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traction is zero throughout the surface of the half-space,

; all

(4)

and that the contact pressure

is zero in the separation region

and

positive in the contact region , that is

in

(5)

in .

(6)

If the contact region A is specified, the equality conditions (2), (4), (5) define a well-posed
boundary value problem for the half-plane which has a unique solution. Then the total contact
force is obtained by

(7)

The inequalities (3) and (6) serve to determine the extent of the contact area for the contact
problem, but it has been shown [109] that the value of , which satisfies (3) and (6), maximizes
the total force

given by equation (7).

In the case of a spherical indenter, by solving the boundary contact problem as performed by
Hertz [106], the following result is obtained,
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(8)

where

is the distance between source

observation point

;

is the angular distance and

Young’s modulus. The contact radius,

and

, where

, is given in terms of the applied force,

is the

, and the

Poisson’s ration, , of the sample

(9)

Sneddon extended the Hertz model from a spherical indenter to an indenter of arbitrary profile
deforming elastic half space [107, 110]. Solutions of the boundary contact problem for other tip
geometries with two-fold symmetry generated models for parabolic [111-113] and pyramidal
[102, 110, 114-115] indenters. The general solution for force as a function of indentation for a
parabolic indenter can be approximated as

(10)

where

is the reduced Young’s modulus of the tip-sample system defined as

(11)
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The general solution for force as a function of indentation for a pyramidal indenter [102, 114115] can be approximated as

(12)

Atomic force microscopy contact problems
In a force curve on a sample indented via AFM, the indentation,

, is equal to

(13)

where

is the deflection of the cantilever on the rigid substrate and

cantilever on the indented half-space. In this particular study,
on the poly-l-lysine coated mica substrate and

is the deflection of the

is the deflection of the cantilever

is the deflection of the cantilever on the

indented erythrocyte surface.

Three important assumptions of the Hertz-Sneddon model are the following: (i) the indenter
must have a parabolic shape, (ii) the indented sample is assumed to be extremely thick in
comparison to the indentation depth, and (iii) there is no adhesive interaction between the
sample and the indenter. The first assumption remains a valid one for the case when a spherical
tip radius is much larger than the indentation depth (

< 0.3 ) [116]. The second assumption

states that elastic models based on Hertz-Sneddon contact mechanics are accurate when the
indentation depth is small compared to the thickness of the cell. This corresponds with the well
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known fact that the effect of the substrate over which the cells are placed is negligible if the
indentation depth is less than 10% of the total thickness of the specimen [117]. In cases where
the third assumption is not satisfied, the Johnson-Kendall-Roberts (JKR) model should be
employed to incorporate the effect of adhesion [118]. The JKR model considers the effect of
contact pressure and adhesion within the area of contact. In the current study, we did not
observe a pull-off force, or rupture force, in the experimental force-distance curves. This can be
attributed to the fact that our AFM indenter was not functionalized. Therefore, the HertzSneddon model appropriately describes the measurements in the present study.

While in the current work only the elastic behavior of RBCs is studied, RBCs have been found to
exhibit viscoelastic behavior under repetitive deformations [119]. The viscoelastic properties of
normal RBCs have been studied via magnetic twisting cytometry. Results indicate that

, the

storage modulus which represents the Young’s modulus, is nearly constant for different
frequencies, while

, the loss modulus, increases with frequency [119]. This result suggests

that the measurement of the effective Young’s modulus presented in this work remains valid
when repetitive loading is applied, at least for normal RBCs. Finally, it should be noted that AFM
has been used to measure the viscoelastic behavior of epithelial cells [102, 115]. In principle,
the employed methods can be used to perform viscoelasticity measurements on normal and
pathological RBCs.

Parabolic tip
When the shape of the AFM tip is approximated by a paraboloid with a radius of curvature
the apex, the force

as a function of indentation

equation [111-113]:
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at

is described by the following

(14)

where

is the reduced Young’s modulus of the tip-sample system defined as

(15)

in which

,

and

,

are the Young’s moduli and the Poisson ratios for the

materials of the tip and the sample, respectively. If
Young’s modulus is 150 GPa [103]),

(in the case of Si3N4 tips, the

can be simplified as:

(16)

Poisson’s ratio, , is defined as the ratio of the transverse, or orthongonal, strain to the strain
along the direction of elongation. It is useful for determining how much the material extends
orthogonally to the direction in which the force is applied. The value of

is always between 0

and 0.5 [120-121].

Pyramidal tip
When the shape of the AFM tip is a four-sided pyramidal indenter, the force
function of indentation

is described by the following equation [102, 110, 114-115]:
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as a

(17)

with an effective radius of contact

with

defined as nominal angle of the

pyramidal geometry [102, 114-115].

Adhesion measurements
In the past, RBC adhesion was traditionally investigated via large-scale flow adhesion assays
[122-125], which measure the average adherence of a large number of RBCs to a
functionalized-substrate under flow-induced shear stress [126-127]. These measurements
provide only estimates of the adhesion force to which cells are subjected because the shear
force exerted on cells in these assays depends on parameters such as cell size, cell shape, how
the cell attaches to the substrate, as well as the viscoelastic and elastic properties of the cells
[128-130]. For example, it is known that RBCs from SCD patients show variability in their
viscoelastic and elastic properties [100, 119], and these properties can change after
biochemical or pharmacologic treatment [87]. Specifically, RBCs from patients taking the drug
hydroxyurea are more compliant than RBCs from patients who are not taking the drug [77].
Further, given the nature of flow adhesion assays, they are unable to provide information
regarding receptor activity, including detachment forces, receptor localization, and changes in
the number of active receptors upon biochemical stimulation. To obtain more controlled and
quantitative measurements of RBC adhesion, single-cell methods must be employed.

AFM studies of RBC adhesion have been employed to provide quantitative evidence of changes
in surface receptor distribution, and unbinding forces with specific ligands [30]. A technique
known as SMFS utilizes cantilever tips functionalized with specific ligands to probe the cell
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surface. SMFS measures the unbinding, or detachment force, between a specific ligand on the
AFM tip and its corresponding receptor on a single cell with piconewton sensitivity [30, 90-92,
131-132]. Because SMFS is broadly used in conjunction with optical microscopy, the user has
the ability to choose a RBC of interest for measurements. SMFS operates by collecting a set of
force-distance curves of the approach-retract cycle of the functionalized tip from the cell surface.
Specifically, the retraction curve, obtained when the functionalized probe pulls away from the
RBC surface gives the detachment force. Individual approach/retract curves can be obtained at
many points on a sample to create a two-dimensional map of detected surface adhesion
receptors [30]. Forces probed by SMFS reflect interactions within or between molecules [133].
Specifically, this technique allows for (i) quantifying the detachment force of specific receptorligand bonds, (ii) mapping the distribution of active receptors on cellular surfaces with high
resolution, (iii) calculating the density of active receptors on the cell surface [90-91, 94-98].
While SMFS presents a very powerful tool to study RBC adhesion at the single-molecule level, it
cannot measure the overall adhesion of a living cell to a substrate or another living cell. Further,
it is currently unknown how SMFS measurements compare to whole cell measurements.

To overcome these limitations, SCFS assays, that are using a living cell as a probe, were
developed [130, 134-138]. This AFM-based method is highly versatile because of its ability to
measure a wide range of forces, from ~5 pN to ~100 nN [130]. In SCFS, a RBC attached to an
AFM cantilever is positioned above a functionalized substrate or another living cell. Similar to
SMFS measurements, SCFS also records force-distance curves of an approach/retract cycle
between the RBC probe and the functionalized substrate or cell. The RBC is lowered onto the
substrate until a preset contact force is reached, and then held stationary for a defined time.
Subsequently, the cell is withdrawn from the substrate at a constant speed and bonds between
the cell and substrate break sequentially until the two entities are completely separated. In this
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case, the maximum detachment force is characterized as the force required to fully remove the
RBC from the functionalized substrate.
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Chapter 3. Microelasticity of Red Blood Cells in Sickle Cell Disease

3.1. Abstract
Translation of cellular mechanics findings is crucial in many diseases, including Alzheimer’s
disease, Parkinson’s disease, type II diabetes, malaria, sickle cell disease, and cancer. Atomic
force microscopy (AFM) is appropriate for measuring mechanical properties of living and fixed
cells due to its high force sensitivity and its ability to measure local and overall properties of
individual cells under physiological conditions. A systematic force-displacement curve analysis
is reported on the quantification of material stiffness via AFM using two theoretical models
derived from the Hertz model. This analysis was applied to red blood cells from patients with
sickle cell disease to determine the Young’s modulus of these cells in the oxygenated and
deoxygenated state. Sickle cell disease pathophysiology is a consequence of the polymerization
of sickle hemoglobin in red blood cells upon partial deoxygenation and the impaired flow of
these cells in the microcirculation. We determined the model for a four-sided pyramidal indenter
to be a better fit for our application as compared to the model for a parabolic indenter. Our
findings conclude that deoxygenation and therapeutic treatment have a significant impact on the
stiffness. This analysis presents a new approach to addressing medical disorders.

3.2. Introduction
A detailed knowledge of the mechanical properties of the cell is required in understanding how
mechanical stresses and deformations regulate cellular functions including fundamental cell
processes including mechanotransduction, growth, differentiation, protein and DNA synthesis,
motility, and apoptosis [139-140]. The most common approach reported to study cell mechanics
is to determine the stiffness or an apparent elastic modulus of the cell, assuming that it is an
elastic body. Atomic force microscopy (AFM) [89] is appropriate for measuring the mechanical
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properties of living and fixed cells due to its high force sensitivity and its ability to measure local
and overall properties of individual cells under physiological conditions [101, 141-146]. AFM
allows simultaneous evaluation of the local mechanical properties and the morphology of the
living cells at a high spatial resolution and force sensitivity. The basic technique for quantitative
study of mechanical characteristics of cells and tissues via AFM is the force-displacement curve
analysis. By recording the force-displacement curves on the sample surface, vertical deflection
of the cantilever represents a basis for estimation of sample Young’s modulus. In the current
study, we apply the force-displacement curve analysis to explore the pathophysiology of sickle
cell disease. Understanding the relationship between proteins and cellular material properties
will allow for detection of diseases and new approaches to addressing medical disorders [147].

3.3. Sickle Cell Disease
In the current study, we measure the Young’s modulus of red blood cells (RBCs, erythrocytes)
from patients with sickle cell disease (SCD), a severe disease caused by polymerization of
abnormal hemoglobin [148], a globular protein which transports oxygen from the lungs to
tissues [59] . Hemoglobin (Hb) is formed by four polypeptide chains, two of type α and two of
type β. In sickle cell hemoglobin (HbS), the normal sequence of Val-His-Leu-Thr-Pro-Glu-GluLys is changed to Val-His-Leu-Thr-Pro-Val-Glu-Lys, with the amino acid valine substituting for
the glutamic acid in the β6 site. The replacement of two charged groups by two hydrophobic
ones leads to polymerization of deoxygenated Hb and to formation of long stiff rodlike fibers [33,
35-36], which force RBCs to assume a wide variety of irregular shapes [37]. The fibers form
noncovalent cross-links and create a gel that gives RBCs their irregular shapes and alters their
viscoelastic behavior, increases their rigidity, fragility, and cytoadherence [36, 69-70]. Other
factors such as lowered pH, RBC dehydration and hyperthermia are also known to prompt
sickling [38]. Pathology in SCD begins with loss of deformability and increased cell adherence of
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the sickle cells resulting in serious and often life threatening complications such as chronic
hemolytic anemia and vaso-occlusion [31, 64, 67, 69]. Persons with sickle cell trait (SCT) have
only one abnormal hemoglobin β gene producing thus both normal hemoglobin (HbA) and sickle
hemoglobin HbS with a prevalence of HbA [44-45].

In the case of SCD, it has been hypothesized that increased association of HbS with the
membrane proteins contributes to the change of the mechanical behavior of sickle erythrocytes
[149]. HbS could alter the mechanical properties of RBCs not only by extending the spectrin
filaments, and by the interaction between HbS filaments and the lipid bilayer but also by altering
the functionality of the membrane proteins [150]. It is known that Hb interacts with the spectrin
network via the protein band 3 [40, 151-152] and the introduction of HbS has recently been
found to have an effect on the mechanical properties of SCT erythrocytes [93]. In the present
study, we employ AFM techniques to measure the Young’s modulus of RBCs from patients with
SCD under both oxygenated and fully deoxygenated conditions.

3.4. Atomic Force Microscopy Probing of Cell Elasticity
In the current work, we perform nanoindentation of RBCs to measure the local cell stiffness. The
measurements are performed via AFM by pushing a tip onto the surface of the sample at the
position of interest. From the resulting force-displacement curves the local Young’s modulus is
determined.

Introduction to contact problems
The general theory of elasticity has been applied to AFM measurements based on the contact
theory of Hertz and Sneddon [105-107]. AFM stiffness measurement is modeled as indentation
of an elastic half-space,

< 0, by a frictionless rigid punch [108], as shown in Figure 3.4.1. The
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profile of the punch is described by the function

, and

is the normal deformation

of the indented elastic half-space surface. In this case, the half-space represents the indented
RBC. The gap

between the punch and the half-space is defined as

.

(1)

Figure 3.4.1. The general indentation problem for a smooth, rigid, frictionless punch.

When the shape of the employed indenter exhibits a two-fold symmetry (e.g. pyramidal or
parabolic) then the contact area
with the center of

preserves the same symmetry as the base of the indenter,

at the coordinate origin (

= 0,

normal to the surface and are compressive inside

= 0,

= 0). The contact tractions act

and zero exactly at the contact perimeter,

as well as outside .

The gap is zero within the contact region

and positive in the separation region

, since

interpenetration of material is prohibited. Therefore, we have two conditions

; in

(2)

; in .

(3)
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The definition of the frictionless contact problem is completed by assuming that the tangential
traction is zero throughout the surface of the half-space,

; all

(4)

and that the contact pressure

is zero in the separation region

and

positive in the contact region , that is

in

(5)

in .

(6)

If the contact region A is specified, the equality conditions (2), (4), (5) define a well-posed
boundary value problem for the half-plane which has a unique solution. Then the total contact
force is obtained by

(7)

The inequalities (3) and (6) serve to determine the extent of the contact area for the contact
problem, but it has been shown [109] that the value of , which satisfies (3) and (6), maximizes
the total force

given by equation (7).

In the case of a spherical indenter, by solving the boundary contact problem as performed by
Hertz [106], the following result is obtained,
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(8)

where

is the distance between source

observation point

;

is the angular distance and

Young’s modulus. The contact radius,

and

, where

, is given in terms of the applied force,

is the

, and the

Poisson’s ration, , of the sample

(9)

Sneddon extended the Hertz model from a spherical indenter to an indenter of arbitrary profile
deforming elastic half space [107, 110]. Solutions of the boundary contact problem for other tip
geometries with two-fold symmetry generated models for parabolic [111-113] and pyramidal
[102, 110, 114-115] indenters. The general solution for force as a function of indentation for a
parabolic indenter can be approximated as

(10)

where

is the reduced Young’s modulus of the tip-sample system defined as

(11)
The general solution for force as a function of indentation for a pyramidal indenter [102, 114115] can be approximated as
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(12)

Atomic force microscopy contact problems
In a force curve on a sample indented via AFM, the indentation,

, is equal to

(13)

where

is the deflection of the cantilever on the rigid substrate and

cantilever on the indented half-space. In this particular study,
on the poly-l-lysine coated mica substrate and

is the deflection of the

is the deflection of the cantilever

is the deflection of the cantilever on the

indented erythrocyte surface.

Three important assumptions of the Hertz-Sneddon model are the following: (i) the indenter
must have a parabolic shape, (ii) the indented sample is assumed to be extremely thick in
comparison to the indentation depth, and (iii) there is no adhesive interaction between the
sample and the indenter. The first assumption remains a valid one for the case when a spherical
tip radius is much larger than the indentation depth (

< 0.3 ) [116]. The second assumption

states that elastic models based on Hertz-Sneddon contact mechanics are accurate when the
indentation depth is small compared to the thickness of the cell. This corresponds with the well
known fact that the effect of the substrate over which the cells are placed is negligible if the
indentation depth is less than 10% of the total thickness of the specimen [117]. In cases where
the third assumption is not satisfied, the Johnson-Kendall-Roberts (JKR) model should be
employed to incorporate the effect of adhesion [118]. The JKR model considers the effect of
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contact pressure and adhesion within the area of contact. In the current study, we did not
observe a pull-off force, or rupture force, in the experimental force-distance curves as shown in
Figure 3.4.2. This can be attributed to the fact that our AFM indenter was not functionalized.
Therefore, the Hertz-Sneddon model appropriately describes the measurements in the present
study.

Figure 3.4.2. Force-distance curves obtained during the retraction cycle of the indention. The
absence of a pull-off force, or rupture force, indicates that there is no adhesion present between
the sample and the indenter during experimentation.

While in the current work only the elastic behavior of RBCs is studied, RBCs have been found to
exhibit viscoelastic behavior under repetitive deformations [119]. The viscoelastic properties of
normal RBCs have been studied via magnetic twisting cytometry. Results indicate that

, the

storage modulus which represents the Young’s modulus, is nearly constant for different
frequencies, while

, the loss modulus, increases with frequency [119]. This result suggests

that the measurement of the effective Young’s modulus presented in this work remains valid
when repetitive loading is applied, at least for normal RBCs. Finally, it should be noted that AFM
has been used to measure the viscoelastic behavior of epithelial cells [102, 115]. In principle,
the employed methods can be used to perform viscoelasticity measurements on normal and
pathological RBCs.
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Parabolic tip
When the shape of the AFM tip is approximated by a paraboloid with a radius of curvature
the apex, the force

as a function of indentation

at

is described by the following

equation [111-113]:

(14)

where

is the reduced Young’s modulus of the tip-sample system defined as

(15)

in which

,

and

,

are the Young’s moduli and the Poisson ratios for the

materials of the tip and the sample, respectively. If
Young’s modulus is 150 GPa [103]),

(in the case of Si3N4 tips, the

can be simplified as:
(16)

Poisson’s ratio, , is defined as the ratio of the transverse, or orthongonal, strain to the strain
along the direction of elongation. It is useful for determining how much the material extends
orthogonally to the direction in which the force is applied. The value of
and 0.5 [120-121].
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is always between 0

Pyramidal tip
When the shape of the AFM tip is a four-sided pyramidal indenter, the force
function of indentation

as a

is described by the following equation [102, 110, 114-115]:

(17)

with an effective radius of contact

with

defined as nominal angle of the

pyramidal geometry [102, 114-115].

3.5. Methods
Experiments were carried out using an Asylum MFP 3D-BIO (Asylum Research, Santa Barbara,
CA) AFM equipped with a “liquid cell” setup.

Red blood cell preparation
Whole blood was drawn from patients with sickle cell disease during clinical visits to the Lea
Center for Hematologic Disorders at the University of Connecticut Health Center (UCHC)
following the guidelines of the Human Subjects Protection Office at UCHC. Blood was drawn by
venipuncture into 5 IU/ml heparin and centrifuged at 400 g for 15 min at 25°C to isolate the
RBCs. The yellowish supernatant containing plasma and the white fluffy coat on the pellet was
discarded. All buffers were pre-warmed to 37°C prior to use. RBCs were washed three times
with phosphate-buffered saline (PBS) and finally re-suspended in PBS at a concentration 5%.
Deoxygenated red blood cells were obtained by bubbling N2 through a suspension of RBCs in a
sealed flask for 1 hr. The state of deoxygenation of the erythrocytes was expected to be
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maintained for 1-1.5h [153] and experiments were performed during this time.

Erythrocyte immobilization
Cells were immobilized on AFM grade mica (Novascan Technologies, Inc., Ames, IA) coated
with poly-L-lysine (PLL) (Sigma-Aldrich, St. Louis, MO) to increase cell adherence. 150 μl of 1
mg/ml PLL solution was allowed to adsorb for 5 min to an unmodified mica surface, and excess
solution was drained away. RBCs of 0.5% concentration in PBS were allowed to adhere to each
PLL-coated mica surface for 10 min in the incubator. Unattached cells were removed by gentle
rinsing of the slide with PBS solution at 25°C. For imaging, fixation was performed by a 1-min
treatment of the cells with 0.5% glutaraldehyde (Sigma-Aldrich, St. Louis, MO) in PBS buffer.
The sample was again rinsed several times with PBS and a volume of PBS was added for
experiments. Glutaraldehyde was not employed for stiffness measurements.

Imaging
Erythrocytes were imaged in tapping mode with a scan rate of 0.2 Hz, and the minimal force
necessary to obtain good image contrast was determined by gradually increasing the force
applied to the sample from zero force (noncontact) to the necessary minimal force. Silicon
nitride probes with a nominal spring constant of 0.01 N/m (Veeco Probes, Camarillo, CA) were
employed for imaging.

Measurements
Erythrocyte’s stiffness measurements were carried out in contact mode using silicon nitride
cantilevers with a nominal spring constant of 0.03 N/m (Veeco Probes, Camarillo, CA). Exact
values for the cantilever spring constants were obtained via a thermal noise based method
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implemented by the manufacturer and were used in all calculations. Probes had nominal tip radii
of 20 nm and nominal angle

of 20°, as provided by the manufacturer. Tip height was 2.5

µm, as provided by the manufacturer. All measurements were performed in PBS at 25°C. Local
elastic properties of erythrocytes were quantitatively determined from the force-distance curves.
The force curves were generated at a loading rate of 15,000 pN/s, and for both states,
oxygenation and deoxygenation, more than 500 measurements were collected.

Data processing
Data was imported into MATLAB (The MathWorks, Natick, MA) and the value of E was
obtained by fitting the theoretical curves generated by Eq. (2) and Eq. (5) to the experimental
data up to a minimum depth of 250 nm, which is approximately 10% of the total thickness of the
cell. The method is in agreement with the well known fact that the effect of the substrate over
which the cells are placed is negligible if the indentation depth is less than 10% of the total
thickness of the specimen [117].

3.6. Results
Morphology of SCD erythrocytes via AFM imaging
Under both oxygenated and deoxygenated states, highly irregular morphologies were observed
in the RBC samples. Normal RBCs are characterized by a biconcave shape which not only
increases the surface area and facilitates O2 and CO2 diffusion into and out of the cell [59-60]
but also increases the compliance of the erythrocytes [61]. Polymerization of Hb fibers forces
RBCs to assume a wide variety of irregular shapes [37]. Two representative examples are
shown in Figure 3.6.1. Repeated cycles of oxygenation and deoxygenation lead to irreversible
sickling, a phenomenon we suspect has occurred to the erythrocyte in Figure 2.6.1A, imaged
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under oxygenated conditions. This cell is characterized by protrusions likely resulting from
polymerized Hb fibers and also an enlarged morphology. Upon deoxygenation, as in Figure
2.6.1B, HbS fibers are expected to polymerize and aggregate, thus forming the highly elongated
and irregular structure shown. In addition, this cell also contains bumps and surface
irregularities which are possibly associated with protruding polymerized HbS fibers and changes
in the RBC membrane cortex.

Figure 3.6.1. Three-dimensional topographical images of SCD erythrocytes obtained via AFM
(A) in an oxygenated environment and (B) in a fully deoxygenated state. Both RBCs have a
highly irregular morphology as compared to the characteristic biconcave shape of a normal
erythrocytes. It is evident that polymerized Hb results in highly irregular RBC morphologies
characterized by protrusions, elongation, bumps, and enlargement associated with aggregation
of HbS fibers.
Determination of the indentation depth
The quantitative determination of the elastic properties of a particular material can be obtained
from the relationship between the applied force

and the indentation depth

using Eq. (14)

and Eq. (17). When force is measured on a hard substrate, the cantilever deflection is
proportional to the relative sample position resulting in a linear slope for the portion of the curve
where the tip and the sample are in contact. When soft samples like erythrocytes are
investigated, the recorded cantilever deflection as a function of the relative sample position is
not linear due to the deformable structure of the RBC. Prior to taking force measurements on
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the RBC surface, the force is measured on the PLL-coated mica substrate. This curve is used
for calibration since no permanent sample deformation is observed. The indentation produced
by the AFM tip was determined by subtracting the calibration curve from the curve recorded for
the erythrocyte using the Igor Pro 6.04 (Wavemetrics, Portland, OR) software program.

Force-displacement curve analysis
The MATLAB output of both the pyramidal indenter model obtained from Eq. (17) and the
parabolic indenter model obtained from Eq. (14) fit to the force v. indentation curve obtained via
experimentation is shown in Figure 3.6.2. The model of the pyramid indenter appears to provide
a better fit, as shown by the representative curves shown in Figure 3.6.2. At small Young’s
modulus values (

< 3 kPa), as in Figure 3.6.2A and Figure 3.6.2B, we observed that both the

pyramid model and the parabolic model appeared to fit the experimental force-displacement
curves to a minimum depth of 250 nm, which is approximately 10% of the thickness of the cell
[112].

However, as indentation continues, the pyramid model continues to follow the trend of the
experimental force-displacement curves while the paraboloid model greatly diverges. As the
stiffness of the erythrocyte’s increased, the pyramid model continued to provide a more
accurate fit to the experimental data as shown in Figure 3.6.2C and Figure 3.6.2D. Although the
paraboloid model appears to fit the data up to 50 nm indentations, the pyramid model continues
to fit the data up to approximately 250 nm, representative of 10% of the total thickness of the
cell. Based on our theoretical model analysis, we opted to continue our cell stiffness analysis via
the model for the four-sided pyramidal indenter.
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Figure 3.6.2. Theoretical models for a pyramid indenter and a parabolic indenter fitted to the
experimental data for clinical SCD erythrocytes obtained via AFM. In these curves, the Young’s
modulus values are (A) 0.65 kPa, (B) 1.20 kPa, (C) 8.50 kPa, and (D) 13.0 kPa. The curves
shown above are representative of force curves obtained for all SCD clinical samples of varying
stiffness values. From the given data at a broad range of Young’s modulus values, it appears
that the pyramid indenter model provides a better fit. Legend in (A) applies for all.
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Figure 3.6.3. Experimental data for Young’s modulus. (A) The data above show the theoretical
pyramid model (Eq. 4) fitted to the experimental data for normal, SCT, and SCD erythrocytes. In
these curves, the Young’s modulus values for the normal, SCT, and both oxygenated and
deoxygenated SCD RBCs are 1.30, 3.30 kPa, and 7.0 kPa, respectively. Curves shown are
representative of the 500-600 force curves obtained for each normal and SCT RBCs, and
1000+ curves for SCD clinical samples. (B) Histograms of the Young’s modulus values
determined for RBCs from normal, SCT, and both oxygenated and deoxygenated SCD
erythrocytes. Values for normal RBCs are
= 1.10 kPa ± 0.40 kPa and SCT RBCs are
= 3.05 kPa ± 1.09 kPa. SCD clinical samples reveal a bimodal distribution with
= 1.0
kPa ± 1.1 kPa, and
= 3.0 ± 2.7 kPa, as well as higher ( > 7.0 kPa) values.

Cell stiffness determination
A representative curve showing experimental data for erythrocytes from patients with SCD is
shown in Figure 3.6.3A. This data was fitted to the theoretical pyramid model and theoretical
pyramid model curves representative of normal and SCT erythrocytes also shown for
comparison. The average values of Young’s modulus for oxygenated and deoxygenated SCD
erythrocytes were obtained by fitting the Gaussian distribution to the generated histograms of
the measured Young’s modulus values (Figure 3.6.3B). It appears that both oxygenated and
deoxygenated sickle cell disease RBCs maintain a bimodal distribution with peaks at
kPa ± 1.1 kPa, and

= 1.0

= 3.0 ± 2.7 kPa. A similar value has been found via optical tweezers

[154]. By overlaying the histogram of the distribution of oxygenated SCD erythrocyte elasticity
values atop the normal and SCT distribution, it is evident that each peak in the focused sickle
cell disease erythrocyte distribution corresponds to the same Young’s modulus value as the
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SCT and normal RBCs, 3.0 kPa and 1.0 kPa, respectively [93]. As seen in Figure 3.6.4,
oxygenated RBCs have an additional peak at approximately 15 kPa, while deoxygenated RBCs
have an additional peak at approximately 40 kPa.

Figure 3.6.4. Histograms of the Young’s modulus determined for sickle cell disease RBCs
maintained in oxygenated and deoxygenated environments. The Young’s modulus values
obtained from fitting the theoretical pyramid indenter model to the experimental data were fitted
with the Gaussian distribution. The full distribution shows evidence of an additional peak
appearing around 15 kPa for the oxygenated RBCs and 40 kPa for the deoxygenated RBCs.

3.7. Discussion
The Young’s modulus is the basic material coefficient of elasticity. It can range from ~100 GPa
for high-strength materials (steel, titanium) [155-156] to 100s MPa for typical polymers
(polystyrene), and 1 MPa for soft gel-like materials (gelatin in its gel-phase) [156]. Typical
values for cells range from 1 kPa to 100 kPa [143-144, 157-163]. In the present study, we
determined that sickle erythrocytes possess Young’s modulus values between 1-60 kPa
depending on their degree of oxygenation and the percentage of HbS present in the
erythrocytes. Both oxygenated and deoxygenated samples of RBCs from patients with SCD
maintain a bimodal distribution with peaks representative of normal RBCs (
kPa) and SCT RBCs (

= 1.0 kPa ± 1.1

= 3.0 ± 2.7 kPa) [93]. Evidence of an additional peak is also present for

both oxygenated and deoxygenated samples at
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= 15 kPa and

= 40 kPa, respectively. The

large variation and presence of multiple peaks within the distribution can likely be attributed to
patient treatment with hydroxyurea.

Significantly higher Young’s modulus values resulting in peaks at
cells and

= 15 kPa for oxygenated

= 40 kPa for deoxygenated cells are a result of the presence of polymerized HbS in

the RBC samples from SCD patients. At high concentrations, deoxy sickle hemoglobin results in
the formation of a seven stranded polymer structure which increases RBC rigidity [164].
Polymerization of deoxygenated HbS is dependent on intraerythrocytic HbS concentration,
degree of cell oxygenation, pH, and the intracellular concentration of HbF. Polymerized HbS
fibers form noncovalent cross-links and create a gel that results in increased rigidity of RBCs
[36, 69-70]. In addition, spectrin, which is the main protein responsible for the mechanical
strength of the erythrocyte, has been found to bind to hemoglobin via the Band 3 protein that
binds almost exclusively to hemoglobin fibers [152, 165]. Thus, in the deoxygenated state,
interaction between the HbS fibers that are connected to the membrane and the HbS fibers in
the cytoplasm could also contribute to the measured increase in stiffness [166]. Our data
present evidence of a minimal doubling of the Young’s modulus upon full deoxygenation of SCD
erythrocytes. This can present major problems in SCD patients because rigid sickle RBC can
cause microcirculatory obstruction, resulting in vaso-occlusive crisis.

Small Young’s modulus values found in the present study for both oxygenated and
deoxygenated SCD erythrocytes are likely due to hydroxyurea treatment, a variable in the
obtained clinical samples. Hydroxyurea is the only approved medication for the treatment of
sickle cell disease in adults; there are no approved drugs for children [7, 77]. Hydroxyurea
stimulates the production of fetal hemoglobin (HbF) in patients with SCD, which inhibits sickling
[167] by preventing effective contact between adjacent HbS molecules and also by forming
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mixed hybrids with HbS that have greater solubility than HbS polymers [77]. Increases in HbF
contribute to an increase in total Hb and a decrease in hemolysis with the release of free
hemoglobin [7]. It has been proposed that hydroxyurea increases HbF indirectly by killing rapidly
dividing late erythroid cells, causing recruitment of more primitive erythroid precursors which in
turn produce high levels of HbF, or by acting directly on the primitive precursors thereby
stimulating HbF production, the exact mechanism by which hydroxyurea induces HbF is unclear
[77].

In summary, the present study suggests a significant impact of deoxy sickle hemoglobin in
significantly increasing the rigidity of SCD erythrocytes, thus resulting in vaso-occlusive crisis.
Our data conclude that Young’s moduli and standard deviations were
and

= 1.0 kPa ± 1.1 kPa

= 3.0 ± 2.7 kPa for both oxygenated and deoxygenated SCD erythrocytes.

Deoxygenated SCD erythrocytes also possessed an additional peak at

= 40 kPa, while

oxygenated SCD erythrocytes possessed an additional peak at the significantly lower value of
= 15 kPa. However, in contrast to normal RBCs and sickle trait RBCs, SCD erythrocytes
substantially deviate from the characteristic biconcave shape and possess highly irregular
morphologies characterized by protrusions, elongation, bumps, and enlargement associated
with aggregation of HbS fibers.
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Chapter 4. Sickle Cell Trait Human Erythrocytes Show a Significant Increase in
their Stiffness Compared to Erythrocytes from Healthy Individuals

4.1. Abstract
Atomic force microscopy (AFM) allows for high-resolution topography studies of biological cells
and measurement of their mechanical properties in physiological conditions. In this work, AFM
was employed to measure the stiffness of abnormal human red blood cells (RBCs) from patients
with the genotype for sickle cell trait. The determined Young’s modulus was compared with that
obtained from measurements of erythrocytes from healthy subjects. The results showed that the
Young’s modulus of pathological erythrocytes was approximately three times higher than in
normal cells. Observed differences indicate the effect of the polymerization of hemoglobin S as
well as possible changes in the organization of the cell cytoskeleton associated with the sickle
cell trait.

4.2. Introduction
Sickle cell disease (SCD) is an inherited blood disorder caused by a single point mutation in one
of the genes encoding hemoglobin. Four polypeptide chains, two of type α and two of type β,
form the globular protein Hb. In sickle cell hemoglobin (HbS), the normal sequence of Val-HisLeu-Thr-Pro-Glu-Glu-Lys is changed to Val-His-Leu-Thr-Pro-Val-Glu-Lys, with the amino acid
valine substituting for the glutamic acid in the β6 site. The replacement of two charged groups
by two hydrophobic ones leads to polymerization of deoxygenated Hb and to formation of long
stiff rodlike fibers [33, 35-36] which force RBCs to assume a sickle shape. Other factors such as
lowered pH, RBC dehydration and hyperthermia are also known to prompt sickling [52]. Healthy
RBCs are very deformable and easily pass through narrow capillaries during their approximately
three-month life span. The characteristic biconcave shape of RBCs does not only increase the
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surface area and facilitate O2 and CO2 diffusion into and out of the cell [59-60] but it has been
shown that it is compatible with the increased compliance of the erythrocytes [61]. The
abnormal morphology and rheology of the sickle cells triggers the obstruction of the
microvasculature which results to the development of hypoxia, vaso-occlusive crisis and organ
damage.

SCT has a very significant social impact because approximately three million people in the
United States have this genotype, making it 40 to 50 times more prevalent than SCD [46].
People with sickle cell trait do not have the symptoms of SCD [168] and thus SCT is not usually
regarded as a disease state because it has complications that are either uncommon or mild
[46]. Although SCT is considered to be benign, in extreme conditions including hypoxia,
acidosis, dehydration, hyperosmolarity, or elevated erythrocyte 2,3-diphosphoglycerate (DPG),
individuals with SCT can develop a syndrome resembling SCD with vaso-occlusive sequelae
resulting from rigid erythrocytes [46, 49-50, 56]. Other complications associated with SCT
include increased urinary tract infection in women, gross hematuria, complications of hyphema,
splenic infarction with altitude hypoxia or exercise, and life-threatening complications of
exercise, exertional heat illness (exertional rhabdomyolysis, heat stroke, or renal failure) or
idiopathic sudden death [46, 53, 57].

The red cell membrane derives its resilience and resistance to mechanical stresses from the
membrane skeleton, a hexagonal lattice network composed of spectrin tetramers. These are
formed by the side-by-side alignment of pairs of heterodimers attached at their ends to
complexes consisted mainly of actin and of several other proteins [59-60, 169]. Horizontal
connections between the spectrin filaments are formed at the actin junctions with proteins such
as protein 4.1R, tropomyosin, tropomodulin, and adducing. Vertical connections between the
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spectrin network and the lipid bilayer are formed at the ankyrin linkers which connect the βspectrin filaments to the band 3 protein along with protein 4.2 (pallidin). A second type of vertical
connection is formed at the actin junctions where, protein 4.1 binds the spectrin network to the
lipid bilayer via the integral protein, glycophorin C [60, 170-171]. Mutations in membrane
proteins related to vertical connections cause hereditary spherocytosis related to membrane
loss because of reduced support to lipid bilayer. Mutations in proteins associated to horizontal
connections cause hereditary elliptocytosis [172].

Normal erythrocytes in adults contain approximately 250 million adult hemoglobin (HbA)
molecules, totaling 25-30% of the cell [33]. Sickle cell trait (SCT, sicklemia), in contrast, is
marked by the presence of both HbS and HbA. Sickle hemoglobin comprises approximately 2046% of the total hemoglobin content in persons with sickle cell trait [44], with most individuals
having 40-42% HbS [45]. In the case of SCD, it has been hypothesized that increased
association of HbS with the membrane proteins contributes in the change of the mechanical
behavior of Sickle cells [149]. HbS could alter the mechanical properties of RBCs not only by
extending the spectrin filaments, and by the interaction between HbS filaments and the lipid
bilayer but also by altering the functionality of the membrane proteins [150]. There is
considerable evidence that HbS is associated with the inner membrane of RBCs and in
particular with the cytoplasmic tail of the band 3 protein [33].

Many case studies have shown that translation of cellular mechanics findings is crucial in many
diseases, including Alzheimer’s disease, Parkinson’s disease, type II diabetes, malaria, sickle
cell disease, and most recently cancer [144, 147]. Understanding the relationship between
proteins and cellular material properties will allow for detection of diseases and new approaches
to addressing medical disorders [147]. Recently, atomic force microscopy methods have shown
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that the stiffness of metastatic cancer cells is more than 70% softer than their benign
counterparts [144]. Because these findings correlate well with the commonly employed
immunohistochemical testing, it is reasonable to argue that AFM methods can enhance cancer
detection methods. SCD is a characteristic case where molecular changes in a protein alter
their structural properties causing the initiation of a disease state. Additional reason for the SCD
is the increased adherence of sickle cells on the endothelial cells and on leucocytes which can
generate an inflammation and chronic vasculopathy [34]. AFM can return information not only
on the stiffness of the cells but also on the specific interaction between proteins expressed on
the cellular erythrocyte membrane and proteins expressed on leucocytes, on endothelial cells
and/or the extracellular matrix [34]. Because of this characteristic, AFM could decisively
enhance our knowledge on the biology and consequently on the therapy of SCD.

Characterization of erythrocyte mechanical properties has been conducted via micropipette
aspiration [173-174], cell poking [175], atomic force microscopy [111-112, 117], optical tweezers
[176-177], optical stretching [177-178], and magnetic tweezers [119], and magnetic twisting
cytometry [179]. However, values of mechanical moduli derived from experimental data tend to
vary largely based on which of the aforementioned techniques is used [180]. In the present
student, we quantified the stiffness of erythrocytes from patients with the genotype for sickle cell
trait using atomic force microscopy, a tool for imaging and characterization of materials at the
nanometer scale [89]. The high force sensitivity of AFM and its ability to measure local and
overall properties of individual cells under physiological conditions make this technique
particularly appropriate for measuring the mechanical properties of living and fixed cells [101,
112, 117, 181-182]. We established that the stiffness of cells from patients with the genotype for
SCT was approximately three times greater than normal RBCs.
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4.3. Methods
AFM allows for high-resolution topography studies of biological cells and measurement of their
mechanical properties in physiological conditions [183]. Experiments were carried out using an
Asylum MFP 3D-BIO (Asylum Research, Santa Barbara, CA) AFM equipped with a “liquid cell”
setup. Normal RBCs and RBCs from patients with the sickle cell trait were purchased from
Research Blood Components, LLC (Brighton, MA). RBCs were maintained in PBS at room
temperature during experiments.

Erythrocyte immobilization
Cells were immobilized on AFM grade mica (Novascan Technologies, Inc., Ames, IA) coated
with poly-L-lysine (PLL) (Sigma-Aldrich, St. Louis, MO) to increase cell adherence. 150 μl of 1
mg/ml PLL solution was allowed to adsorb for 5 min to an unmodified mica surface, and excess
solution was drained away. RBCs of 0.5% concentration in PBS were allowed to adhere to each
PLL-coated mica surface for 10 min in the incubator. Unattached cells were removed by gentle
rinsing of the slide with PBS solution at 25°C. For imaging, fixation was performed by a 1-min
treatment of the cells with 0.5% glutaraldehyde (Sigma-Aldrich, St. Louis, MO) in PBS buffer.
The sample was again rinsed several times with PBS and a volume of PBS was added for
experiments. Glutaraldehyde was not employed for stiffness measurements.

Erythrocyte imaging
Erythrocytes were imaged in tapping mode with a scan rate of 0.2 Hz, and the minimal force
necessary to obtain good image contrast was determined by gradually increasing the force
applied to the sample from zero force (noncontact) to the necessary minimal force. Silicon
nitride probes with a nominal spring constant of 0.01 N/m (Veeco Probes, Camarillo, CA) were
employed for imaging. While the characteristic biconcave shape was observed for the fixed
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normal erythrocyte (Figure 4.3.1A) the SCT erythrocyte

appeared to have an irregular

biconcave shape accompanied by a decrease in size which is most likely due to dehydration
associated with the polymerization of HbS (Figure 4.3.1B).

Figure 4.3.1. Three-dimensional topographical images of RBCs from a (A) normal subject and
(B) a patient with the SCT genotype measured by AFM. While the normal RBC has the
characteristic biconcave shape, the SCT erythrocyte has an irregular biconcave morphology. In
addition, the SCT erythrocyte is smaller than the normal erythrocyte, most likely due to
dehydration associated with HbS polymerization.

Cell stiffness determination
Stiffness measurements were carried out in contact mode using silicon nitride cantilevers with a
nominal spring constant of 0.03 N/m (Veeco Probes, Camarillo, CA). Exact values for the
cantilever spring constants were obtained via a thermal noise based method implemented by
the manufacturer and were used in all calculations. Probes had nominal tip radii of 20 nm and
nominal angle of 20°, as provided by the manufacturer. The force curves were generated at a
loading rate of 10,000 pN/s, and for each cell type between 500-600 measurements were
collected.

The Young’s modulus was calculated using the Hertz model describing the elastic deformation
of the two bodies in contact under load. This theory was extended by Sneddon assuming an
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appropriate shape of indenter deforming elastic half space [107, 110]. It characterizes the
relationship between the applied force and the indentation depth [142, 184]. When the shape of
the AFM tip is a four-sided pyramidal indenter, the force as a function of indentation is described
by the following equation:

F

3E tan  2

4(1  2 )

(1)

where E and  are the Young’s modulus and the Poisson’s ratio of the cell, respectively [102,
114-115]. The Poisson ratio used in the present study was assumed to be 0.5 [111].

Figure 4.4.1. Theoretical model for a pyramidal shaped indenter fitted to the experimental data
for normal and SCT erythrocytes obtained via AFM. In these curves, the Young’s modulus
values for the normal and SCT cell are 1.30 and 3.30 kPa, respectively. The curves shown
above are representative of the 500-600 force curves obtained for each normal and SCT
erythrocytes. Minor variations can be seen in other curves obtained during experimentation,
representative of the standard deviation we observe in the calculation of the Young’s modulus.
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4.4. Results
Determination of the indentation depth
The quantitative determination of the elastic properties of a particular material can be obtained
from the relationship between the applied force F and the indentation depth

 using Eq. (1).

When force is measured on a hard substrate, the cantilever deflection is proportional to the
relative sample position resulting in a linear slope for the portion of the curve where the tip and
the sample are in contact. When soft samples like erythrocytes are investigated, the recorded
cantilever deflection as a function of the relative sample position is not linear due to the
deformable structure of the RBC. Prior to taking force measurements on the RBC surface, the
force is measured on the PLL-coated mica substrate. This curve is used as calibration curve
since no permanent sample deformation is observed.

The indentation produced by the AFM tip was determined by subtracting the calibration curve
from the curve recorded for the erythrocyte using the Igor Pro 6.04 (Wavemetrics, Portland, OR)
software program. The force vs. indentation curves obtained for normal erythrocytes indicate a
greater compliance than that of the sickle trait RBCs.

Data processing
Data was imported into MATLAB (The MathWorks, Natick, MA) and the value of E was
obtained by fitting the theoretical curve generated by Eq. (1) to the experimental data up to a
minimum depth of 250 nm, which is approximately 10% of the total thickness of the cell. The
method is in agreement with the well known fact that the effect of the substrate over which the
cells are placed is negligible if the indentation depth is less than 10% of the total thickness of
the specimen [117]. Figure 4.4.1 shows the MATLAB output of the pyramidal indenter model fit
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to the force v. indentation curve obtained via experimentation. It appears that the theoretical
model for a pyramidal indenter fits the SCT data up to a greater indentation depth (700 nm) than
that of the normal RBC (400 nm), indicating that SCT follow the elastic model for larger
indentation depth.

The average values of Young’s modulus for normal erythrocytes and SCT erythrocytes were
obtained by fitting the Gaussian distribution to the generated histograms of the measured
Young’s modulus values (Figure 4.4.2A-B, respectively). The measured Young’s moduli and
standard deviations were: E1 = 1.10 kPa, σ1 = 0.40 kPa, and E2 = 3.05 kPa, σ2 = 1.09 kPa, for
normal and sickle cell trait, respectively.

Figure 4.4.2. Histograms of the Young’s modulus determined for RBCs from (A) normal and (B)
sickle cell trait blood samples. The Young’s modulus values obtained from fitting the theoretical
model to the experimental data were fitted with the Gaussian distribution. Normal RBCs are
more elastic and their Young’s modulus values have a lesser standard deviation (E1 = 1.10 kPa,
σ1 = 0.40 kPa) while SCT erythrocytes have a stiffness approximately three times greater as
well as a larger standard deviation (E2 = 3.05 kPa, σ2 = 1.09 kPa). The observed increase in
stiffness for the pathological erythrocytes is likely due to changes in the affinity of spectrin and
actin filaments resulting from the presence of abnormal hemoglobin, HbS.
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4.5. Discussion
The main goal of this work was the determination of the erythrocyte’s stiffness in blood samples
taken from patients with the sickle cell trait genotype. The obtained Young’s modulus of
erythrocytes from patients with SCT was approximately three times larger than that of normal
erythrocytes.

Hemoglobin S is responsible for converting normal RBCs into “sickled” cells in patients with SSSCD. At high concentrations, deoxy sickle hemoglobin results in the formation of a seven
stranded polymer structure which increases RBC rigidity [164]. As expected, we observe the
characteristic biconcave shape for normal erythrocytes (Figure 4.3.1a) when imaging on a PLLcoated mica substrate. In contrast, due to an increased membrane stiffness and dehydration,
the sickle trait RBC digresses from its characteristic biconcave shape (as shown in Figure
4.3.1b) and also experiences a decrease in size.

Our findings show that the Young’s modulus of normal erythrocytes is 1.10 kPa with a standard
deviation of 0.40 kPa, while erythrocytes from patients with the genotype for sickle cell trait have
a Young’s modulus of 3.05 kPa with a standard deviation of 1.09 kPa. Other techniques, such
as micropipette aspiration and optical tweezers, result to RBC moduli values in similar range
[154, 174, 185]. AFM has previously been used in the measurement of the Young’s modulus of
various types of cells e.g., platelets (1-50 kPa), lymphocytes (1.24 kPa), fibroblasts (1-5 kPa),
mesenchymal stem cells (1-2.5 kPa) and osteoblasts (1-200 kPa) [143, 157-163].

The threefold increase in the stiffness of SCT erythrocytes is probably due to changes in the
affinity of the spectrin and actin filaments that comprise the membrane skeleton. It has been
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proposed that SCT erythrocytes show an increased concentration in Ca+2 which results in a
higher cytoskeleton rigidity via an increased binding of Band 3 to the spectrin bound ankyrin
[186-187]. Another possible source of the measured increased stiffness is the dehydration of the
SCT erythrocytes that promotes polymerization of deoxygenated HbS [188-189]. It has been
shown that activation of the Gardos channel by an increase of the intracellular free Ca+2
concentrations results to expulsion of potassium and H2O. In addition, spectrin which is the main
protein responsible for the mechanical strength of the erythrocyte has been found to bind to
hemoglobin via the Band 3 protein that binds almost exclusively to hemoglobin fibers [152, 165].
Thus, interaction between the HbS fibers that are connected to the membrane and the HbS
fibers in the cytoplasm could also contribute to the measured increase in stiffness [166].

In summary, the present study suggests that sickle hemoglobin promotes a threefold increase in
the stiffness of sickle trait erythrocytes. Our data conclude that Young’s moduli and standard
deviations were E1 = 1.10 kPa, σ1 = 0.40 kPa, and E2 = 3.05 kPa, σ2 = 1.09 kPa, for normal and
sickle trait erythrocytes, respectively. In contrast to normal RBCs with a characteristic biconcave
shape, SCT erythrocytes deviate from this configuration with irregularities in the expected
morphology and a decrease in both diameter and height.
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Chapter 5. Dietary Supplementation with Docosohexanoic Acid (DHA) Increases
Red Blood Cell Membrane Flexibility in Mice with Sickle Cell Disease

5.1. Abstract
Humans and mice with sickle cell disease (SCD) have stiff red blood cells (RBCs). Omega-3
fatty acids, such as docosahexanoic acid (DHA), may influence RBC deformability via
incorporation into the RBC membrane during dietary supplementation. In this study, sickle cell
(SS) mice were fed natural ingredient rodent diets supplemented with 3% DHA (DHA diet) or a
control diet matched in total fat (CTRL diet). After 8 weeks of feeding, we examined the RBCs
for: 1) stiffness, as measured by atomic force microscopy; 2) deformability, as measured by
ektacytometry; and 3) percent irreversibly sickled RBCs on peripheral blood smears. Using
atomic force microscopy, stiffness is increased and deformability decreased in RBCs from SS
mice fed CTRL diet compared to wild-type mice. In contrast, RBCs from SS mice fed DHA diet
had markedly decreased stiffness and increased deformability compared to RBCs from SS mice
fed CTRL diet. Furthermore, examination of peripheral blood smears revealed less irreversibly
sickled RBCs in SS mice fed DHA diet as compared to CTRL diet. In summary, our findings
indicate that DHA supplementation improves RBC flexibility and reduces irreversibly sickled
cells in SS mice. These results point to potential therapeutic benefits of dietary omega-3 fatty
acids in SCD.

5.2. Introduction
Individuals with sickle cell disease (SCD) exhibit increased red blood cell (RBC) stiffness and
adhesion, multiorgan and vascular pathology, and complex pain syndromes [12, 122, 190-198].
In addition, there is evidence of activation of the inflammatory and coagulation pathways [80,
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199-204]. Berkeley sickle cell (SS) mice exclusively express human sickle hemoglobin and have
a phenotype that mimics many features of severe SCD in humans [205-207].

Omega-3 fatty acids, such as docosahexanoic acid (DHA), are essential fatty acids that have
anti-inflammatory and anti-thrombotic activities [208-210]. As dietary supplements, omega-3
fatty acids are beneficial in many cardiovascular diseases [208-209, 211-213]. In addition, Ren
et al [214-216] demonstrated that humans with SCD have decreased omega-3 fatty acids and
increased arachidonic acid (AA, an omega-6 fatty acid) in the RBC membrane. To date, trials in
humans with SCD have indicated that dietary supplementation with omega-3 fatty acids may
reduce severe anemia, vaso-occlusive pain episodes, white blood cell count, and prothrombotic
activity [217-219].

Several studies have demonstrated that dietary supplementation with omega-3 fatty acids
results in increased incorporation of these fatty acids into the RBC membrane, which can
influence RBC deformability [220-221]. In the present study, we sought to determine whether
dietary supplementation with the omega-3 fatty acid DHA would improve RBC stiffness and
other hematologic and disease parameters in SS mice. Our results indicate that 8-week dietary
supplementation with DHA increases RBC flexibility and decreases irreversibly sickled RBCs in
SS mice.

5.3. Methods
Mice
C57BL/6J mice (hereafter, WT mice) were purchased from The Jackson Laboratory (Bar
Harbor, ME; stock number 000664). Berkeley SCD mice (Tg(Hu-miniLCR1G

A

S)

Hba0//Hba0 Hbb0//Hbb0; hereafter, SS mice) on the Berkeley mixed genetic background have
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been previously described [205-206]. Mice were cared for according to AAALAC specifications.
Animal experiments were approved by the Institutional Animal Care and Use Committee of the
Medical College of Wisconsin. Experimental groups contained comparable numbers of male
and female mice; the average age of mice when placed on diets was 27 wks (range 14 - 36
wks).

Table 5.3.1. Fatty Acid Composition
Fatty Acid

CTRL Diet

DHA Diet

Saturated, % of total fatty acids

32

29

Monounsaturated, % of total fatty acids

19

22

Polyunsaturated, % of total fatty acids

48

49

1.0

0.0

C10:0 Capric

1.1

0.9

C12:0 Lauric

5.4

3.6

C14:0 Myristic

4.4

9.9

C16:0 Palmitic

13.8

12.8

C16:1 Palmitoleic

0.4

1.1

C18:0 Stearic

4.7

1.2

C18:1 Oleic

18.1

20.1

C18:2 Linoleic

47.0

18.0

C18:3 Linolenic

1.3

1.2

C22:6 DHA

0.0

30.1

Predominant fatty acid

18:2 linoleic acid

22:6 DHA

Energy Density, kcal/g

3.5

3.5

Fatty acid profile, % of total fatty acids
C8:0 Caprylic

Dietary Feeding
Mice were fed natural ingredient 2016 Teklad Global 16% Protein Rodent Diet supplemented
with 3% DHA, an omega-3 fatty acid (DHA diet), or a control diet supplemented with safflower
oil, which predominantly contains the omega-6 fatty acid linoleic acid (CTRL diet) (Table 5.3.1).
The macronutrient composition of the CTRL and DHA diets is shown in Table 5.3.1. Diets were
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matched in total fat and had a similar distribution of saturated/monounsaturated versus
polyunsaturated fatty acids (Table 5.3.1). Detailed information on the base 2016 Teklad Global
16%

Protein

Rodent

Diet

can

be

found

at

http://www.harlan.com/products_and_services/research_models_and_services/laboratory_anim
al_diets/teklad_natural_ingredient_diets/teklad_global_diets/global_rodent_diets/teklad_global_r
odent_diet_16_protein_2016.hl#Macronutrient_Information. DHA oil was a kind gift from Martek
Biosciences (a division of DSM Nutritional Products, Columbia, MD). DHA and CTRL diets were
designed in consultation with nutritionists at Harlan-Teklad Laboratories and diets were
compounded at Harlan-Teklad Laboratories (Madison, WI). Mice were weighed prior to being
placed on CTRL or DHA diet, fed their respective diets for 8 weeks, and then weighed again
prior to harvest. No significant differences in weight gain were observed between CTRL and
DHA diet groups (data not shown).

CBC and reticulocyte measurements
Blood was obtained from deeply anesthetized mice by cardiac puncture and drawn into heparin
anticoagulant. Complete blood count (CBC) and reticulocyte analyses were performed as
previously described [222].

Flow adhesion assay
RBCs were separated from whole blood and washed twice in citrate/glucose/saline buffer as
previously described [122, 223]. Washed RBCs were resuspended at a 2% hematocrit in M199
serum free medium (Sigma, St. Louis, MO) containing 0.2% bovine serum albumin (Sigma, St.
Louis, MO). RBC adhesion to immobilized thrombospondin (TSP, 1 g/75 l) was carried out
using Vena8 Fluoro Biochips on the VenaFlux Platform (Cellix, Dublin, Ireland). RBCs were
perfused through the channel at a wall shear stress of 0.4 dyne/cm2, and adherent RBCs
manually quantified by analyzing five different images captured from the middle of the channel.
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Atomic Force Microscopy
Whole blood was collected as described above and stored overnight at 4oC. RBCs were
sedimented by centrifugation at 500 x g at 4°C for 10 minutes and the plasma, buffy coat, and
uppermost erythrocytes removed by aspiration and discarded. The remaining erythrocytes were
washed three times in Cell Wash Buffer (21.0 mM tris (hydroxymethyl)aminomethane, 4.7 mM
KCl, 2.0 mM CaCl2, 140.5 mM NaCl, 1.2 mM MgSO4, 5.5 mM glucose, 0.5% bovine serum
albumin (BSA) fraction V; pH 7.4) [224]. Cells were immobilized on a glass surface coated with
1 mg/ml poly-L-lysine solution for 10 min in the incubator (37°C, 5% CO2). Unattached cells
were removed by gentle rinsing of the surface with Cell Wash Buffer. Cells were prepared on
the day of use and experiments were performed in Cell Wash Buffer maintained at 37°C.

Stiffness measurements were carried out as previously described [93] on non-fixed adhered
erythrocytes. All force measurements were recorded with a loading rate of 24000 pN/s for small
indentation depths up to 150 nm and small indentation forces up to 300 pN [101, 112, 117]. The
Young’s modulus was calculated using the Hertz model which describes the elastic deformation
of two bodies in contact under load, in this case the contact between the erythrocyte and the
AFM probe. Further detail regarding AFM measurements and calculations is found in
Supplemental Methods. Five mature RBCs were evaluated for stiffness measurements from
each mouse; reticulocytes were excluded based on their larger size [225].

Ektacytometry
Red cell membrane deformability was assessed by ektacytometry as described previously [226],
using a Technicon model 152 Ektacytometer (Spectra Physics, France) at Purdue University.
Whole blood was collected as described above and stored overnight at 4oC, followed by
centrifugation at 1000 x g for 3 min to pellet RBCs. Packed RBCs were washed twice with Cell
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Wash Buffer lacking BSA, then resuspended at 0.3% hematocrit in isoosmotic sample buffer
(136mM NaCl, 6.3mM Na2HPO4, 1.2mM NaH2PO4) containing ~4% polyvinylpyrrolidone (PVP).
Samples were loaded into the ektacytometer and subjected to increasing shear stresses (0-250
dynes/cm2, increased linearly over 125s) at constant osmolarity. The deformation of the cells
was quantified by laser diffraction as elongation index (EI) which was recorded as a function of
time. RBCs from each mouse were analyzed in duplicate ektacytometer runs, and the overall
RBC deformability for each mouse was determined from the average maximum EI of the
duplicate trials.

Quantification of Irreversibly Sickled RBCs
Blood smears were prepared on glass slides using anticoagulated whole blood. Unstained
smears were examined using a Nikon Eclipse 80i microscope and fields of well-separated RBCs
selected for photography using a Nikon Digital DS-Fi1 camera. The total number of RBCs in
each field and the number of irreversibly sickled RBCs, defined as having a length greater than
2-fold its width [227], were enumerated by manual counting. Five representative fields were
examined and the average percent of irreversibly sickled RBCs was determined for each
mouse.

Statistics
GraphPad Instat or GraphPad Prism were used for all statistical analyses. For data that passed
tests for normality, unpaired t-tests were used, with Welch’s correction applied when comparing
populations with unequal SDs. For data that were not normally distributed, nonparametric MannWhitney U-tests were used for comparisons of two groups. Kruskal-Wallis nonparametric
ANOVA with Dunn’s Multiple Comparisons Post-Hoc Test was used for comparisons of more
than two groups. P<0.05, with corrections for multiple comparisons when appropriate, was
considered significant.
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5.4. Results
DHA supplementation decreases RBC stiffness in SCD mice
Atomic force microscopy (AFM) was used to assess RBC stiffness of mature RBCs in wild-type
(WT) and SS mice after 8-week dietary feeding on CTRL or DHA diets. RBC stiffness is
comparable in WT mice fed either CTRL or DHA diets (Figure 5.4.1A, left panel, representative
WT-CTRL and WT-DHA mice; Figure 5.4.1C, group data). RBC stiffness in WT-CTRL and WTDHA mice is similar to that seen in WT mice fed a standard fat diet (Figure 5.4.1A, right panel,
representative WT mouse on standard Teklad Global 2016 diet; Figure 5.4.1C, group data),
indicating that the increased fat composition of the diets used in this study does not alter normal
RBC stiffness.

In comparison to WT RBCs, RBC stiffness is increased in SS mice fed CTRL diet (Figure
5.4.1B, left panel, filled bars, representative SS-CTRL mouse; Figure 5.4.1C, group data,
P<0.001 vs. WT-2016, WT-CTRL, or WT-DHA). RBC stiffness in SS-CTRL mice is comparable
to that obtained from SS mice fed a standard fat diet (Figure 5.4.1A, right panel, representative
SS mouse on standard Teklad Global 2016 diet; Figure 5.4.1C, group data), indicating that the
increased fat composition of the CTRL diet is not the cause of increased RBC stiffness in CTRL
diet-fed SS mice. In addition, since only mature RBCs were assessed for RBC stiffness
measurements, the observed difference in RBC stiffness between SS and WT mice is not
influenced by the higher presence of reticulocytes in SS as compared to WT blood samples. In
marked contrast, RBCs from DHA diet-fed SS mice had decreased stiffness compared to RBCs
from CTRL diet-fed SS mice (Figure 5.4.1B, open bars, representative SS-DHA mouse; Figure
5.4.1C, group data, P<0.001 vs. SS-CTRL or SS-2016). In fact, RBC stiffness in SS-DHA mice
was decreased to nearly WT levels (Figure 5.4.1C, P value is not significant for SS-DHA vs.
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Figure 5.4.1. Dietary supplementation with DHA decreases RBC stiffness in SS mice. (A, B):
Representative results from individual wild-type (WT) (A) and sickle (SS) (B) mice fed either: left
panels: CTRL (filled bars) or DHA (open bars) diet; right panel: Teklad Global Diet 2016
standard fat diet (grey bars; “2016”). Data are presented as Gaussian histograms of the
frequency of measurements versus the Young’s modulus in Pascals (Pa). (C): Box-Whisker plot
of Young’s modulus from the groups indicated on the X axis. Data are presented as median with
max and min whiskers. The ‘n’ indicated on X-axis indicates the total number of mature RBCs
analyzed in each group, obtained from the following numbers of mice: WT-2016: 2 mice; WT-
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CTRL and WT-DHA: 4 mice; SS-2016: 2 mice; SS-CTRL: 12 mice; SS-DHA: 11 mice. Statistical
comparisons by Kruskal-Wallis nonparametric ANOVA with Dunn’s Multiple Comparisons PostHoc Test: **, P<0.001 SS-2016 vs. WT-2016, WT-CTRL, or WT-DHA; ***, P<0.01 SS-CTRL vs.
WT-2016, and P<0.001 SS-CTRL vs WT-CTRL or WT-DHA; #, P<0.001 SS-DHA vs. SS-2016
or SS-DHA. All other differences (including SS-DHA vs. WT-2016, WT-CTRL, or WT-DHA) are
not significant.

Table 5.4.1. Red blood cell and reticulocyte measures
Group
WT
SS

Diet

Hgb, g/dL

Hct, %

MCV, fl

MCHC, g/dL

Retic, %

CTRL

13.3+0.6

41.2+2.5

45+1

32.2+1.6

ND

DHA

12.6+0.6

40.5+2.5

45+1

31.1+1.0

ND

CTRL

5.0+1.1

15.0+3.3

45+4

33.8+4.4

60+16

DHA

5.0+1.1

16.1+3.7

48+6

31.4+2.9

41+18†

All values mean+SD. ND, not determined; retic (reticulocytes) is given as % of total RBCs. WTCTRL, n=10; WT-DHA, n=11. SS-CTRL, n=18 for Hgb/Hct/MCV/MCHC and n=7 for Retic; SSDHA, n=22 for Hgb/Hct/MCV/MCHC and n=9 for Retic. No significant differences between WTCTRL and WT-DHA or between SS-CTRL and SS-DHA groups for Hgb, Hct, MCV or MCHC
after correcting for multiple comparisons. †Difference in retic % between SS-CTRL and SS-DHA
groups is not significant but trending towards a decrease in SS-DHA mice (P=0.051).

WT-2016, WT-CTRL, or WT-DHA). Analysis of hematologic parameters revealed no statistically
significant differences in red blood cell or reticulocyte parameters in CTRL versus DHA diet
groups, although there was a trend (P=0.051) towards decreased reticulocytes in SS-DHA as
compared to SS-CTRL mice in the small sample subset analyzed (Table 5.4.1).

DHA supplementation improves RBC deformability in SCD mice
To verify the decrease in RBC stiffness seen by AFM, deformability of RBCs from a subset of
SS mice fed CTRL or DHA diets was examined using ektacytometry. Consistent with other
studies [228-233], RBCs from SS mice fed CTRL diet exhibit low deformability by ektacytometry
as compared to RBCs from WT mice (Figure 5.4.2; WT data for comparison only). Similar to the
AFM results, RBCs from SS mice fed DHA diet had improved deformability compared to RBCs
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from SS mice fed CTRL diet (Figure 5.4.2, P<0.02).

Figure 5.4.2. Dietary supplementation with DHA increases RBC deformability in SS mice.
Scatter plot of average maximum Elongation Index (EI) for SS mice fed CTRL (SS-CTRL, n=5)
or DHA (SS-DHA, n=9) diets. Each symbol represents the maximum EI (average of two
replicates) for an individual mouse; horizontal line represents mean for each SS diet group. WT
data average of two samples from normal mice fed standard diet, and is shown for comparison
only. *, P<0.05, SS-CTRL vs. SS-DHA, unpaired t-test with Welch correction.

DHA supplementation decreases irreversibly sickled RBCs in SCD mice
Both AFM and ektacytometry indicated increased RBC flexibility in SS mice fed DHA diet,
suggesting a change in RBC membrane properties. RBC adhesion is known to be elevated in
human and murine SCD, and has been attributed to multiple factors including altered membrane
properties [122, 124, 197, 234-235]. In addition, repeated cycles of sickling of RBCs results in
cytoskeletal damage and membrane changes that eventually become permanent, leading to the
appearance of “irreversibly sickled RBCs” with altered shape even in the presence of
oxygenated sickle hemoglobin [227, 236].

Therefore, we next examined whether there was a decrease in: 1) in vitro RBC adhesion; or 2)
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numbers of irreversibly sickled RBCs in SS-DHA as compared to SS-CTRL mice. While the
mean RBC adhesion to thrombospondin in vitro was reduced in DHA as compared to CTRL diet
fed SS mice, this difference was not significant in the small number of samples examined
(Figure 5.4.3A). In contrast, enumeration of irreversibly sickled RBCs from blood smears
revealed a notable decrease in irreversibly sickled RBCs in SS-DHA as compared to SS-CTRL
mice (Figure 5.4.3B, P<0.04). These data suggest that the improvement in RBC membrane
flexibility after 8 weeks of dietary DHA supplementation decreases the cytoskeletal and
membrane damage that leads to irreversibly sickled RBCs.

5.5. Discussion
The results of our studies indicate that 8-week dietary supplementation with DHA improves RBC
flexibility and decreases irreversibly sickled RBCs in sickle cell mice. The complete
normalization of RBC stiffness (Figure 5.4.1) as compared to only partial improvement in RBC
deformability (Figure 5.4.2) is not completely surprising. Since deformability reflects not only cell
stiffness but also hydration status [226, 237], the lack of complete normalization of RBC
deformability in SS-DHA mice may reflect the improvement in RBC stiffness without a
concomitant improvement in RBC hydration. In addition, only individual mature RBCs were
evaluated for stiffness by AFM, while deformability measurements involve the assessment of a
population of erythroid cells, which in SS mice includes ~40% reticulocytes. Therefore, it is also
possible that the difference in the AFM versus ektacytometry results reflects incorporation of
DHA into erythroid membranes with effects that are more pronounced in mature RBCs than in
reticulocytes.
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Figure 5.4.3. Dietary supplementation with DHA does not affect in vitro adhesion to TSP but
decreases irreversibly sickled RBCs in SS mice. (A) Scatter plot of adhesion of washed RBCs
from SS-CTRL (n=7) or SS-DHA (n=7) mice to human thrombospondin (TSP, 1 g/75 l) at a
wall shear stress of 0.4 dyne/cm2. Adherent RBCs per unit area were quantified as described in
Methods. Each symbol represents an individual mouse; horizontal line represents mean for
each group. (B) Scatter plot of percent irreversibly sickle RBCs in SS-CTRL (n=6) and SS-DHA
(n=8) mouse groups. Each symbol represents an individual mouse; horizontal line represents
mean for each group. ns, not significant SS-CTRL vs. SS-DHA, unpaired t-test; *, P<0.05, SSCTRL vs. SS-DHA, unpaired t-test.

There are several potential avenues through which DHA supplementation could improve RBC
flexibility in SS-DHA mice. Ren et al have demonstrated that humans with SCD have decreased
omega-3 fatty acids and increased arachidonic acid (AA, an omega-6 fatty acid) in the RBC
membrane [214-215]. It is known that omega-3 and omega-6 fatty acids compete for
incorporation into the phospholipids of the erythrocyte membrane [238], suggesting that DHA is
replacing AA in the RBC membrane in SS mice. Increasing the degree of unsaturation for a
given phospholipid influences membrane fluidity less than increasing phospholipid content itself
[239], indicating that the improvement in RBC membrane flexibility in SS-DHA mice is not
primarily the result of the increased degree of unsaturation of DHA (22:6, n-3) compared to AA
(20:4, n-6) or linoleic acid (18:2, n-6; the major fatty acid in the CTRL diet). However, DHA in
phospholipid bilayers possesses higher stability toward non-enzymatic lipid peroxidation than
AA or linoleic acid, which may also contribute to membrane stability [240].
In addition, omega-3 and omega-6 fatty acids can interact and react with the same receptors
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and enzymes with divergent physiologic effects [239]. For instance, 15-lipoxygenase-1 (15-LOX1) is activated after erythroblast enucleation and is instrumental in initiating the degradation of
mitochondria in maturing reticulocytes [241]. Using AA as substrate, 15-LOX-1 produces the
pro-inflammatory, pro-oxidant molecules 15-hydroxyeicosatetranoic acid (15-HETE) and lipoxins
A4 and B4 [239]. In contrast, if DHA is the substrate, 15-LOX produces docosatrienes and
protectins, which are anti-inflammatory and protect from oxidative stress [239]. Furthermore,
dietary supplementation with omega-3 versus omega-6 fatty acids leads to enhanced
transcription of antioxidant enzymes and suppressed transcription of enzymes that produce
reactive oxygen species [239]. There is also increased activity of RBC catalase and lowered
malondialdehyde levels in rat RBCs after dietary supplementation with omega-3 fatty acids
[242]. Taken together, this suggests greater protection from RBC lipid peroxidation and
oxidative injury. Finally, supplementation with omega-3 fatty acids influences the acylation of
proteins and functions of ion channels, which can alter intracellular calcium, membrane
flexibility, protein-protein interactions, and catalytic activity of enzymes [239].

To date, studies of omega-3 fatty acids in human SCD showed a decrease in acute
painful/vaso-occlusive episodes [217-219], but have not carefully assessed the effect of DHA on
sickle RBC structural and functional characteristics. Although individuals with SCD are known to
have increased daily pain and allodynia [194], effects of omega-3 fatty acid supplementation on
chronic or neuropathic pain in SCD have not been reported. SS mice are also known to exhibit
nociceptive sensitivities at steady state that are exacerbated by acute sickling [207].

In summary, our findings indicate that DHA supplementation improves RBC membrane flexibility
and reduces irreversibly sickled cells in SS mice. The current studies evaluated RBCs in SS
mice at steady-state. The increased RBC flexibility and decrease in irreversibly sickled RBCs
found in our studies at steady state suggest that the RBCs in SS-DHA mice may be more

68

resistant to an acute sickling event and resultant tissue injury, such as can be induced using
hypoxia-reoxygenation in SS mice [243-244]. A recent study has shown that dietary
supplementation with omega-3 fatty acids does not exacerbate oxidative stress in human SCD,
a complication that has been suggested in studies of omega-3 supplementation in non-SCD
individuals [245]. Therefore, dietary supplementation with omega-3 fatty acids may provide a
safe and effective way to ameliorate pathologies associated with vaso-occlusive crises in
human and murine SCD.
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Chapter 6. Epinephrine Modulates BCAM/Lu and ICAM-4 Expression on the Sickle
Cell Trait Red Blood Cell Membrane

6.1. Abstract
Collapse and sudden death in physical training are the most serious complications of sickle cell
trait (SCT). During strenuous exercise, there is evidence that erythrocytes from SCT patients
aggregate likely because of adhesive interactions with the extracellular matrix (ECM) and
endothelial cells, and because of their irregular viscoelastic properties. This results in
inflammation, blood flow impairment, and vaso-occlusive events. However, the exact role of
stress conditions and how they lead to these complications is virtually unknown. Using singlemolecule atomic force microscopy experiments, we report that epinephrine, a hormone secreted
under stressful conditions, increases both the frequency and strength of adhesion events
between BCAM/Lu (basal cell adhesion molecule) and ECM laminin, and between intercellular
adhesion molecule-4 (ICAM-4) and endothelial αvβ3, compared to non-stimulated SCT
erythrocytes. Increases in adhesion frequency present significant evidence of the role of
epinephrine in BCAM/Lu-laminin and ICAM-4-αvβ3 bonding, and suggest mechanisms of vasoocclusion during physical exertion in SCT.

6.2. Introduction
Sickle cell trait (SCT) is a risk factor for collapse and sudden death in physical training [9, 49-50,
53, 57, 246-247]. SCT is characterized by the presence of both normal adult hemoglobin (HbA)
and abnormal sickle hemoglobin (HbS) in the red blood cell (RBC, erythrocyte). SCT affects
over three million people in the United States, about 40 to 50 times more than sickle cell
disease (SCD) [46]. In HbS, the normal sequence Val-His-Leu-Thr-Pro-Glu-Glu-Lys is changed
to Val-His-Leu-Thr-Pro-Val-Glu-Lys, with the amino acid valine substituted for glutamic acid in
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the β6 site. The replacement of two charged groups by two hydrophobic ones leads to
polymerization of deoxygenated Hb and to the formation of stiff HbS fibers comprising a fibrous
gel [33, 35, 42]. Between 40-42% of the hemoglobin content of most individuals with SCT is
HbS [45]. In comparison to the homozygous SCD, the heterozygous SCT is traditionally
regarded as a benign condition [28, 47-48]. However, during strenuous exercise, individuals can
develop a syndrome resembling SCD with vaso-occlusive events resulting from changes in the
RBC morphology, viscoelasticity, and adhesion [38, 49-54]. Vaso-occlusion occurs in crises in
which the arterial circulation is blocked at one or many sites, leading to organ damage and
ischemic pain [55]. Endothelial cell activation, cytoadherence, inflammation, and coagulation
activation contribute to blood flow obstruction and play a critical role in the pathophysiology of
vaso-occlusion [64, 66, 68].

It is known that SCD RBCs adhere abnormally to extracellular matrix (ECM) components as well
as to endothelial cells (ECs) via changes in their adhesive interactions. Immature (reticulocytes)
and mature erythrocytes express several adhesion receptors. One of them is the Lutheran (Lu)
blood group RBC antigen and basal cell adhesion molecule (BCAM), known as BCAM/Lu which
is a high-affinity laminin receptor. Another one is the intercellular adhesion molecule-4 (ICAM-4,
LW glycoprotein), a receptor for a number of integrins [248].

While it is known that epinephrine enhances SCD erythrocyte adhesion, the mechanism has not
yet been quantitatively explored in SCT or in SCD [72, 249]. Epinephrine is a hormone secreted
from the adrenal medulla during periods of stress and strenuous exercise [250]. Increased
circulating levels of epinephrine act on the RBC β2-adrenergic receptor, thereby activating Gαs
proteins which stimulate adenylyl cyclase (AC). This enzyme catalyzes the conversion of
adenosine triphosphate (ATP) to cyclic adenosine monophosphate (cAMP), leading to protein
kinase A (PKA) activation, an intermediate step in the up-regulation of BCAM/Lu- and ICAM-4-
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mediated adhesion [72, 249, 251]. The interaction of BCAM/Lu with the α5 chain of laminin
(LAMA5) on the ECM, as well as the interaction of ICAM-4 with the αvβ3 integrin on ECs, may
contribute to vaso-occlusive events in SCD due to over-expression of BCAM/Lu and ICAM-4 on
SCD RBCs in the presence and absence of epinephrine [72, 248-249].

6.3. Design and Methods
Preparation of BCAM/Lu and ICAM-4 substrate
To attach purified CD239 (Sigma Aldrich, St. Louis, MO), commonly known as BCAM/Lu, onto a
gold-coated mica substrate (Novascan Technologies, Inc., Ames, IA), the substrate was first
incubated for 2 hours in 50 mM mercaptoethanesulfonate. Mercaptoethanesulfonate was
prepared by adding sodium 2-mercaptoethanesulfonate to equal parts ethanol and 18 MΩ
water. The gold surface was allowed to dry, then a drop of 1 µg/mL protein in PBS was added to
the surface. After 20 min, the prepared gold surface was rinsed with PBS and a volume of PBS
is added for experiments. The same method was employed in the attachment of ICAM-4-1
(Sigma Aldrich, St. Louis, MO) onto a gold-coated mica substrate.

Preparation of laminin and αvβ3 probes
Silicon nitride cantilevers were gently rinsed with ethanol and 18 MΩ water before being placed
in a clean, dry petri dish with 30 μL APTES (3-aminopropy-triethoxysilane) and 10 µL
triethylamine for 1h. N3-dPEG-NH2 linker was prepared by adding dry methylene chloride (0.5
mL), triethylamine (7 µL), and 7.5 mg (7.5 µL) of N3-dPEG-NH2 linker (Quanta Biodesign,
Powell, OH) to a small, dry glass vial. The vial was sealed and inverted several times until all of
the solid substances dissolved. After the atomic force microscopy (AFM) probes were tightly
sealed with APTES for 1h, they were removed and immediately added to the N3-dPEG-NH2
linker at 4°C. After 1 h, the probes were rinsed with methylene chloride, ethanol, and then 18
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MΩ water. The probes were placed in a parafilm-coated dish with their tips pointed upwards and
inwards in a circular manner. 50 μL of 250 μg/mL purified Laminin α5, clone 4C7 (Millipore,
Temecula, CA) or 50 μL of 210 μg/mL purified human integrin αvβ3 (Millipore, Temecula, CA) is
added to the center of the cantilevers, in contact with the probes. After 2 hours, AFM probes
were rinsed with PBS buffer.

Erythrocyte preparation
The study included RBCs from a SCT adult subject (n = 1) and RBCs from a healthy adult
subject (n = 1) purchased from Research Blood Components, LLC (Brighton, MA). An IRB
approved consent form was obtained by the company for each donor giving permission to use
the acquired sample for research purposes. Sodium citrate anticoagulant is used, RBCs were
utilized for experiments within 14 days of blood draw, and maintained at 4ºC prior to use. Cell
age did not appear to have an effect on the data. Erythrocytes were diluted to a concentration of
50% in Alsever’s solution (Sigma Aldrich, St. Louis, MO) and maintained in 5% CO 2 at 37ºC
prior to immobilization and experiments.

Erythrocyte immobilization
Cells were immobilized on glass-bottom petri dishes (MatTek Corporation, Ashland, MA) coated
with poly-L-lysine (PLL) to increase cell adherence. 150 μl of 1 mg/ml PLL solution (Sigma
Aldrich, St. Louis, MO) was allowed to adsorb for 5 min to a sterile glass surface, and excess
solution was drained away. RBCs of 50% concentration in Alsever’s solution were allowed to
adhere to each PLL-coated glass surface for 10 min in the incubator (37ºC and 5% CO2).
Unattached cells were removed by gentle rinsing of the surface with Alsever’s solution at 25°C
and a volume of 3.0 mL Alsever’s solution was added for experiments. In epinephrine-mediated
adhesion experiments, a volume of 3.0 mL of 10 nM epinephrine (Sigma Aldrich, St. Louis, MO)
was added for experiments.
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Atomic force microscopy measurements
Adhesion maps and force-distance curves were obtained using an Asylum MFP 3D-BIO
(Asylum Research, Santa Barbara, CA) AFM equipped with a “liquid cell” setup. A petri dish
heater was employed to maintain the RBCs at physiological body temperature (37ºC) during
experiments. The temperature inside the sample was controlled (±0.1ºC) via closed loop
temperature control using an environmental controller (Asylum Research, Santa Barbara, CA).
Baseline measurements were performed in Alsever’s solution at 37ºC. Epinephrine-mediated
experiments were performed in a 10 nM epinephrine solution, using Alsever’s as the base, at
37ºC. Unless otherwise specified, all force measurements were recorded with a loading rate of
24000 pN/s, calculated by multiplying the tip retraction velocity (nm/s) by the spring constant of
the cantilever (pN/nm).

The nominal spring constant kc of the employed cantilever was 30 pN/nm, as provided by the
manufacturer (Bruker Probes, Camarillo, CA). Exact values for the cantilever spring constants
were obtained via a thermal noise based method implemented by the manufacturer and were
used in all calculations. We chose this cantilever stiffness because it is known that when kc > 10
pN/nm, the soft linkage of the protein-protein interaction dominates the behavior of the
cantilever-protein effective spring system [104]. The approach and retraction velocities were
held constant at 800 nm/s. Probes had nominal tip radii of 20 nm and nominal angle of 20°, as
provided by the manufacturer.

Statistical analysis
Reported adhesion interaction forces for the BCAM/Lu-laminin complex and ICAM-4-αvβ3
complex in the text are average values obtained via the Gaussian distribution. The differences
among the groups are assessed using the two-tailed t-test for independent samples to evaluate
respectively the effect of the SCT genotype and that of the epinephrine stimulation. The
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significance level is defined as p < 0.05. The statistical analyses are conducted with the Data
Analysis Toolpack in Microsoft Excel (Microsoft, Redmond, WA).

Figure 6.4.1. Strategy for measuring the BCAM/Lu-laminin binding force at the single-molecule
level using AFM. (A) Schematic of the surface chemistry used to functionalize the AFM tip and
substrate with LAMA5 and BCAM/Lu. A PEG-linker was attached to an AFM tip terminated with
NH2 groups, and BCAM/Lu was bound to a gold substrate via mercaptoethanesulfonate. (B)
Force-distance curves are three representative examples obtained using independent tips and
substrates. The blue curve demonstrates zero adhesive interaction, while the red and black
curves show rupture forces associated with adhesion events. (C) Dynamics of the BCAM/Lulaminin interaction. Dependence of the adhesion force on the loading rate applied during
retraction, measured between a LAMA5 tip and a BCAM/Lu substrate, while keeping the
interaction time (0 s) and loading rate during approach (24000 pN/s) constant. The mean
adhesion force does not notably change with the loading rate, indicating the measurements
were performed close to thermodynamic equilibrium
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6.4. Results
Dynamics of the BCAM/Lu-laminin and ICAM-4-αvβ3 interaction
Direct measurements of the BCAM/Lu-laminin and ICAM-4-αvβ3 adhesive interactions are
obtained via single molecule force spectroscopy [90, 94, 96]. Adhesive forces, defined as the
maximum rupture force (Figure 6.4.1B) associated with the force-distance curves, are extracted
from each of the 1024 force curves acquired to determine the rupture force. Upon investigation
of the dynamics of the BCAM/Lu-laminin interaction, force curves between the LAMA5 tip and
the BCAM/Lu-coated substrate are recorded at various retraction rates. The mean adhesion
force does not substantially depend on the loading rate applied during retraction, over the
experimentally tested range (Figure 6.4.1C). Dynamics of the ICAM-4-αvβ3 interaction shows a
similar trend. This observation, in contrast to the behavior of several other receptor-ligand
complexes that usually have an increase in adhesion force with the logarithm of loading rate,
indicates that the force measurements are performed close to thermodynamic equilibrium [252].

Interaction force of the BCAM/Lu-laminin and ICAM-4-αvβ3 pairs
For the BCAM/Lu-laminin pair, force-distance curves are recorded between the LAMA5 probe
and the BCAM/Lu-coated substrate. Adhesive forces are extracted from each of the 1024 force
curves acquired and an average rupture force of 50 ± 11 pN (Figure 6.4.2A). In atomic force
microscopy, the specificity of ligand-receptor binding is demonstrated by performing blocking
experiments with free ligands, which are injected into the solution to block the receptor sites on
the cell surface. Consequently, almost all specific recognition signals completely disappear and
only occasional adhesion events are observed [56, 90]. The specificity of the interaction is
demonstrated by performing experiments in 250 μg/mL laminin solution, thus blocking the
BCAM/Lu receptors. By recording force-distance curves between the LAMA5 tip and the
BCAM/Lu-coated substrate in the laminin solution, the number of curves showing adhesion
events dramatically reduces from 26% to 6% (p < 10-6, Figure 6.4.2A). For the ICAM-4-αvβ3 pair,
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Figure 6.4.2. Measurement of the binding force of the BCAM/Lu-laminin and ICAM-4-αvβ3
complexes. (A) Adhesion force histogram obtained from 1024 force curves (n = 1024) measured
in PBS between a LAMA5 tip and a BCAM/Lu substrate. The distribution of adhesion forces
reveals a maximum value at 50 ± 11 pN as determined by a Gaussian fit. The frequency of
adhesion events was 26%, as determined by the percentage of curves showing rupture forces.
Overlay shows the adhesion force histogram (n = 1024) obtained after injection of free laminin
(250 µg/mL) into the solution. The dramatic reduction of adhesion frequency and broadening of
the distribution reflect the blocking of the BCAM/Lu receptors. (B) Adhesion force histogram
obtained from 1024 force curves (n = 1024) measured in PBS between an integrin αvβ3 tip and a
ICAM-4 substrate. The distribution of adhesion forces reveals a maximum value at 47 ± 15 pN
as determined by a Gaussian fit. The frequency of adhesion events was 18%. Overlay shows
the adhesion force histogram (n = 1024) obtained after injection of free integrin αvβ3 (210
µg/mL) into the solution. The dramatic reduction of adhesion frequency reflects the blocking of
the ICAM-4 receptors.
force-distance curves are recorded between the αvβ3 probe and the ICAM-4-coated substrate,
resulting in an average rupture force of 47 ± 15 pN (Figure 6.4.2B). The specificity of the
interaction is demonstrated by performing experiments in 210 μg/mL integrin αvβ3 solution, thus
blocking the ICAM-4 receptors. The number of curves showing adhesion events dramatically
reduces from 18% to 3% (p < 10-6, Figure 6.4.2B).

Non-stimulated SCT RBC adhesion to laminin and integrin αvβ3
In this paper, we measure, on single erythrocytes, the effects of epinephrine on the bond
strength and on the frequency of binding events between (1) the BCAM/Lu antigen, expressed
on the surface of SCT RBCs, and the laminin complex, expressed on the ECM, and (2) the
ICAM-4 antigen expressed on the surface of SCT RBCs, and the αvβ3 integrin, expressed on
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ECs. We also measure the adhesion of non-stimulated SCT RBCs compared to non-stimulated
wild-type RBCs. The methodology followed requires functionalization of the AFM probe [90, 9496] with LAMA5 or integrin αvβ3 to measure the interaction between the α5 chain of laminin and
BCAM/Lu receptor expressed on the tested RBC (Figure 6.4.3), or the interaction between
integrin αvβ3 and ICAM-4 receptor expressed on the tested RBC. From these measurements,
the distribution of the BCAM/Lu and ICAM-4 receptor on the RBC surface is also obtained. The
RBCs are placed in an environment with a physiologically relevant level of epinephrine to
explore the effect of the stress-induced epinephrine environment on the frequency and
distribution of adhesive interactions.

Figure 6.4.3. AFM topographic image of a SCT erythrocyte displaying the characteristic
biconcave shape associated with healthy, wild-type RBCs. This erythrocyte is a representative
example of those scanned during experiments to map the distribution of BCAM/Lu and ICAM-4
receptors on human erythrocytes.

To detect the distribution of the receptors on the cell surface, as well as to measure the
physiologic BCAM/Lu-laminin bond strength, spatially-resolved adhesion maps are recorded
using a LAMA5 tip over 1 µm x 1 µm areas. Adhesive forces are extracted from each of the
1024 force curves acquired from tests on n=6 wild-type and n=6 SCT erythrocytes. The average
magnitude of the BCAM/Lu-laminin bond is the same for wild-type and SCT (Figure 6.4.4A)
erythrocytes, 46 ± 6 pN and 46 ± 10 pN, respectively. This bond strength is also the same as
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the average rupture force of 50 ± 11 pN (Figure 6.4.2A) measured between a BCAM/Lu-coated
gold substrate and a functionalized LAMA5 probe. The number of observed binding events,
however, shows an increase from 10.42% to 16.89% (p < 0.05).

Figure 6.4.4. Measurement of the binding force of the BCAM/Lu-laminin and ICAM-4-αvβ3
complexes on erythrocytes. (A) Foreground: Adhesion force histogram obtained from 6,144
force curves (n = 6 cells x 1024 force curves) measured in Alsever’s solution between a LAMA5
tip and a wild-type (WT) RBC. The distribution of adhesion forces reveals a maximum value at
46 ± 6 pN, as determined by a Gaussian fit. Background: Adhesion force histogram obtained
from 6,144 force curves (n = 6 cells x 1024 force curves) obtained between a LAMA5 tip and a
sickle cell trait RBC reveals a distribution of adhesion forces with a maximum value at 46 ± 10
pN. The frequency of adhesion events increased significantly from 10.42% on the wild-type
RBC to 16.89% on the SCT RBC (p < 0.05). (B) Foreground: Adhesion force histogram
obtained from 6,144 force curves (n = 6 cells x 1024 force curves) measured in Alsever’s
solution between a αvβ3 tip and a wild-type RBC. The distribution of adhesion forces reveals a
maximum value at 46 ± 10 pN, as determined by a Gaussian fit. Background: Adhesion force
histogram (n = 6 cells x 1024 force curves) obtained between a αvβ3 tip and a sickle cell trait
RBC reveals a distribution of adhesion forces with a maximum value at 47 ± 10 pN. There is a
non-significant increase from 5.91% to 7.56% (p > 0.05) in the number of adhesion events.
For the measurements of the ICAM-4-αvβ3 pair bond strength and local distribution, adhesive
forces are extracted from each of the 1024 force curves acquired from tests on n=6 wild-type
and n=6 SCT erythrocytes. The average magnitude of the ICAM-4-αvβ3 bond is the same for
wild-type and SCT (Figure 6.4.4B) erythrocytes, 46 ± 10 pN and 47 ± 10 pN, respectively. This
bond strength is also nearly the same as the average rupture force of 47 ± 15 pN (Figure.
6.4.2B) measured between an ICAM-4-coated gold substrate and a functionalized integrin αvβ3
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probe. The number of observed binding events show an insignificant increase from 5.91% to
7.56% (p > 0.05).

Figure 6.4.5. Measurement of the physiologic implications of epinephrine-stimulated adhesion.
(A) Foreground: Adhesion force histogram (n = 6 cells x 1024 force curves) obtained in 10 nM
epinephrine between a LAMA5 tip and a wild-type RBC reveals a distribution of adhesion forces
with a maximum value at 45 ± 8 pN, comparable to the baseline value. The frequency of
adhesion events increased from 10.42% to 14.86% (p > 0.05) as compared to baseline
measurements of wild-type RBCs. Background: Adhesion force histogram (n = 6 cells x 1024
force curves) obtained between a LAMA5 tip and a SCT RBC. The frequency of adhesion
events increased significantly from 16.89% to 35.04% (p < 0.01) as compared to baseline
measurements of SCT RBCs. The distribution reveals a maximum value at 48 ± 10 pN,
comparable to the baseline SCT value. (B) Foreground: Adhesion force histogram (n = 6 cells x
1024 force curves) obtained in 10 nM epinephrine between an integrin αvβ3 tip and a wild-type
RBC reveals a distribution of adhesion forces with a maximum value at 48 ± 9 pN, comparable
to the baseline value. The frequency of adhesion events increased insignificantly from 5.91% to
8.99% (p > 0.05) as compared to baseline measurements of wild-type RBCs. Background:
Adhesion force histogram (n = 6 cells x 1024 force curves) obtained between a integrin αvβ3 tip
and a SCT RBC. The frequency of adhesion events increased from 7.56% to 19.89% (p < 0.05)
as compared to baseline measurements of SCT RBCs. The distribution reveals a maximum
value at 45 ± 11 pN, comparable to the baseline value.
Epinephrine-stimulated SCT RBC adhesion to laminin and integrin αvβ3
To test the hypothesis that an increase in epinephrine levels results in an increase in the
frequency of adhesive interactions, we employed a similar approach. Treatment of wild-type
RBCs with 10 nM epinephrine, a physiologically relevant level, induced an insignificant increase
from 10.42% to 14.86% (p > 0.05) in the frequency of BCAM/Lu-laminin binding events (n = 6,
Figure 6.4.5A), and an insignificant increase from 5.91% to 8.99% (p > 0.05) in the frequency of
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ICAM-4-αvβ3 binding events (n = 6, Figure 6.4.5B). There was no notable increase in the bond
strength of either pair with epinephrine stimulation. The specificity of the BCAM/Lu-laminin
interaction was validated via blocking experiments (Figure 6.4.6). By recording force-distance
curves between a LAMA5 tip and wild-type RBCs in Alsever’s solution, the number of curves
showing adhesion events dramatically reduces to 0.52% from 10.42% (p < 0.001).

Figure 6.4.6. Validation of the specificity of the BCAM/Lu-laminin interaction on wild-type RBCs.
(A) Adhesion force histogram obtained from 6,144 force curves (n = 6 cells x 1024 force curves)
measured between a LAMA5 tip and a wild-type RBC. The distribution of adhesion forces
reveals a maximum value at 46 ± 6 pN, as determined by a Gaussian fit. (B) Adhesion force
histogram (n = 6 cells x 1024 force curves) obtained after injection of free laminin (250 μg/mL)
into solution. Force-distance curves were measured in a LAMA5 tip and a wild-type RBC. The
dramatic reduction of adhesion frequency to 0.52% from 10.42% on the wild-type in (A) (p <
0.001) demonstrates the specificity of the BCAM/Lu-laminin interaction.

Treatment of sickle cell trait RBCs (n = 6) with epinephrine induced an increase in the frequency
of BCAM/Lu-laminin binding events from 16.89% to 35.04% (p < 0.01) (Figure 6.4.5A). The
distribution of the wild-type RBCs with epinephrine has been overlaid on the distribution of the
SCT RBCs with epinephrine in Figure 6.4.5A to demonstrate the broadened variability of the
Lu/BCAM-laminin adhesion force on the treated SCT erythrocytes. Treatment of sickle trait
RBCs (n = 6) with epinephrine induced an increase in the frequency of ICAM-4-αvβ3 binding
events from 7.56% to 19.89% (p < 0.05) (Figure 6.4.5B). The distribution of the wild-type RBCs
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with epinephrine has been overlaid on the distribution of the SCT RBCs with epinephrine in
Figure 6.4.5D to demonstrate the broadened variability of the ICAM-4-αvβ3 adhesion force on
the treated SCT erythrocytes.

Figure 6.4.7. Distribution of BCAM/Lu and ICAM-4 on the surface of wild-type RBCs and sickle
cell trait RBCs using different probes and cell preparations. (A,B) Adhesion force maps (color
scale as shown) recorded with LAMA5 functionalized probes over wild-type RBCs (A) and sickle
cell trait RBCs (B). (C,D) Adhesion force maps recorded with LAMA5 tips over wild-type RBCs
(C) and sickle cell trait RBCs (D) in 10 nM epinephrine. (E,F) Adhesion force maps recorded
with integrin αvβ3 probes over wild-type RBCs (E) and sickle cell trait RBCs (F). (G,H) Adhesion
force maps recorded with integrin αvβ3 tips over wild-type RBCs (G) and sickle cell trait RBCs
(H) in 10 nM epinephrine. Scale bars, 250 nm.

Notably, 1 µm x 1 µm spatially-resolved adhesion maps revealed that the BCAM/Lu-mediated
laminin binding activity is not homogeneously distributed over the SCT RBC surface, but
concentrated on nanodomains. These nanodomains, often attributed to membrane rafts, are
only observed on SCT RBCs (n = 6) in the presence of epinephrine (Figure 6.4.7D). In contrast,
wild-type RBCs (n = 6) stimulated with epinephrine (Figure 6.4.7C) demonstrate a nearly
homogeneous distribution of BCAM/Lu receptors. Furthermore, ICAM-4 receptor nanodomains
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are also observed, to a lesser degree, on the SCT RBC (n = 6) surface in the presence of
epinephrine (Figure 6.4.7H), with a heterogeneous receptor distribution on the wild-type RBC (n
= 6) stimulated with epinephrine (Figure 6.4.7G). In the non-stimulated environment, both wildtype (Figure 6.4.7A, 6.4.7E) and sickle cell trait (Figure 6.4.7B, 6.4.7F) RBCs maintain a
homogenous distribution of BCAM/Lu and ICAM-4 receptors.

6.5. Discussion
Although it is known that the BCAM/Lu-laminin and ICAM-4-αvβ3 binding complexes contribute
to SCD vaso-occlusion, the quantitative characteristics of these adhesion interactions has not
been explored in SCD or SCT erythrocytes. In wild-type RBCs and sickle cell trait RBCs, the
magnitude of the BCAM/Lu-laminin binding complex (46 ± 6 pN and 46 ± 10 pN, respectively) is
equal to the average rupture force of 50 ± 11 pN recorded between a functionalized laminin
probe and a BCAM/Lu-coated gold substrate. In wild-type RBCs and sickle cell trait RBCs, the
magnitude of the ICAM-4-αvβ3 binding complex (46 ± 10 pN and 47 ± 10 pN, respectively) is
nearly the same as the average rupture force of 47 ± 15 pN recorded between a functionalized
integrin αvβ3 probe and a ICAM-4-coated gold substrate.

Interactions of receptor molecule cytoplasmic domains with the cytoskeleton can play critical
roles in adjusting receptor function. It has been determined that BCAM/Lu has a high degree of
connectivity to the erythrocyte membrane cytoskeleton via erythroid spectrin [253-254].
Importantly, disruption of the BCAM/Lu-spectrin linkage is accompanied by enhanced cell
adhesion to laminin [254]. A major finding of the current study is that BCAM/Lu adhesion events
in SCT erythrocytes increased (p < 0.05) as compared to the wild-type. It is known that Hb
interacts with the spectrin network via band 3 [40, 151] and the introduction of HbS has recently
been found to have an effect on the mechanical properties of SCT erythrocytes [93]. We
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conjecture that HbS partially disrupts the spectrin network via its interaction with band 3,
indirectly disrupting the BCAM/Lu-spectrin linkage. This results in increased diffusion and
aggregation and thus significantly enhanced sickle trait RBC adhesion to ECM laminin.

Epinephrine, acting through the β2-adrenergic receptor, increases Lu-laminin α5 sickle
mediated red cell binding via a cAMP and PKA-dependent signaling pathway [72]. Further, the
Lu cytoplasmic tail is phosphorylated in epinephrine-stimulated sickle cells, which may be a
critical factor in sickle RBC’s enhanced adhesion to laminin [83]. The BCAM cytoplasmic tail,
which lacks the last 40 amino acids of the sequence, does not undergo phosphorylation. It has
been demonstrated that PKA-mediated phosphorylation of the Lu glycoprotein at serine 621
positively regulates the adhesion function of Lu under flow conditions. While the molecular basis
for the resulting increased adhesion is not yet understood, it has been hypothesized that
phosphorylation of the Lu cytoplasmic tail weakens its interaction with spectrin, enabling the
freely-floating transmembrane Lu molecules to cluster and thereby generate a larger adhesive
force [83]. A major finding of our current study is the mapping of Lu nanodomains on
epinephrine-stimulated SCT erythrocytes, accompanied by an increase in the frequency of
binding events (p < 0.01) from the baseline SCT erythrocytes. The significant broadening of the
bond magnitude distribution agrees with the aggregation of receptors into nanodomains
detected in Figure 6.4.7D. While the frequency of adhesive interactions increases on the wildtype RBC in the stress-induced epinephrine environment, this increase (from 10.42% to
14.86%) is not significant and receptor clustering is not observed (see Figure 6.4.7C). This
observation strengthens our conjecture that HbS disrupts the spectrin network resulting in
aggregation of BCAM/Lu receptors in SCT RBCs. It is noted that, receptor aggregation is not
detected in the case of SCT RBCs without epinephrine (see Figure 6.4.7B).

ICAM-4 mediated binding to endothelial cells and leukocytes is also activated by epinephrine via

84

stimulation of the β2-adrenergic receptor which triggers a cAMP and PKA-dependent signaling
pathway [255]. In addition, ICAM-4 on epinephrine-stimulated sickle cells undergo a significant
increase in serine phosphorylation, which may be a critical factor in sickle RBC’s enhanced
adhesion to endothelial integrin αvβ3 [249]. It has been hypothesized that phosphorylationinduced changes in the ICAM-4 cytoplasmic domain cause a conformational change in its
extracellular domain, thus generating a larger adhesive force. We observed an increase in the
frequency of binding events (p < 0.05) from the baseline SCT erythrocytes (see Figure 6.4.5D)
on epinephrine-stimulated SCT erythrocytes. Another important finding of the present data is the
quantification of the insignificant increase (p > 0.05) of ICAM-4-αvβ3 adhesion events on the
wild-type RBCs in the stress-induced epinephrine environment (see Figure 6.4.5B). This is
consistent with the known fact that there is minimal ICAM-4 phosphorylation in wild-type RBCs,
due to an age-related reduction in the cell’s ability to produce cAMP and thereby enhance PKA
activity in response to stimulation [72, 256-257]. While the current study tests the effect of
epinephrine on single molecule adhesion interactions thought to contribute to vascular blockage
in sickle cell vaso-occlusion, epinephrine has also been found to work via increasing RBC
trapping in the spleen and liver [255, 258].

6.6. Conclusions
The observed increases in adhesion frequency along with the detected receptor aggregation
into nanodomains is significant evidence of the contribution of epinephrine to enhancing
BCAM/Lu-laminin and ICAM-4-αvβ3 bond interactions. These findings suggest a mechanoadhesive role for epinephrine in the pathophysiology of vaso-occlusive incidents related to
sudden death in SCT individuals during strenuous exercise.
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Chapter 7. Establishing the Sensitivity of Force Nanoscopy in the Detection of
Native SK Channels in Living Neurons

7.1. Abstract
The spatial distribution of ion channels is an important determinant of neuronal excitability.
However, there are currently no quantitative techniques to map endogenous ion channels with
single-channel resolution in living cells. Here, we demonstrate that integration of pharmacology
with single molecule atomic force microscopy (AFM) allows for the high-resolution mapping of
native potassium channels in living neurons. We focus on calcium-activated small conductance
(SK) potassium channels, which play a critical role in brain physiology. By linking apamin, a
toxin that specifically binds to SK channels, to the tip of an AFM cantilever, we are able to detect
binding events between the apamin and SK channels. We find that native SK channels from rat
hippocampal neurons reside primarily in dendrites as single entities and in pairs. Importantly, we
establish the sensitivity of force nanoscopy and show that SK channel dendritic distribution is
dynamic and under the control of protein kinase A. Our study demonstrates that integration of
toxin pharmacology with single molecule AFM can be used to quantitatively map individual
native ion channels in living cells, and thus provides a new tool for the study of ion channels in
cellular physiology.

7.2. Introduction
A major challenge in cellular biology is to determine the subcellular distribution of ion channels
resident in neurons and other cells in living tissue. In neurons, the differential localization of ion
channels specifies the intrinsic excitability and computational properties of the subcellular
neuronal compartments (dendrites, soma, axon). The distribution of ion channels is typically
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determined using antibodies raised against ion channel subunits together with light, confocal,
total internal reflection fluorescence (TIRF) microscopy or electron microscopy (EM). These
studies have revealed that ion channels can be polarized within cells and can concentrate in
high and low density areas within the plasma membrane [259-260].

Unlike confocal or TIRF microscopy that have an in-plane spatial resolution of ~250 nm,
immunogold-EM has a spatial resolution of 20-30 nm making it the highest resolution method to
determine the subcellular distribution of ion channels [261-262]. However, it is limited by its
inability to map ion channels in living cells. Lately, several advances in super-resolution
fluorescence microscopy have made it possible to image proteins in either living or fixed tissue
at high spatial resolutions (30-70 nm) [261]. Still, these approaches are generally limited by
antibody specificity and/or the use of fluorescent labels that require overexpression of tagged
channels in cells.

Recently, single molecule atomic force microscopy (AFM) has been used to localize native
proteins in living cells at high resolution (~10 nm) [263]. The technique involves detection of
binding events occurring between a cell surface protein and a protein attached to the tip of the
AFM cantilever [90]. However, single molecule AFM inherently relies on the specificity and
affinity of the protein-protein interactions, which are often unknown. Given the wealth of
knowledge available regarding the binding of natural toxins to specific ion channels, we
hypothesized that combination of AFM with toxin pharmacology could reveal the localization of
endogenous ion channels in neurons with single-channel resolution.

Following neuronal activity, calcium can activate apamin-sensitive SK channels with relatively
high affinity [264-266]. Such activation can regulate synaptic plasticity and dendritic neuronal
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excitability [267]. SK channels are enriched in dendrites and post-synaptic densities, although
other evidence indicates an approximately uniform neuronal distribution [268-272]. Moreover,
the spatial organization of these channels within a neuronal compartment is unclear. At least
one SK channel isoform (SK2-L) is prone to clustering in heterologous cells [273], raising the
possibility that SK channels might not be uniformly distributed on neuronal surfaces, even within
a neuronal compartment. To determine SK channel subcellular distribution, we speculated that
by attaching apamin molecules to the tip of an AFM cantilever we could detect binding forces
between apamin and single SK channels on neuronal surfaces of living cells. Apamin is a bee
venom toxin that specifically binds to SK channels at their extracellular region with high affinity
and with 1:1 stoichiometry [274].

7.3. Materials and Methods
Experiments were carried out according to the guidelines of the University of Connecticut
Institutional Animal Care and Use Committee.

Preparation of functionalized cantilever probes
Silicon nitride AFM cantilevers were rinsed with ethanol and 18MΩ water before being treated
with 30μL APTES and 10µL triethylamine for 1h. Cantilevers were then added to the PEG-linker
solution containing: 0.5mL methylene chloride, 7µL triethylamine, and 7.5µL PEG-linker (Quanta
Biodesign) at 4°C for 1h. Probes were rinsed with methylene chloride, ethanol, and 18MΩ
water. 50μL of 100 nM apamin was added in contact with the probes for 2h. Cantilevers were
rinsed in PBS buffer and stored in PBS at 4°C.

Atomic force microscopy measurements
Binding force maps and force-distance curves were obtained using a MFP-3D-BIO (Asylum
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Research) AFM. HEK293T cell measurements were performed in culture media at 25°C.
Neuronal cell measurements were performed in neurobasal media stabilized with 30µL of 20
mM HEPES buffer at 25°C. Cells were located via differential interference contrast microscopy
and a scan area of 1µm2 was chosen with a lateral resolution of 31.25nm.

Unless otherwise specified, measurements were recorded with a loading rate of 24000 pN/s,
calculated by multiplying the tip retraction velocity (nm/s) by the cantilever spring constant
(pN/nm). The nominal spring constant

of the employed cantilever was 30 pN/nm, as provided

by the manufacturer. Exact values for the cantilever spring constants were obtained via a
thermal noise based method implemented by the manufacturer and used in all calculations. This
cantilever stiffness was chosen because it is known that when

10 pN/nm, the soft linkage

of the protein-protein interaction dominates the behavior of the cantilever-protein effective spring
system [104]. Probes had nominal tip radii of 20 nm and nominal angle of 20°.

Electrophysiology
HEK293T cells were transfected with recombinant DNA (0.1 - 3µg) using Lipofectamine 2000
(Invitrogen) and recorded 24-hr post-transfection. SK2 currents were recorded with conventional
whole-cell patch-clamp recordings. The recording electrodes were filled with solution containing
(in mM): 110 K-gluconate, 10 KCl, 20 KOH, 4 Mg·ATP, 8.73 CaCl2, 20 HEPES, 10 EGTA·KOH
(pH 7.2). Based on the Ca-Mg-ATP-EGTA Calculator v1.0 using constants from NIST database
#46 v8 the free Ca2+ concentration was 1.1µM. The electrode resistances were 4–5MΩ. The
extracellular solution contained (in mM): 144 NaCl, 2.5 KCl, 2.5 CaCl2, 1.2 MgCl2, 10 HEPES,
and 22 D-Glucose (pH 7.2). A voltage ramp was applied from a holding potential of -100mV to
+20mV (13mV/s). The data were low-pass filtered at 2kHz and sampled at 10kHz. For all
recordings, we used a Multiclamp 700B amplifier interfaced to a computer through a Digidata
1440A digitizer (Molecular Devices). Data were acquired with Clampex v10.2 (Molecular
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Devices).

Primary hippocampal cultures
Dissociated hippocampal cultures were prepared from Sprague-Dawley pups of either sex as
described previously [275].

Molecular biology
SK2-S subcloned into a pEGFP-N1 vector (Clontech) was a gift of Dr. Chul-Seung Park
(Gwangju Institute of Science and Technology, Gwangju, Korea) while SK2-L was a gift from
John P. Adelman (Vollum Institute, OHSU)

Data Analysis
To detect the distribution of SK2 channels on the cell surface, spatially-resolved binding force
maps were recorded using an apamin functionalized probe over 1µm2 areas. Binding forces
were extracted from each of the 1024 force curves acquired from each test. A MATLAB
(MathWorks) program was used to create visual binding force maps.

7.4. Results
To test our approach, we functionalized the tip of an AFM cantilever with apamin through a
PEG-linker (Figure 7.4.1A) and transiently transfected HEK293T cells with the most commonly
used SK2 channel isoform, SK2-S. Force-distance curves were recorded between the apaminfunctionalized tips and SK2-S channels. Binding forces are defined as the maximum rupture
force associated with the force-distance curves (Figure 7.4.1B). We expected that binding
forces would be higher in areas where the apamin-functionalized cantilever made contact with
underlying SK channels compared to areas without SK channels, as the attraction between
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Figure 7.4.1. Detection of SK2 channels on living cells using Atomic Force Microscopy (AFM).
(A) AFM cantilever probe is functionalized with apamin, a toxin that specifically binds to SK
channels. (B) When apamin attached to the AFM probe adheres to an SK2 channel on the cell
surface, the force-displacement curve exhibits an abrupt shift to zero value as shown in the red
curve. The shift corresponds to the rupture force. If there is no SK2 channel at the detection
point and consequently no binding interaction, the retraction curve is smooth similar to the black
curve. The arrow pointing from right-to-left shows the movement of the AFM probe approaching
and making contact with the cell surface, while the arrow pointing downward and to the right
demonstrates the movement of the AFM probe retracting from the cell surface. (C) Binding force
map of a HEK293T cell transfected with SK2-S channels in the absence (i) and presence of 100
nM ambient apamin (ii) to mask SK2 channels apamin binding sites. (iii) Binding force map of an
untransfected HEK293T cell probed with an apamin functionalized probe shows minimal
attraction. Each pixel corresponds to a rupture force according to the color scale shown. (D)
Frequency graph of untransfected and SK2-S transfected cells in the absence or presence of
ambient apamin. Star indicates statistical significance of p<0.01 (ANOVA Tukey post-hoc test).
(F) Expression of SK2-S channels in HEK293T lead to apamin sensitive currents. Scale bars,
250 nm. Color scale as shown.
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apamin and the channels would require a higher rupture force compared to apamin interactions
with the plasma membrane. Binding forces were measured over a 1µm2 area of HEK293T
plasma membrane in cells transfected with SK2-S. For each recording, 1024 force-distance
curves were obtained with a lateral resolution of 31.25nm. Potassium channel width has been
reported to be ~10nm [276]. Figure 7.4.1Ci shows an example of a SK2-S binding force map
with rupture forces detected between 21.0 to 56.4 pN for events above baseline. Such events
were detected in 4.56 ± 0.75% of sampled sites (n=6). We also investigated the dynamics of the
apamin SK2-S interaction by recording the force-distance curves at different cantilever
retraction rates (2400 pN/s, 32 ± 7 pN; 24000 pN/s, 33 ± 10 pN; 240000 pN/s, 34 ± 10 pN; n=3).
The mean binding force did not depend on the retraction rate suggesting that the observed
interactions between apamin and SK2-S were at thermodynamic equilibrium [104].

To determine the specificity of the measured binding forces, we repeated experiments in SK2-S
transfected cells pre-incubated with apamin as well as untransfected HEK293T cells. As shown
in Figure 7.4.1C and 7.4.1D, we found that the frequency of binding force events was not
significantly different between SK2-S transfected cells pre-incubated with apamin (Figure
7.4.1Cii) and untransfected cells (Figure 7.4.1Ciii). Events with significant binding forces most
likely reflected SK2-S channels that were not bound by bath-applied apamin. Lastly, we
measured SK2-S current using patch clamp electrophysiological recordings to verify that the
expressed channels were functional and apamin-sensitive (Figure 7.4.1E).

Do the detected events indicate the presence of a single SK channel? To answer this question,
we transfected varying concentrations of two SK channel isoforms, SK2-S and SK2-L in
HEK293T cells. Previously it has been shown that the SK2-L isoform tends to form clusters
possibly due to its cysteine rich N-terminus [273], unlike the SK2-S isoform. We found that
increasing the concentration of transfected SK2-S plasmid (0.5 to 3.0 µg) did not substantially
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change the mean binding force of detected events (0.5 µg, 27 ± 7 pN; 1.5µg, 32 ± 8 pN; 3.0 µg,
31 ± 10 pN) (Figure 7.4.2A). By plotting a histogram of binding forces, a unimodal Gaussian
distribution was obtained for each concentration. The unimodal distribution together with the
unchanged mean binding force suggested that we primarily detected a single population of SK2S channels with no more than one SK2-S channel per 31.25nm.

A different situation was encountered with the SK2-L isoform. Increasing the concentration of
transfected SK2-L plasmid from 0.1µg to 3.0µg substantially increased the mean binding force
(0.1µg, 27 ± 6 pN; 1.5µg, 44 ± 10 pN; 3.0µg, 43 ± 11 pN) (Figure 7.4.2B). Cells transfected with
0.1µg of SK2-L resulted in force distributions similar to experiments on cells transfected with the
SK2-S isoform, suggesting that at this very low concentration single SK2-L channels can be
identified. At the higher concentrations of 1.5 and 3.0µg, the mean binding forces for SK2-L
were approximately twice as large as the mean force obtained with 0.1µg SK2-L or the nonclustering SK2-S.

Considering that both isoforms share the same apamin binding site sequence [273], the higher
mean binding force most likely reflected the presence of two SK2-L channels per recorded site.
If this was the case, cells pre-incubated with 20pM apamin should have a similar mean binding
force to the value obtained for single SK2-L channels. This is because the dissociation constant
(KD) for apamin binding to SK2 channels is ~10pM [274]. Thus, in the presence of 20pM apamin
at least one of the two SK2-L channels in a cluster should be occupied by apamin thereby
becoming unavailable for detection by the AFM probe. Indeed, in cells transfected with 3µg
SK2-L and in the presence of ambient 20pM apamin, the binding force histogram became
bimodal (Figure 7.4.2C) with a major peak at 27 ± 5 pN (n=5), a value similar to that obtained
with low plasmid concentrations (27 pN; Figure 7.4.2D). A minor second peak was also
recorded (39 ± 9 pN, n=5) likely reflecting remaining clustered channels not bound by the pre-
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applied apamin. In summary, our data suggest that the apamin-dependent binding forces
measured by AFM are specific and can be used to quantitatively map SK channels on living cell
surfaces.

Figure 7.4.2. Counting SK2 channels in living cells. Binding force map and corresponding
frequency histograms of HEK293T cells transfected with (A) 3.0 µg SK2-S (n=6), 1.5 µg SK2-S
(n=6), and 0.5 µg SK2-S (n=6), (B) 0.1 µg SK2-L (n=6), 1.5 µg SK2-L (n=6), and 3.0 µg SK2-L
(n=6). (C) Binding force frequency histograms of HEK293T cells transfected with 3.0 µg SK2-L
(n=5) in cells pre-incubated with 20 pM apamin. (D) Summary graph showing the relationship
between binding force and increased levels of SK2-L transfection. Scale bars, 250 nm. Color
scale as shown.
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After establishing the technique in HEK293T cells, we next employed AFM using apaminfunctionalized tips to map the subcellular distribution of native SK channels in cultured
hippocampal pyramidal neurons. Although SK channels play a critical role in hippocampal
neurons, there is no consensus about their subcellular localization with some studies indicating
a somatic localization of SK channels [272] whereas others a more dendritic localization of SK
channels [268-269]. We probed different 1µm2 cell surface regions, focusing on the soma and
dendrites (Figure 7.4.3). Based on our recordings, SK channel distribution in neurons was
polarized with the highest binding event frequency found on dendritic regions furthest from the
soma (>30 µm) (6.2 ± 1.1%, n = 11), and the lowest frequency at the soma itself (0.29 ± 0.1%, n
= 5), a 20-fold difference (Figure 7.4.3A-C; p<0.001 Student’s t-test). The frequency of binding
events at dendritic areas proximal to the soma (~10-20µm) was 0.70 ± 0.2% (n=7). Interestingly,
the binding force distribution at more distal dendritic regions (>30µm) did not follow a unimodal
distribution, but instead was best fitted as a mixture of two Gaussians with peaks at 22 ± 6 pN
and 41 ± 14 pN (Figure 7.4.3A). These values are similar to those we obtained for single and
clustered channels in HEK293T cells (Figure 7.4.2), suggesting that native SK channels are
distributed as single channels or as groups of two channels in distal dendritic regions of
hippocampal pyramidal neurons. Therefore, the density of SK channels on dendritic surfaces is
~60-90 channels/µm2, assuming a 6.2% event detection frequency over the 1024 samples in the
1µm2 area (Figure 7.4.3).

The absence of apamin-sensitive SK channels at the soma was intriguing given that they had
been detected in the soma of cultured pyramidal neurons in prior studies [264]. However, this
work focused on the localization of transfected SK2-S channels rather than endogenous
channels and may have resulted in artificially high levels of SK2 channels throughout the cell.
To determine whether overexpression changed the distribution of channels, we overexpressed
SK2-S channels in cultured hippocampal pyramidal neurons and repeated measurements with
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the apamin functionalized AFM probe. In this situation, binding forces were readily detectable at
the soma from SK2-S transfected neurons (Figure 7.4.3D). The binding force histogram could
be fitted as a mixture of two Gaussians, with peaks of 40 ± 11 pN and 67 ± 14 pN (Figure
7.4.3D), values approximately two- and three-fold greater than the mean binding force for a
single SK channel. This confirms that overexpressed SK2 channels are localized to the soma
and suggests that they cluster in groups of two to three channels. However, the absence of
significant binding events in the soma of untransfected neurons indicates that native SK
channels are minimally expressed in this subcellular compartment.

Figure 7.4.3. SK channels are polarized in pyramidal neurons. (A) Binding force maps and
corresponding histogram showing detected SK2 channels on the distal region of the dendrite
(n=11). (B) Binding force maps and corresponding histogram showing detected SK2 channels
on the proximal region of the dendrite (n=7). (C) Binding force maps and corresponding
histogram showing the detection of SK2 channels on the soma (n=7). (D) Binding force maps
and corresponding histogram showing the detection of SK2 channels on the soma after
transfection with SK2 channels (n=6). Scale bars, 250 nm. Color scale as shown.
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Finally, we used the quantitative nature of this technique to determine how the dendritic SK
channel distribution changes in response to neuromodulation. SK channel activity is affected by
multiple neuromodulators, often through generation of cAMP and subsequent activation of
protein kinase A (PKA). Studies in neurons and heterologous cells have shown that application
of forskolin, a strong PKA activator, causes the internalization of SK2 channels from cell
surfaces [277-278]. Therefore, we measured binding events in neurons that had received either
15µM or 30µM forskolin for 15 minutes. Compared to untreated neurons, the more distal
dendrites (>30µm from the soma) of forskolin-treated neurons exhibited fewer apamindependent binding events (Figure 7.4.4). Interestingly, the mean binding force histograms are
different in all three conditions (Figure 7.4.4C): 1) in untreated neurons there is a bimodal
histogram with relatively equal peaks at 22 and 44 pN; 2) the histogram for neurons treated with
15 µM FSK is bimodal with a larger peak at 31 pN and a smaller peak at 42 pN; and 3) the
apamin binding force histogram follows a unimodal distribution after 30 µM forskolin treatment
centered on 27 pN. The peak in the presence of 30 µM forskolin is centered at 27 pN a value in
between the two peaks in the untreated neurons, thus making it difficult to conclude whether
clusters were preferentially lost. Future studies are needed to explore the effect of FSK on the
SK channels subcellular distribution.

7.5. Discussion
In this work we show that integration of single molecule AFM with toxin pharmacology allowed
us to map the spatial organization and density of endogenous SK channels in living neurons. By
taking advantage of the nanometer resolution of single molecule AFM, we demonstrate that SK
channels are highly concentrated on neuronal dendrites. Importantly, we show that SK channels
are organized on neuronal membranes as either groups of two or single entities. This differential
clustering might represent the distribution of the two SK2 channel isoforms, plasma membrane
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diffusional barriers, or areas of exocytosis. Currently, we cannot distinguish between these
alternatives.

Figure 7.4.4. SK channel maps in pyramidal neurons are dynamic. (A) Binding force maps
showing detected SK2 channels without FSK on the soma, proximal dendrite, and outward
dendrite. (B) Binding force maps showing a significant decrease in detected SK2 channels after
administration of 30 µM FSK for 15 minutes. (C) Binding force histograms showing the
distribution of rupture forces in the native state (tan, background) and after 15 µM (green; n=4)
and 30 µM FSK administration (red, foreground; n=6). Scale bars, 250 nm. Color scale as
shown.

The high density of SK channels in dendrites is also consistent with electrophysiological and
imaging work showing that SK channels are critical in regulating dendritic integration [279],
controlling the kinetics of excitatory postsynaptic potentials, and induction of long-term
potentiation, and learning and memory [267]. But is there a particular advantage for the high SK
channel concentration in dendrites? We suggest that high SK channel concentration might
increase the gain and reliability of SK channel activation. This might be necessary as SK
channels are found in calcium microdomains. That is, SK channels and calcium channels are
found within 100-150nm distances from each other, unlike BK channels that are in calcium

98

nanodomains (10-30nm) [280]. As the calcium concentration decays very rapidly following
calcium channel closure, the likelihood of activating SK channels would also decrease quickly.
SK channels partly counteract this effect by having high calcium affinity (Km: ~500-700nM)
[280]. However, SK channel activation might also be boosted though their high dendritic density.
This will further increase their prospect of activation, as more SK channels will be available to
capture calcium. Future studies and modeling are required to test this possibility and to examine
whether high SK channels density could lead to buffered diffusion of calcium within the SK
channel clusters [281]. Calcium buffered diffusion will further increase the probability of SK
channel activation.

In conclusion, by using naturally derived toxins that bind with high affinity to ion channels, we
can map the subcellular distribution of native ion channels at the cell surface. Over the years,
toxins have emerged as an invaluable tool to study ion channels physiology as well as the
relationship between their structure and function [282]. Other studies have also used toxins for
ion channel localization however, these studies relied on non-living tissue and the use of either
radioactive labeled toxins or toxins conjugated with fluorescence probes. Although conjugating
toxins with fluorescent dyes would allow for the determination of ion channel density in living
neurons, it would be difficult to visualize ion channels on the single channel level without
appropriate computational tools. Integration of toxin pharmacology with single molecule AFM
bypasses these issues, as it only requires knowledge of the forces between the toxin and the
ion channel of interest. We expect our approach to have a significant impact to the study of ion
channels and other surface proteins for which high affinity toxins exist.
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Chapter 8. AKAP-Dependent Modulation of BCAM/Lu Adhesion on Normal and
Sickle Cell Disease RBCs Revealed by Force Nanoscopy

8.1. Abstract
Human normal and sickle red blood cells (RBCs) adhere with high affinity to laminin via the
basal cell adhesion molecule/Lutheran (BCAM/Lu) receptor which is implicated in vasoocclusive
episodes (VOEs) in sickle cell disease (SCD) and activated through the cyclic adenosine
monophosphate (cAMP) signaling pathway. However, the effect of the cAMP pathway on the
expression of active BCAM/Lu receptors at the single-molecule level is unknown. We
established an in vitro technique, based on atomic force microscopy, which enables detection of
single BCAM/Lu proteins on the RBC surface and measures the unbinding force between
BCAM/Lu and laminin. We showed that the expression of active BCAM/Lu receptors is higher in
homozygous sickle RBCs (SS-RBCs) than normal RBCs and that it is critically dependent on
the cAMP signaling pathway on both normal and SS-RBCs. Importantly, we illustrated that Akinase anchoring proteins (AKAPs) are crucial for BCAM/Lu receptor activation. Furthermore,
we found that SS-RBCs from hydroxyurea-treated patients show a lower expression of active
BCAM/Lu receptors, a lower unbinding force to laminin, and insignificant stimulation by
epinephrine as compared to SS-RBCs from untreated patients. These findings may lead to
novel anti-adhesive targets for VOEs in SCD.

8.2. Introduction
Red blood cells (RBCs) express several surface adhesion receptors known to modulate cellular
physiology [62, 122]. In sickle cell disease (SCD) [28-29], cytoadherence of RBCs to endothelial
laminin via the basal cell adhesion molecule/Lutheran (BCAM/Lu) receptor is thought to be a
major contributor to and possibly the primary cause of vasoocclusive episodes (VOEs) [64, 71].
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On normal and homozygous sickle RBCs (SS-RBCs), the activation of adhesion receptors can
be modulated by hormones such as epinephrine [30, 72], pharmaceutical drugs such as
hydroxyurea [73, 78], and other biochemical stimuli [283]. Because SCD patients have
extensive endothelial damage [80] and elevated plasma levels of laminin [81], RBC adhesion
studies have focused on the specific interaction between BCAM/Lu and the α5 chain on laminin
(LAMA5), a component of the subendothelial matrix [82-83, 284]. Although it is known that this
interaction is mediated by cyclic adenosine monophosphate (cAMP) [72], the effects of the
cAMP signaling pathway on the expression of BCAM/Lu receptors and on the interaction
between BCAM/Lu and LAMA5 at the single-molecule level are unknown. Further, it is unknown
if scaffold or anchoring proteins, such as A-kinase anchoring proteins (AKAPs) [88], play a role
in BCAM/Lu receptor activation. It is also unknown, at the single-molecule level, if treatment with
hydroxyurea (HU) modulates BCAM/Lu receptor expression or modifies the strength of the bond
between BCAM/Lu and LAMA5.

In this paper, we employed single-molecule atomic force microscopy (AFM) [30, 96, 285] to
quantitatively study the modulation of BCAM/Lu expression on the membrane of normal and
SS-RBCs. Single-molecule AFM measures the unbinding force between a specific ligand and its
corresponding receptor on a single cell with piconewton sensitivity [89, 91-92, 132]. We
detected the unbinding force between BCAM/Lu and LAMA5, which is interpreted as adhesive
force. The generated data are used to calculate the expression of active BCAM/Lu receptors on
the RBC surface and their spatial distribution on the membrane at high resolution (~30 nm) [30,
91, 286].

Previous experimental approaches utilizing flow adhesion assays [72] have shown that in SSRBCs, the interaction between BCAM/Lu and LAMA5 is strongly mediated by cAMP-dependent
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protein kinase A (PKA) [72, 83]. Stimulation of the β2-adrenergic receptor (β2-AR) [85-86]
activates the G-protein coupled receptor Gαs, which stimulates adenylyl cyclase (AC) [87]. AC
then catalyzes the conversion of adenosine triphosphate (ATP) to cAMP, resulting in PKA
activation and ensuing BCAM/Lu-laminin adhesion. Normal RBCs, however, adhere minimally
to the vascular endothelium [122] and their response to stimulation by epinephrine or forskolin
has not been detected by flow adhesion experiments [72]. Here, by using a single-molecule
assay, we clearly detected variability in the expression of BCAM/Lu on normal and SS-RBCs as
it is modulated by the cAMP signaling pathway.

It is currently unknown if the scaffold protein AKAPs [88] play a role in BCAM/Lu receptor
activation by localizing PKA activity to specific subcellular domains within RBCs. In other cell
types, it has been found that PKA activity is localized within the cell by attachment of the PKA
molecule to an AKAP. Specifically, a PKA tetrameric holoenzyme [79], consisting of two
catalytic and two regulatory subunits, binds to an AKAP via its regulatory subunits. The resultant
PKA/AKAP complex is localized to a unique subcellular domain due to the AKAP-specific
targeting domain [85, 287]. In this work, we showed that AKAPs mediate the activation of
BCAM/Lu by PKA in RBCs, signifying that cAMP activates PKA locally, close to the cell
membrane.

Hillery et al. [78] first demonstrated that SS-RBCs from patients receiving hydroxyurea undergo
a decrease in adhesion to LAMA5. This finding was contrasted by another result [288] showing
that the expression of BCAM/Lu receptors on SS-RBCs from HU-treated patients increased. A
resolution to this conflicting evidence was offered by a recent work which demonstrated that the
reduced adhesion of SS-RBCs to LAMA5 is likely due to inhibition of BCAM/Lu phosphorylation
by HU [73]. However, it is still unclear if the lower adhesion is only due to the reduced
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expression of active BCAM/Lu receptors as a result of inhibition of BCAM/Lu phosphorylation, or
if HU also affects the unbinding force between BCAM/Lu and LAMA5. In our experiments, we
measured the expression and unbinding force to LAMA5 of active BCAM/Lu receptors on SSRBCs from untreated and HU-treated patients. We found that both the expression and adhesive
force of active BCAM/Lu molecules is decreased in HU-treated patients. These data
demonstrate a very beneficial effect of HU in reducing the propensity of SS-RBCs to adhere to
LAMA5.

In summary, we employed single-molecule AFM to investigate interactions between RBCs and
the endothelium, and their regulation via cAMP. We quantified cAMP-dependent modulation of
active BCAM/Lu receptor expression in normal and SS-RBCs. We are first to demonstrate that
AKAPs are crucial for the activation of BCAM/Lu receptors. Lastly, we showed that HU
treatment results in decreased erythrocyte adhesion to the endothelium due to lower expression
of BCAM/Lu receptors and lower binding forces between BCAM/Lu and LAMA5.

8.3. Methods
Patients and blood samples
Homozygous SCD patients (SS) at steady-state, and age-/race-matched healthy volunteers at
least 18 years old were eligible to participate in this study which was approved by the
Institutional Review Boards of the UCONN Health Center and UCONN-Storrs. Individuals with
SCD were eligible to participate if they had not been transfused in ≥ three months and were not
having an acute VOE, suggesting a phenotype of milder severity. A complete blood count test
was obtained for each patient. The untreated patients average HbF concentrations of 9.6±4.0%
(range: 0%–18.2%), while HU-treated patients average 34.1% (range: 18.1%-56.1%).
Reticulocyte percentages average 10.8±2.0% (range: 4.2%-15.7%) for untreated patients and
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4.1±0.9% (range: 2.3%-6.7%) for HU-treated patients. Healthy volunteers were eligible to
participate if they did not have a blood disorder or hemoglobinopathy, which was confirmed by
screening blood samples via hemoglobin electrophoresis. Experiments were performed using
fresh-drawn, heparin-anticoagulated venous blood.

Red blood cell preparation
Whole blood was centrifuged at 500g for 10min at 4°C to isolate RBCs. The buffy coat was
aspirated and discarded. RBCs were washed 3x with Alsever’s solution. RBCs were
immobilized by incubation on a poly-l-lysine coated glass petri dish for 10min at 37°C and
unattached RBCs were removed by rinsing.

Reagents
Human laminin subunit alpha-5 (LAMA5) was obtained from MyBioSource (San Diego, CA), StHt31 inhibitor peptide and St-Ht31P control peptide (reconstituted in Alsever’s solution) were
obtained from Promega (Madison, WI). Alsever’s solution, forskolin (Coleus forskohli)
(reconstituted in DMSO), Rp-Adenosine 3’,5’-cyclic monophosphorothioate triethylammonium
salt (Rp-cAMPS; reconstituted in DMSO), KT-5720 (reconstituted in methanol), epinephrine
(reconstituted in Alsever’s solution), bovine serum albumin (BSA; reconstituted in PBS) were
purchased from Sigma Aldrich (St. Louis, MO).

Preparation of LAMA5 probes
Silicon nitride cantilevers (Bruker Probes, Camarillo, CA) were silanized with 2% v/v 3aminopropyltriethoxysilane in acetone (10min), then rinsed with deionized (DI) water and
immersed in glutaraldehyde (0.5%, 30min). Cantilevers were rinsed with DI water, incubated in
LAMA5 solution (100μg/mL, 30min), rinsed again, and incubated in BSA (100μg/mL, 5min) to
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block remaining aldehyde groups. Cantilevers were stored at 4°C and utilized within 48 hours.

Atomic force microscopy assays
Force-distance curves were recorded between laminin-functionalized probes and BCAM/Lu
receptors on the RBC surface (Figure 8.3.1A) using the MFP-3D-BIO AFM (Asylum Research,
Santa Barbara, CA). An unbinding force is defined as the maximum rupture force associated
with the force-distance curve. A representative curve highlighting regions of the approach and
retraction cycle is shown in Figure 8.3.1B. On surface regions void of BCAM/Lu receptors, we
expected the unbinding force to be approximately zero, while unbinding forces are significantly
higher in regions where the laminin-functionalized cantilever made contact with active BCAM/Lu
receptors. Unbinding forces were measured on 1μm x 1μm areas of the RBC membrane with a
lateral resolution of 31.25nm (1024 sampled sites per experiment). To determine the spatial
distribution of BCAM/Lu receptors on the RBC surface, unbinding forces were plotted as a force
map (Figure 8.3.1D) using MATLAB (Mathworks) in which the color of each square indicates the
magnitude of the corresponding unbinding force obtained from an individual curve [30].

An inverted microscope (Zeiss Axiovert A1) was used to position the AFM cantilever in contact
with a chosen RBC (Figure 8.3.1C). Chosen RBCs were less than 10µm in diameter and
exhibited a distinct biconcave shape, suggesting RBC maturity. Experiments were performed in
Alsever’s solution at 37°C, and biochemical modulators were added at least 30min prior to
experiments. For each assay, 3 RBCs were tested from each subject’s blood. Values reporting
“N = ” denote the number of unique donors per condition and “n = ” denote the total number of
tested cells. Measurements were recorded with a loading rate of 24000pN/s [30]. The nominal
spring constant of the employed cantilever was 30pN/nm and the exact spring constant value
was obtained via a thermal noise-based method and used in all calculations [289].

105

Figure 8.3.1. Measurement of the frequency of active BCAM/Lu surface receptors and the
unbinding force with LAMA5 on RBCs using AFM. (A) AFM cantilever probe functionalized with
LAMA5. Illustration corresponds to the force curve shown in (B). (B) Force curve obtained from
experiments highlighting regions of the approach and withdrawal of the cantilever from the
sample. When LAMA5 attached to the AFM probe adheres to a BCAM/Lu receptor on the cell,
the force-displacement curve exhibits an abrupt shift to zero which corresponds to the rupture
force (red curve). If there is no BCAM/Lu receptor at the detection point and consequently no
adhesive interaction, then the retraction curve is similar to the black curve. Specific regions are
as follows: (i) No interaction between the tip and cell; (ii) Functionalized cantilever deflects
downward towards the cell as a result of van der Waals forces; (iii) Positive deflection of the
cantilever due to repulsive forces; (iv) Negative deflection of the cantilever tip as a result of
adhesion forces between the tip and the cell. (C) Representative optical microscopy image
showing a human RBC and an AFM cantilever probe. (D) Unbinding force maps of single
normal RBCs (i) in the absence and (ii) presence of bath laminin to mask BCAM/Lu binding
sites. (iii) Unbinding force maps of single normal RBCs in epinephrine (1μM) show an increase
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in active BCAM/Lu receptors. Scale bars, 250nm. Color scale as shown. (E) Frequency
distributions of measured unbinding forces fit with the Gaussian model to obtain the average
unbinding force and (F) box-whisker plot of the collective frequency of detected BCAM/Lu
receptors on normal RBCs per experimental condition. Data are presented as median with max
and min whiskers and the average denoted as (+).The ‘n’ on the x-axis indicates the total
number of mature RBCs analyzed in each group, obtained from the following numbers of human
subjects: – Bath laminin: 4 subjects; + Bath laminin, + Epinephrine: 3 subjects. Significance
relative to – bath laminin is denoted as * such that p<0.05 and ** such that p<0.005 (two-tailed ttest).

Statistical methods
Values for the unbinding force between BCAM/Lu and LAMA5 are reported as average ±
standard deviation (SD) as determined by a frequency distribution fit with the Gaussian model
(GraphPad Prism). In the frequency (%) distribution, each bin contains the number of unbinding
forces with values within the bin’s range divided by the total number of sampled sites. We note
that the frequency of zero force points is not shown since it is much larger than the frequency of
non-zero force points and would obscure the graphs. Collective frequency (%), denoted CF, is
defined as the total number of all non-zero force points, without respect to specific unbinding
forces, divided by the total number of sampled sites for each experimental condition. It is
reported as average ± standard error of the mean (SEM) and is illustrated by box-whisker plots.
The collective frequency of active receptors was compared between groups using a one-way
ANOVA with the Tukey post hoc test, and between two conditions using a two-tailed t-test.
Results were considered significant if p<0.05.

8.4. Experimental Validation
Immunofluorescence following probe functionalization
Immunofluorescence was used to validate cantilever functionalization with LAMA5. Freshly
prepared cantilevers were incubated (1 hour at 25°C) with anti-LAMA5 antibody (200 μg/mL)
conjugated to AlexaFluor®488 (EMD Millipore). Fluorescent images were obtained using a
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Leica TCS SP2 Confocal Microscope (Figure 8.4.1.). Negative controls were produced using the
specific anti- LAMA5 antibody with non-functionalized probes and with probes functionalized
with the toxin apamin.

Figure 8.4.1. Immunofluorescence following probe functionalization.

Scan area determination
To determine the ideal scan area for the detection of active BCAM/Lu receptors, we recorded
unbinding force maps on 2 μm x 2 μm areas of the RBC membrane with a lateral resolution of
31.25nm (4096 sampled sites per experiment). Multiple cells (n=10) were scanned from one
healthy subject. Using a MATLAB script, each 2μm x 2μm binding force map was then divided
into areas of the following sizes: 1 μm x 1 μm, 500 nm x 500 nm, and 250 nm x 250 nm.

First, the frequency of detected receptors was calculated for each unbinding force map. For
each cell, the total number of force maps is as follows: 2 μm x 2 μm, n = 1; 1 μm x 1 μm, n = 4;
500 nm x 500 nm, n = 16; 250 nm x 250 nm, n = 64. The results are illustrated using a boxwhisker plot of the collective frequency of detected BCAM/Lu receptors for each scan size
(Figure 8.4.2). The ‘n’ on the x-axis indicates the total number of scan areas analyzed in each
group, obtained from n=10 RBCs from one healthy subject. Using a one-way ANOVA with the
Tukey post hoc test and Bartlett’s test, we find that differences among the standard deviations
are statistically significant (p < 0.0001). As expected, there is no difference among the means.
Analysis was also performed on individual cells, yielding the same result. To validate this result,
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the D’Agostino-Pearson omnibus test was employed to determine if the collective frequency
values exhibit normality. It was determined that 500 nm x 500 nm and 250 nm x 250 nm
unbinding force maps do not exhibit normality (p<0.0001). To make experimental testing more
efficient, we performed all atomic force microscopy tests on 1μm x 1μm areas of the RBC
membrane.

Figure 8.4.2. Scan area size determination. Box-whisker plot of the collective frequency of
detected BCAM/Lu receptors for each scan size. Data are presented as median with max and
min whiskers. The ‘n’ on the x-axis indicates the total number of scan areas analyzed in each
group, obtained from n=10 RBCs from one healthy subject.

Specificity of experimental assay
To determine the specificity of the measured unbinding forces, we performed experiments on
normal RBCs at baseline and on normal RBCs pre-incubated with laminin. As shown in Figure
8.4.3, we found that the frequency of binding force events significantly decreased on RBCs preincubated with laminin (p < 0.01, from 4.23 ± 1.27% to 0.868 ± 0.197%). Furthermore, the
unbinding force decreased in the presence of bath laminin (from 43.45 ± 9.64 pN to 35.42 ±
6.72 pN) Events with significant binding forces most likely reflected BCAM/Lu receptors that
were not bound by bath-applied laminin.
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Figure 8.4.3. Specificity of unbinding forces.

8.5. Results
Single-molecule measurement of active BCAM/Lu receptors on normal RBCs
We first performed experiments on normal RBCs in Alsever’s solution to determine the baseline
frequency (- bath laminin) of active BCAM/Lu receptors and the unbinding force of BCAM/Lu to
LAMA5. Figure 8.3.1D(i) shows representative BCAM/Lu-LAMA5 force maps with forces
detected between 21.66 and 65.39pN. The frequency of non-zero unbinding forces detected on
normal RBCs is shown in Figure 8.3.1E. By accumulating all of the non-zero unbinding forces
per cell we obtained the collective frequency, as explained in the methods. The results,
illustrated using a box-whisker plot, show that unbinding forces were detected in 3.31±0.67% of
sampled sites (Figure 8.3.1F).

To determine the specificity of measured unbinding forces, we repeated experiments on normal
samples preincubated with laminin. As shown in Figures 8.3.1D(ii),F, the CF of events detecting
unbinding forces on RBCs preincubated with laminin (+ bath laminin) was 0.89±0.21%, which is
significantly lower (p<0.01) than the baseline frequency (- bath laminin, CF: 3.31±0.67%).
Recorded unbinding forces likely reflected BCAM/Lu receptors that were not bound by bath
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laminin. To establish that the assay can detect variations in the number of active BCAM/Lu
receptors, we preincubated RBCs with epinephrine (1μM), a β-AR agonist known to increase
BCAM/Lu binding to LAMA5, and found that events were detected in 10.27±2.02% of sampled
sites, a significant increase (p<0.001) in the CF from baseline (Figure 8.3.1D(iii),F). Frequency
distributions (Figure 8.3.1E) show that while the average unbinding force between BCAM/Lu
and LAMA5 did not change in these experimental conditions, the frequency of detected events
changed significantly. Further, the data in Figure 8.3.1F illustrate that the AFM-based assay can
detect differences in the collective frequency of active BCAM/Lu receptors on normal RBCs at
baseline and preincubated with laminin or epinephrine.

BCAM/Lu adhesion of normal RBCs to endothelial laminin is PKA-dependent
Taking advantage of the high-resolution and high-sensitivity of single-molecule AFM, we
investigated changes in the frequency of active BCAM/Lu receptors on normal and SS-RBCs
via pharmacologic modulation of the cAMP-PKA pathway. First, we treated normal RBCs with
forskolin (30μM, FSK), a strong AC activator that stimulates cAMP production, subsequently
activating PKA. Compared to untreated RBCs, forskolin-treated RBCs exhibited significantly
more unbinding events as shown by the frequency distribution and box-whisker plots (Figure
8.5.1A,C; CF: 18.19±4.68%; p<0.001). Previous evidence suggests that the interaction between
BCAM/Lu and LAMA5 is stimulated significantly by FSK in SS-RBCs but insignificantly in normal
RBCs [72]. These studies used a FSK concentration (80μM) much higher than that currently
used (30μM). To understand the discrepancy between ours and previous results, we
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Figure 8.5.1. Distribution of BCAM/Lu on normal RBCs and unbinding force of BCAM/Lu to
LAMA5. (A) Unbinding force maps and corresponding unbinding force frequency histograms of
normal RBCs measured at baseline and after treatment with 30μM FSK, and (B) measured in
the presence of the PKA inhibitors Rp-cAMPS and KT-5720. (C) Box-whisker plot showing the
collective frequency of detected BCAM/Lu receptors on normal RBCs for the biochemical
modulators indicated on the x-axis, presented as in Figure 8.3.1. The ‘n’ on the x-axis indicates
the total number of mature RBCs analyzed in each group, obtained from the following numbers
of human subjects: Baseline: 4 subjects; FSK (30μM), Rp-cAMPS, KT-5720: 3 subjects.
Significance relative to baseline is denoted as * such that p<0.001 (ANOVA, Tukey post hoc
test).
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used the higher concentration of FSK employed in the previous study [72]. In this case, we
found that the interaction between BCAM/Lu and LAMA5 was stimulated (data not shown; CF:
10.10±1.89%, N=3, n=9) significantly more than normal RBCs at baseline (p<0.05), albeit not
significantly more than those treated with 30μm FSK. It is possible that flow adhesion assays,
which measure the average adhesion of a large number of erythrocytes to a functionalizedsubstrate under flow-induced shear stress, are not sensitive enough to detect increases in the
overall low adhesion of normal RBCs.

To quantify the effect of PKA inhibition on the frequency of active BCAM/Lu receptors, we
treated RBCs with Rp-cAMPS (100μM), a strong inhibitor of PKA activation by cAMP. RBCs
pretreated with Rp-cAMPS exhibited fewer unbinding events (Figure 8.5.1B-C; CF: 1.17±0.47%)
than normal RBCs at baseline. An apparent decrease in the unbinding force following
preincubation with Rp-cAMPS compared to baseline results is statistically insignificant. Next, we
directly inhibited PKA using KT-5720 (1μM) and recorded a decrease in the unbinding event
frequency (Figure 8.5.1B-C; CF: 2.16±0.41%), albeit not as large as with Rp-cAMPS. Figure
8.5.1C shows a box-whisker plot summarizing changes in the collective frequency of active
BCAM/Lu receptors on normal RBCs in response to cAMP-dependent pathway modulation. It is
clear that there is a significant increase in the collective frequency of active BCAM/Lu receptors
resulting from 30μM forskolin, demonstrating that our system can detect changes in the
adhesive properties of human RBCs in response to increases in intracellular cAMP.

SS-RBCs demonstrate greater PKA-dependence of BCAM/Lu adhesion to endothelial
laminin than normal RBCs
After establishing our single-molecule AFM technique on normal RBCs and confirming that we
can detect differences in the frequency of active BCAM/Lu in response to cAMP-dependent
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Figure 8.5.2. Distribution of BCAM/Lu on SS-RBCs and unbinding force of BCAM/Lu to LAMA5.
(A) SS-RBCs show a significantly greater number of BCAM/Lu surface receptors than normal
RBCs at baseline. Measurement after treatment with (B) 30μM FSK, (C) 100μM Rp-cAMPS,
and (D) 1μM KT-5720 indicate that SS-RBCs behave similar to normal RBCs upon cAMP-PKA
pathway modulation. (E) Box-whisker plot of the collective frequency of detected BCAM/Lu
receptors on SS-RBCs for the biochemical modulators indicated on the x-axis. The ‘n’ on the xaxis indicates the total number of mature RBCs analyzed in each group, obtained from the
following numbers of human subjects: Baseline: 5 subjects; FSK (30μM), Rp-cAMPS, KT-5720:
4 subjects. Significance relative to baseline is denoted as * such that p<0.05 and ** such that
p<0.01 (ANOVA, Tukey post hoc test).
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pathway modulators, we applied the same experimental approach to SS-RBCs. In agreement
with previous reports [72, 122], we measured a significant increase in the frequency of
BCAM/Lu receptors on SS-RBCs (Figure 8.5.2A,E; CF: 8.89±2.05%) as compared to normal
RBCs (p<0.01). Next, we quantified changes in the frequency of active BCAM/Lu receptors on
SS-RBCs in response to cAMP-dependent pathway modulation. Following preincubation with
FSK (30μM), we observed an increase in the CF to 20.56±3.63% on SS-RBCs, which was
significantly greater than that measured at baseline (Figure 8.5.2E; p<0.01) and similar to that
observed on normal RBCs (Figure 8.5.2B). Importantly, when treated with Rp-cAMPS, the
adhesion level of SS-RBCs reduced to that of normal RBCs treated with Rp-cAMPS. However,
preincubation with KT-5720 (Figure 8.5.2D) did not decrease the BCAM/Lu receptor frequency
on SS-RBCs to the adhesion level of normal RBCs, but still significantly decreased below the
baseline measurement to 2.66±1.02% (Figure 8.5.2E; p<0.05). Frequency distributions illustrate
that the response to modulation of BCAM/Lu on SS-RBCs was analogous to that on normal
RBCs (Figure 8.5.2B-D). Further, the collective frequency of detected BCAM/Lu receptors was
highly sensitive to cAMP-dependent pathway modulators (Figure 8.5.2E).

A-kinase anchoring proteins regulate BCAM/Lu adhesion
After establishing that our assay can detect cAMP-dependent modulation of active BCAM/Lu
receptors on normal and SS-RBCs, we investigated the possibility of localized BCAM/Lu
activation via AKAPs [85, 287]. To detect the presence of AKAPs on normal and SS-RBCs, cells
were treated with St-Ht31 peptide (5μM), which inhibits binding of PKA to AKAPs. Our
experiments revealed that following pretreatment with St-Ht31, the CF of active BCAM/Lu
receptors decreased significantly in normal RBCs (Figure 8.5.3A-B; CF: 5.71±1.23% to
3.15±1.09%; p<0.05) and in SS-RBCs (Figure 8.5.3C-D; CF: 7.19±1.42% to 2.02±0.37%;
p<0.005). As a negative control, RBCs were pretreated with St-Ht31P control peptide (5μM),
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Figure 8.5.3. Modulation of BCAM/Lu via AKAPs on the RBC membrane. (A) Measurements in
5μM St-Ht31 inhibitor peptide demonstrate the presence of AKAPs on normal RBC membranes
as revealed by the reduction of the frequency of active BCAM/Lu receptors. (B) Box-whisker plot
of the collective frequency of detected BCAM/Lu receptors on normal RBCs for the biochemical
modulators indicated on the x-axis, presented as in Figure 8.3.1. The ‘n’ on the x-axis indicates
the total number of mature RBCs analyzed in each group, obtained from the following numbers
of human subjects: Baseline, St-Ht31: 5 subjects; St-Ht31P: 4 subjects; St-Ht31 + FSK (30μM):
3 subjects. Significance relative to baseline is denoted as * such that p<0.05 and ** such that
p<0.005 (ANOVA, Tukey post hoc test). (C) Measurements in 5μM St-Ht31 inhibitor peptide
demonstrates the presence of AKAPs on SS-RBC membranes as revealed by the reduction of
active BCAM/Lu receptors. (D) Box-whisker plot of the collective frequency of detected
BCAM/Lu receptors on SS-RBCs for the biochemical modulators indicated on the x-axis,
presented as in Figure 8.3.1. The ‘n’ on the x-axis indicates the total number of mature RBCs
analyzed in each group, obtained from the following numbers of human subjects: Baseline, StHt31, St-Ht31P, St-Ht31 + FSK (30μM): 4 subjects. Significance denoted as in (B).
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which did not alter the collective frequency of active BCAM/Lu receptors in normal RBCs (Figure
8.5.3B; CF: 5.92±1.09%) or in SS-RBCs (Figure 8.5.3D; CF: 6.49±1.27%) as compared to
baseline measurements. To ensure that AKAP inhibition would block BCAM/Lu receptor
activation, RBCs were treated with St-Ht31 (5μM) and subsequently with FSK (30μM). On
normal RBCs, the CF of active BCAM/Lu receptors was measured to be 5.83±1.65% versus
18.19±4.68% following only FSK stimulation (Figure 8.5.3B; p<0.005). Similarly, on SS-RBCs
the CF of active BCAM/Lu receptors was measured to be 6.57±1.60% in this case versus
19.63±3.44% following only FSK stimulation (Figure 8.5.3D; p<0.005). This indicates the
presence of AKAPs in the RBC membrane and suggests their importance in the mediation of
RBC cytoadherence to the endothelium in both normal and SS-RBCs.

Hydroxyurea decreases the frequency and the strength of BCAM/Lu-dependent adhesion
events on SS-RBCs
Hydroxyurea is currently the only pharmacologic treatment to reduce the frequency of VOEs in
SCD, yet only two-thirds of patients respond favorably to the drug [74]. The drug has specifically
been found to inhibit phosphorylation of BCAM/Lu receptors and consequently to decrease SSRBC adhesion to laminin [73, 78]. Here, we investigated the quantitative effect of HU treatment
on the frequency of active BCAM/Lu receptors and on the magnitude of the unbinding force
between BCAM/Lu and LAMA5, which could be another reason for the reduced adhesion of SSRBCs to laminin. Our experiments showed that SS-RBCs from HU-treated patients have a
significantly lower frequency of active BCAM/Lu receptors than SS-RBCs from untreated
patients (Figure 8.5.4A; CF: 8.89±2.05% to 2.43±0.51%; p<0.001). Importantly, we also
detected that the unbinding force between BCAM/Lu and LAMA5 was lower on SS-RBCs from
HU-treated patients (Figure 8.5.4B; CF: 35.14±7.18pN versus 40.00±8.12pN; p<0.0001). Next,
the physiologic implication of epinephrine-stimulated adhesion of HU-treated SS-RBCs was
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studied. We treated SS-RBCs with epinephrine and found that for SS-RBCs from patients
undergoing HU-treatment, the frequency of BCAM/Lu did not increase significantly. Figure
8.5.4C shows that while the CF of BCAM/Lu receptors increased significantly following
treatment with epinephrine on both normal RBCs and untreated SS-RBCs, there was no
significant increase in hydroxyurea-treated SS-RBCs.

Figure 8.5.4. Modulation of the collective frequency of BCAM/Lu receptors on SS-RBCs from
HU-treated patients. (A) SS-RBCs from HU-treated patients (N=4, n=12) have a significantly
lower frequency of BCAM/Lu receptors than SS-RBCs from untreated patients (N=5, n=15) and
healthy subjects (N=4, n=12). (B) Normalized cumulative distribution clearly shows significant
shift in the unbinding force of BCAM/Lu and laminin on SS-RBCs from HU-treated patients
(p<0.0001). (C) Preincubation with epinephrine causes a significant increase in the collective
frequency of BCAM/Lu receptors on both normal RBCs (N=3, n=9) and SS-RBCs from
untreated patients (N=5, n=15) but not on SS-RBCs from HU-treated patients (N=4, n=12).
Significance is denoted as * such that p<0.05 and ** such that p<0.005 as computed using the ttest.
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8.6. Discussion
In this work, we established a technique, based on AFM, which enables the detection of single
BCAM/Lu molecules on the RBC surface and measures the unbinding force between BCAM/Lu
and LAMA5. The technique is used to study the effect of the cAMP signaling pathway on the
activation of BCAM/Lu receptors at the single-molecule level. Importantly, we demonstrate that
AKAPs are essential for BCAM/Lu receptor activation, and that the collective frequency of
BCAM/Lu receptors, present on both the normal and SS-RBC membrane, is critically dependent
on the cAMP pathway. Lastly, we found that SS-RBCs from hydroxyurea-treated patients have
a lower frequency of active BCAM/Lu receptors than SS-RBCs from untreated patients, and
undergo insignificant stimulation by epinephrine. We also demonstrated that the unbinding force
between BCAM/Lu and LAMA5 in hydroxyurea-treated patients is lower than in untreated
patients.

cAMP-dependent modulation of BCAM/Lu on normal RBCs
We first determined how the frequency of active BCAM/Lu receptors changes in response to
cAMP signaling. Forskolin activates AC which raises levels of cAMP and subsequently activates
the cAMP-dependent pathway. Normal RBCs treated with FSK (30μM) showed an increase in
the frequency of active BCAM/Lu receptors significantly above baseline, in accordance with
established cAMP-dependent pathway modulation. However, previous studies based on flow
adhesion assays showed that adhesion of normal RBCs via BCAM/Lu is not mediated
significantly by forskolin, likely due to low levels of intracellular cAMP [72]. In contrast, our
results indicate that normal RBC adhesion to LAMA5 via the BCAM/Lu receptor is significantly
modulated by the cAMP-dependent pathway. This difference is due to two reasons. First,
previous studies used a forskolin concentration of 80μM, which is more than 2x greater than the
concentration we initially employed (30μM). When normal RBCs were treated with 80μM FSK,
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the frequency of active BCAM/Lu receptors did not increase as significantly above the baseline
as in the case of 30μM FSK. This suggests that high concentrations of FSK may desensitize
BCAM/Lu to cAMP-dependent pathway signaling, as shown for the ICAM-4 receptor on RBCs
and signaling receptors on other cell types [249, 290-291]. Second, because the adhesiveness
of normal RBCs is low, the high-sensitivity of AFM allows for a more precise detection of active
adhesion receptors than traditional flow adhesion assays. We also note that flow adhesion
assays did not detect adhesion of non-stimulated normal RBCs to laminin [72-73].

cAMP-dependent modulation of BCAM/Lu on SS-RBCs
While the pathway by which cAMP mediates BCAM/Lu receptor activation is well-established,
the possibility that AKAPs are involved in the localization of cAMP close to the RBC membrane
has not been investigated. In the current work, we used specific biochemical modulators to
investigate the subcellular targeting of the cAMP-dependent PKA [79]. PKA activity can be
mediated by AKAPs, which sequester PKA to specific subcellular sites through binding to its
regulatory subunits [85, 287, 292]. Each AKAP contains two classes of binding sites: an
anchoring motif, which binds to the regulatory subunit of PKA, and a targeting domain, which
directs the subcellular localization of the PKA-AKAP complex through association with structural
proteins, membranes, or other cell elements [287]. BCAM/Lu-mediated SS-RBC adhesion to
LAMA5 is activated by the phosphorylation of serine 621 in the BCAM/Lu cytoplasmic domain,
but this phosphorylation does not occur as readily in normal RBCs [83]. We conjecture that this
is due to the presence of more PKA-AKAP complexes in SS-RBCs, and resultant AKAP
assistance in the phosphorylation of BCAM/Lu on RBCs. Also, because protein activation is
highly selective despite the high cAMP diffusion constant of 270-280 μm2/s, it is likely that the
cAMP is compartmentalized [293-294] and has a basal effect on normal RBCs which only
requires increases in cAMP near the membrane. This may explain why we detected modulation
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of BCAM/Lu via the cAMP-dependent pathway despite low levels of cAMP in normal RBCs [72].

Hydroxyurea reduces the adhesion of SS-RBCs via the BCAM/Lu receptor
Hydroxyurea, a pharmacologic treatment for SCD VOEs, is known to stimulate an increase in
HbF [75-76] synthesis, and may also alter RBC signaling [73, 77-78]. The drug has been found
to decrease SS-RBC adhesion to laminin [73, 78], although it increases BCAM/Lu surface
expression [73, 288]. Hillery et al. [78] first demonstrated that RBCs from SCD patients
receiving HU undergo a decrease in adhesion to laminin. Recently it was shown that although
BCAM/Lu receptor expression is increased on SS-RBCs from HU-treated patients, SS-RBC
adhesion to laminin is decreased because of inhibition of cAMP phosphorylation [73, 288]. In
our experiments, we measured a lower frequency of active BCAM/Lu receptors on SS-RBCs
from HU-treated patients versus SS-RBCs from untreated patients. In addition, AFM
measurements revealed a lower unbinding force between BCAM/Lu on SS-RBCs from HUtreated patients with LAMA5 as compared to untreated patients. The lower unbinding force
between BCAM/Lu and LAMA5 in conjunction with the lower frequency of active BCAM/Lu
receptors on SS-RBCs from HU-treated patients demonstrate the beneficial effect of HU in
reducing SS-RBC adherence to LAMA5, a mechanism thought to be critical to VOE genesis.

To determine the physiological implications of cAMP-stimulated adhesion of HU-treated RBCs,
we preincubated SS-RBCs from untreated and HU-treated patients with epinephrine, a hormone
released during stress and known to stimulate the β2-AR [30, 72]. Our results indicate that
epinephrine does not significantly increase the frequency of active BCAM/Lu receptors on the
surface of SS-RBCs from HU-treated patients. Further, because we did not detect a difference
in the unbinding force or the receptor frequency, we conjecture that HU modifies the β2-AR
pathway thereby reducing the ability for epinephrine-stimulation. Consistent with previous
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studies related to the phenotypic variability of SCD [72], we also found that the patient response
to epinephrine was variable.

A determinant of clinical phenotype in SCD is the adhesive property of RBCs, defined by the
subcellular density and distribution of adhesion receptors, and the unbinding force associated
with specific ligands. In this work, single-molecule AFM was employed to quantify the response
to cAMP-dependent pathway modulation via measurement of specific ligand-receptor unbinding
forces and the CF of active adhesion receptors on the RBC. Importantly, we detected the
presence of AKAPs on the membrane of both normal and SS-RBCs, and revealed that these
proteins play a significant role in the modulation of BCAM/Lu via the cAMP pathway. Lastly, we
demonstrated that HU-treatment reduces the ability for stimulation by epinephrine suggesting
that HU modifies the β2-pathway. The study shows new, important implications for AFM
cytoadhesion assays in evaluating the pharmacologic response of adhesion receptors on RBCs.
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Chapter 9. Single-Cell Force Spectroscopy as a Technique to Quantify Human
Red Blood Cell Adhesion to Subendothelial Laminin

9.1. Abstract
Single-cell force spectroscopy (SCFS), an atomic force microscopy (AFM)-based assay,
enables quantitative study of cell adhesion while maintaining the native state of surface
receptors in physiological conditions. Human healthy and pathological red blood cells (RBCs)
express a large number of surface proteins which mediate cell-cell interactions, or cell adhesion
to the extracellular matrix. In particular, RBCs adhere with high affinity to subendothelial matrix
laminin via the basal cell adhesion molecule and Lutheran protein (BCAM/Lu). Here, we
established SCFS as an in vitro technique to study human RBC adhesion at baseline and
following biochemical treatment. Using blood obtained from healthy human subjects, we
recorded adhesion forces from single RBCs attached to AFM cantilevers as the cell was pulledoff of substrates coated with laminin protein. We found that an increase of the overall cell
adhesion measured via SCFS is correlated with an increase in the resultant total force
measured on 1 µm2 areas of the RBC membrane. Further, we showed that SCFS can detect
significant changes in the adhesive response of RBCs to modulation of the cyclic adenosine
monophosphate (cAMP) and protein kinase A (PKA) pathway. Lastly, we identified variability in
the RBC adhesion force to laminin amongst the human subjects, suggesting that RBCs maintain
diverse levels of active BCAM/Lu adhesion receptors. By using single-cell measurements, we
established a powerful new method for the quantitative measurement of the adhesion of single
RBCs with specific receptor-mediated binding.

9.2. Introduction
Although red blood cells (RBCs) are generally considered to be relatively inactive due to their
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lack of a nucleus and other organelles, they express several surface adhesion receptors which
modulate cellular function [62]. Many of these receptors mediate cell-cell interactions, or
adhesion, on both healthy and pathological RBCs. Knowledge of cytoadhesion is necessary to
understand normal physiology, the pathophysiology of disease, and the cellular-level effects of
pharmacotherapies. Atomic force microscopy (AFM) [89] has introduced a wide range of novel
approaches for imaging and manipulating biological systems in their native environment [132,
144, 157, 286, 295-296]. AFM allows for measurements of native biological samples under
physiological conditions [30, 92] while avoiding complex sample preparation procedures and the
artifacts accompanying them. In this paper, we present single-cell force spectroscopy (SCFS)
as a new tool [130, 134-135] which enables the quantitative study of RBC adhesion while
maintaining surface receptors in their native state. The technique is performed by measuring the
adhesion between a single RBC attached to an AFM cantilever and a surface coated with either
purified proteins or other cells.

In the past, RBC adhesion was traditionally investigated via large-scale flow adhesion assays
[122-125], which measure the average adherence of a large number of RBCs to a
functionalized-substrate under flow-induced shear stress [126-127]. These measurements
provide only estimates of the adhesion force to which cells are subjected because the shear
force exerted on cells depends on parameters such as cell size and shape, as well as the
viscoelastic and elastic properties of the cells [128-130]. For example, it is known that RBCs
from sickle cell disease (SCD) patients show variability in their viscoelastic and elastic
properties [100, 119], and these properties can change after biochemical or pharmacologic
treatment [87]. Further, flow adhesion assays are unable to provide information regarding
receptor activity, including detachment forces, receptor localization, and changes in the number
of active receptors upon biochemical stimulation. To obtain more controlled and quantitative
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measurements of RBC adhesion, single-molecule and single-cell methods must be employed.

AFM studies of RBC adhesion have been utilized to provide quantitative evidence of changes in
surface receptor distribution and values for the unbinding forces with specific ligands [30]. A
technique known as single-molecule force spectroscopy (SMFS) utilizes cantilever tips
functionalized with specific ligands to probe the cell surface. SMFS measures the unbinding, or
detachment force, between a specific ligand on the AFM tip and its corresponding receptor on
the membrane of a single cell with piconewton sensitivity [30, 91-92, 131-132]. Because SMFS
is broadly used in conjunction with optical microscopy, the user has the ability to choose a RBC
of interest for measurements. SMFS operates by collecting a set of force-distance curves of the
approach-retract cycle of the functionalized tip from the cell surface. Specifically, the retraction
curve, obtained when the functionalized probe pulls away from the RBC surface, gives the
detachment force. Individual approach/retract curves can be obtained at many points on a RBC
surface to create a two-dimensional map of detected surface adhesion receptors [30, 297].
Forces probed by SMFS reflect interactions between molecules [91]. Specifically, this technique
allows for (i) quantifying the detachment force of specific receptor-ligand bonds, (ii) mapping the
distribution of active receptors on cellular surfaces with high resolution, and (iii) calculating the
density of active receptors on the cell surface [94, 96-98]. While SMFS is a very powerful
technique to study RBC adhesion at the single-molecule level, it cannot provide the overall
adhesion of a living cell to a substrate or to another living cell. Further, it is currently unknown
how SMFS measurements compare to whole cell measurements.

To overcome these limitations, SCFS assays which use a living cell as a probe were developed
[130, 134-138]. This AFM-based method is highly versatile because of its ability to measure a
wide range of forces, from ~5 pN to ~100 nN [130]. In SCFS, a RBC attached to an AFM
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cantilever is positioned above a functionalized substrate or another living cell. Similar to SMFS
measurements, SCFS also records force-distance curves of an approach/retract cycle between
the RBC probe and the functionalized substrate or cell. The RBC is lowered onto the substrate
until a preset contact force is reached, and then held stationary for a defined time.
Subsequently, the cell is withdrawn from the substrate at a constant speed and bonds between
the cell and substrate break until the two entities are completely separated. In this case, the
maximum detachment force is characterized as the force required to fully disengage the RBC
from the functionalized substrate.

The adhesion of single RBCs is central to disease pathology. In this work, we established the
technique of single-cell force spectroscopy as a method to probe RBC adhesion, specifically
with subendothelial laminin proteins. Importantly, we found a significant correlation between
SMFS measurements and SCFS measurements. To our knowledge, these two measurement
techniques had not been directly compared until now. Finally, we showed that SCFS can detect
significant changes in the adhesive response of RBCs to modulation of the cyclic adenosine
monophosphate (cAMP) pathway. Based on these measurements, we identified variability in the
RBC adhesion force to laminin amongst the human subjects, suggesting that RBCs maintain
diverse intracellular levels of tonic protein kinase A (PKA). This is especially important in the
case of blood pathologies in which specific blood cell adhesion receptors are targeted for antiadhesive therapies, suggesting that individual treatment remedies may be needed.

9.3. Methods
Human subjects, blood samples, and blood preparation
Healthy volunteers at least 18 years old were eligible to participate in this study if they did not
have a blood disorder or hemoglobinopathy, which was confirmed by screening blood samples
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via complete blood count and hemoglobin electrophoresis. This study was approved by the
Institutional Review Boards of the UCONN Health Center and UCONN-Storrs. Written informed
consent was obtained from all subjects. Whole blood was centrifuged at 500g for 10min at 4°C
to isolate the RBCs. The buffy coat and plasma were discarded and RBCs were washed 3x with
Alsever’s solution.

Reagents
Alsever’s solution, laminin, glutaraldehyde, biotinamido-caproyl-labeled bovine serum albumin
(biotin-BSA, reconstituted in PBS), streptavidin (reconstituted in PBS), biotinylated concanavalin
A (ConA, reconstituted in PBS), 3-aminopropyltriethoxysilane (APTES, reconstituted in
acetone), forskolin (Coleus forskohli, reconstituted in DMSO), KT-5720 (reconstituted in
methanol),

epinephrine

(reconstituted

in

Alsever’s

solution),

bovine

serum

albumin

(reconstituted in PBS), were purchased from Sigma Aldrich (St. Louis, MO). Anti-laminin-5
antibody conjugated to AlexaFluor®488 was obtained from EMD Millipore (Billerica, MA). BCAM
protein was obtained from Novus Biologicals (Littleton, CO).

Surface coating with laminin
Clean glass petri dishes (Ted Pella, Inc., Redding, CA) were divided using a hydrophobic PAP
pen (Sigma Aldrich, St. Louis, MO) enabling us to separate RBCs from the laminin surface
(Figure 9.3.1a). One half of the glass surface was silanized with 2% v/v 3-APTES for 10min,
then rinsed with deionized (DI) water and treated with 0.5% glutaraldehyde for 30min. Surfaces
were rinsed with DI water, incubated in laminin solution for 30min, rinsed again, and incubated
in bovine serum albumin (100μg/mL) for 5min to block remaining aldehyde groups. Dishes were
prepared on the same day of use.
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Preparation of cantilevers
Tipless silicon nitride AFM cantilevers (NanoWorld, Neuchâtel, Switzerland) were cleaned in
ethanol and thoroughly rinsed with DI water. Cantilevers were then soaked in acetone for 5min,
and UV irradiated for 15min. Next, cantilevers were incubated overnight in 0.5 mg/ml biotin-BSA
at 37°C. After rinsing with PBS, cantilevers were fixed in 1% glutaraldehyde for 30s. Cantilevers
were rinsed again, then incubated in 0.5 mg/ml streptavidin for 10min at 25°C, rinsed, and finally
incubated in 0.5 mg/ml biotinylated Con A (in PBS) for 10min at room temperature.

Silicon nitride cantilevers (Bruker Probes, Camarillo, CA) for single-molecule experiments were
functionalized with BCAM protein as follows. Cantilevers were silanized with 2% v/v APTES for
10min, then rinsed with DI water and immersed in 0.5% glutaraldehyde for 30min. Cantilevers
were rinsed with DI water, incubated in BCAM solution (100μg/mL) for 30min, rinsed again, and
incubated in bovine serum albumin (100μg/mL) for 5min to block remaining aldehyde groups.
Cantilevers were stored at 4°C and utilized within 48 hours.

Cell capture and experimental setup
Cells were allowed to weakly bind to the non-functionalized region of the glass substrate via
incubation at 37°C for 10min followed by rinsing with Alsever’s solution. This gentle
immobilization on the glass substrate allowed for engagement of the tipless cantilever on a
chosen RBC. Single cells were captured by positioning the ConA-functionalized cantilever
above the center of a cell (Figure 9.3.1a) and gently lowering it onto the cell for ~30 s with a
contact force of 1nN. Cells were precisely attached at the very end of the tipless cantilevers
(Figure 9.3.1c) to prevent the cantilever surface (incubated with ConA) from interacting with the
laminin substrate. The cell was lifted from the surface and allowed to establish firm adhesion on
the cantilever for 1min before being moved to the laminin-functionalized area of the glass dish.
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Figure 9.3.1. Measurement of red blood cell adhesion to subendothelial matrix laminin using
single-cell force spectroscopy. (a) The apex of a tipless ConA-functionalized AFM cantilever is
positioned above a RBC. It is then gently pushed (~1 nN) for 30 s onto the cell. The cantileverbound RBC is separated from the substrate and allowed to establish firm adhesion to the
cantilever for 1 min. The cantilever is then slowly moved to the functionalized segment of the
petri dish to perform adhesion measurements. (b) Representative force-distance curves
obtained from experiments for an RBC probing a laminin substrate. The measured detachment
forces are 0.64 nN in the first curve which shows a single rupture and 1.06 nN in the second
curve which shows multiple rupture events. (c) Optical microscopy image showing a human
RBC attached to the apex of a ConA-functionalized cantilever.

AFM setup for SCFS
SCFS experiments were conducted using the MFP-3D-BIO AFM (Asylum Research, Santa
Barbara, CA) mounted on an inverted optical microscope (Zeiss Axiovert A1). The nominal
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spring constant of the employed cantilever was 80 mN/m and the effective spring constant was
obtained via a thermal noise-based method prior to cell capture and used in all calculations
[289]. The effective cantilever stiffness was lower than then nominal spring constant for each
functionalized cantilever, as expected [298-299]. All experiments were performed in Alsever’s
solution at 37°C, and biochemical modulators were added 30min prior to experiments. For each
assay, 5 RBCs were tested from each subject’s blood. Values reporting “N = ” denote the
number of unique donors per condition and “n = ” denote the total number of tested cells.

Each measuring session involved testing a single RBC probe attached to a previously calibrated
cantilever for 100 approach/retraction cycles on a laminin-functionalized glass substrate. As
monitored by optical microscopy, the captured cells rarely detached from the cantilever during
pulling. Tests were performed with a preset trigger force of 500 pN. After the approach and a
contact time of 0.1 s (unless otherwise noted), the cantilever was retracted at 800 nm/s until the
RBC completely detached from the laminin substrate. Recorded force-distance curves were
used to determine the detachment force of the RBC from the laminin substrate. A detachment
force is defined as the maximum rupture force associated with the force-distance curve. Two
representative curves are shown in Figure 9.3.1b. A relatively high number of curves exhibited
single rupture events, as shown in the first curve. The experiments also resulted in curves
compatible with multiple rupture events as shown in the second curve.

Statistical methods
Values for the detachment forces are reported as average ± standard deviation (SD) as
determined by a frequency (%) distribution fit with the Gaussian function (GraphPad Prism). In
the frequency (%) distribution, each bin contains the number of detachment forces with values
within the bin’s range divided by the total number of approach/retraction cycles. For SMFS,
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frequency (%) is defined as the total number of all non-zero force points divided by the total
number of sampled sites for each experimental condition. It is reported as average ± standard
error of the mean (SEM).

9.4. Results and Discussion
Surface density of laminin for functionalized substrates
To obtain the experimental parameters used in our SCFS assay, we first needed to determine
the appropriate solution concentration of laminin to be used for functionalization of the glass
substrate. SMFS experiments were performed using a BCAM-functionalized probe against a
laminin substrate. Substrates were prepared with various solution concentrations of laminin (1
µg/ml, 5 µg/ml, 10 µg/ml, 25 µg/ml, 50 µg/ml, and 100 µg/ml) and three 1 µm x 1 µm areas of
each substrate were scanned with a lateral resolution of 31.25 nm yielding a total of 3072
measurements for each laminin solution concentration.

The average detachment force of BCAM with laminin was nearly constant across all solution
concentrations, measuring 105 ± 11 pN (Figure 9.4.1a,b). Interestingly, this detachment force
was approximately double what our lab had previously measured for the inverse interaction
between BCAM on the RBC and laminin on the AFM probe using SMFS [30, 300]. In this case,
we conjectured that more BCAM proteins attached to the AFM tip make contact with multiple
laminin proteins on the substrate. BCAM proteins are approximately 6nm [301-302], whereas
laminin is a cruciform structure with four arms of lengths ranging between 40 nm and 80 nm
[303], therefore it is possible for multiple BCAM proteins to attach to multiple laminin binding
sites. Upon functionalizing a substrate with BCAM and measuring the detachment force using a
laminin-functionalized probe, we confirmed that the bond force is 43 ± 13 pN, in agreement with
our previous measurements (Figure 9.4.1a).
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For laminin-functionalized substrates, the percentage of sampled sites where a detachment
force was detected increased with higher laminin concentrations (Figure 9.4.1c; 1 µg/ml: 35.22 ±
6.28%; 5 µg/ml: 60.19 ± 5.47%; 10 µg/ml: 51.66 ± 6.45%; 25 µg/ml: 73.21 ± 7.63%; 50 µg/ml:
63.93 ± 7.09%; 100 µg/ml: 71.13 ± 2.53%; p < 0.01, one-way ANOVA with Tukey post hoc).
Variability reflects different substrate and probe preparations. To determine background noise,
measurements were recorded on a substrate in which the laminin functionalization step was
omitted (0 µg/ml). For the 0 µg/ml laminin substrate, interactions were detected in 4.1 ± 0.65%
of sampled sites. The substrate density appeared to reach a plateau at 25 µg/ml, suggesting
that 25 µg/ml, 50 µg/ml, or 100 µg/ml were suitable for our assay.

We next determined the effect of different laminin solution concentrations on the adherence of
RBC probes to the laminin substrate. RBCs were attached to ConA-functionalized tipless AFM
cantilevers (Figure 9.3.1a,c). Five cells from each healthy human subject were used as a probe
and pressed onto laminin substrates with a contact time of 0.1 s and the cantilever was
subsequently retracted until the cell was completely detached from the laminin substrate.
Background noise was quantified by using a RBC to probe a substrate in which the laminin step
was omitted from the functionalization procedure. Small forces of 73 ± 23 pN were detected in
25.70 ± 7.43% of sampled curves. The specificity of the interaction is demonstrated by
performing experiments in a bath solution of 100 μg/mL laminin, thus blocking the BCAM/Lu
receptors prior to interaction with the laminin functionalized substrate. By recording
approach/retraction cycles between RBC probes and a substrate functionalized with 50 µg/ml
laminin, the number of curves showing detachment forces dramatically reduced from 88% to 8%
(p < 0.0001, Figure 9.4.1d). Further, detachment forces recorded in bath laminin decreased fivefold, from 511 ± 216 pN to 106 ± 23 pN (p < 0.0001) reflecting bath laminin bound to many
BCAM/Lu receptors and thereby significantly reducing the propensity for binding of the RBC

132

probe to the laminin substrate.

Figure 9.4.1. Determination of laminin solution concentration to be employed in SCFS assay.
(a) Frequency distributions obtained from SMFS experiments of measured detachment forces
between (i) a substrate coated with laminin (50 µg/ml) and a BCAM/Lu probe, and (ii) a
substrate coated with BCAM (50 µg/ml) and a laminin probe. (b) Plot of the average detachment
force measured at each tested laminin solution concentration shows the values are nearly
consistent (1 µg/ml: 111 ± 33 pN; 5 µg/ml: 116 ± 41 pN; 10 µg/ml: 114 ± 46 pN; 25 µg/ml: 129 ±
93; 50 µg/ml: 78 ± 34 pN; 100 µg/ml: 100 ± 38). (c) Plot of the substrate density measured at
each tested laminin concentration shows that the density appears to reach a plateau at 25 µg/ml
(1 µg/ml: 35.22 ± 6.28%; 5 µg/ml: 60.19 ± 5.47%; 10 µg/ml: 51.66 ± 6.45%; 25 µg/ml: 73.21 ±
7.63%; 50 µg/ml: 63.93 ± 7.09%; 100 µg/ml: 71.13 ± 2.53%; p < 0.01, one-way ANOVA with
Tukey post hoc). (d) Frequency distributions obtained from SCFS experiments of detachment
forces between a RBC probe and laminin substrate (50 µg/ml) measured in the (i) absence and
(ii) presence of bath laminin. The significant reduction in the number of curves showing
detachment forces, from 99% to 8% (p < 0.0001) demonstrates the specificity of the
measurements. (e) Plot of mean detachment force for human RBC probes (N=2, n=10) at each
laminin solution concentration. Detachment forces were found to increase with higher laminin
concentrations (1 µg/ml: 97 ± 49 pN; 5 µg/ml: 100 ± 49 pN; 10 µg/ml: 205 ± 79 pN; 25 µg/ml:
245 ± 142 pN; 50 µg/ml: 511 ± 216 pN; 100 µg/ml: 479 ± 118 pN; p < 0.0001), appearing to
plateau at the 50 µg/ml concentration. (f) Plot of RBC binding frequency shows an increase in
binding as laminin substrate concentration increases (1 µg/ml: 51.16 ± 13.31%; 5 µg/ml: 66.01 ±
5.43%; 10 µg/ml: 96.04 ± 2.97%; 25 µg/ml: 65.02 ± 10.91%; 50 µg/ml: 87.46 ± 1.78%; 100
µg/ml: 72.11 ± 10.90%; p < 0.0001).
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After confirming the specificity of the measured interaction, RBC probes were used to record
forces against each laminin substrate. Detachment forces were found to increase with higher
laminin solution concentrations (1 µg/ml: 97 ± 49 pN; 5 µg/ml: 100 ± 49 pN; 10 µg/ml: 205 ± 79
pN; 25 µg/ml: 245 ± 142 pN; 50 µg/ml: 511 ± 216 pN; 100 µg/ml: 479 ± 118 pN; p < 0.0001),
appearing to stabilize around the 50 µg/ml concentration (Figure 9.4.1e). For the 50 µg/ml
concentration, we obtained force curves characterized by maximal detachment forces up to 3.4
nN. In contrast, the 1, 5, 10, and 25 µg/ml concentrations resulted in maximal detachment
forces of less than 2.2 nN reflecting the need for a denser laminin concentration on the
substrate to maximize BCAM/Lu receptor binding. These detachment force values are
comparable to those observed for RBCs in other experiments [136]. Moreover, the frequency of
RBC binding to the laminin substrate, or the percentage of approach/retract cycles which
recorded detachment forces, also increased with higher laminin concentrations (Figure 9.4.1f)
confirming the need for a higher density of laminin (1 µg/ml: 51.16 ± 13.31%; 5 µg/ml: 66.01 ±
5.43%; 10 µg/ml: 96.04 ± 2.97%; 25 µg/ml: 65.02 ± 10.91%; 50 µg/ml: 87.46 ± 1.78%; 100
µg/ml: 72.11 ± 10.90%; p < 0.0001).

From the experiments employed to determine the appropriate solution concentration of laminin
to be used for substrate functionalization, and the effect of different concentrations on RBC
detachment forces, we found that detachment forces appear to reach a plateau at the 50 µg/ml
laminin concentration (Figure 9.4.1e), whereas the surface density detected via SMFS appears
to reach a plateau at the 25 µg/ml laminin concentration (Figure 9.4.1c). Tethered polymer
layers are comprised of polymer molecules attached to a surface, with a density high enough
that the chains must stretch away from the surface [304-305]. By maximizing the brush height,
the free-energy cost per chain is minimized, thus minimizing the strength of repulsion between
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chains. This situation may have a large effect on the binding of tested cells and molecules to
proteins attached to a surface. The surface distribution of a tethered polymer layer can be
characterized by the distance between attachment points,
gyration,

. As

approaches the radius of

, of the polymer chain, the molecules interact and the polymer layer structure

gradually passes from the single-chain (mushroom) regime to the brush regime. In the
'mushroom' regime the reduced tethered density,

, where

, is Σ < 1, the

'mushroom-to-brush' transition regime occurs for 1 < Σ < 5, and the transition to 'brush' regime
occurs at Σ = 5. The value Σ = 1 corresponds to
where

[306]. For the case of laminin,

[307-308], the 'mushroom' regime appears for

transition to 'brush' regime occurs at

and the

[306]. Because the lateral step

size was 31.25 nm during our SMFS experiments, after we reach the first transition point, from
'mushroom' to 'mushroom-to-brush' regime, it is difficult to distinguish between different surface
densities. Based on Figure 9.4.1c, we conjecture that the transition point was reached at
approximately 25 µg/ml laminin solution concentration. This conclusion is reinforced by the fact
that the binding frequency for SCFS experiments plateau at the same laminin concentration (25
µg/ml), meaning that at this concentration, most of the substrate is covered with laminin chains
in the 'mushroom' form. We found however, that the detachment force reaches a plateau at
approximately 50 μg/ml solution concentration, meaning that the binding between all active RBC
adhesion receptors and laminin molecules reaches equilibrium at this concentration. We
conjecture that this is the second transition point, from 'mushroom-to-brush' to 'brush' regime,
and determined the corresponding concentration of 50 μg/ml to be most suitable for SCFS
assays of human RBCs.
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Figure 9.4.2. Human RBC adhesion to laminin substrates (50 µg/ml) at increasing contact times
(N=2, n=10). (a) Frequency distributions show that the mean detachment force for RBCs from
laminin substrates are the same for 0.1 s and 5 s contact times, however the range of measured
detachment forces increases. (b) Plot shows that the mean detachment force does not
significantly change with increasing contact time, however the deviation increases (0.1 s: 0.70 ±
0.28 nN; 1 s: 0.68 ± 0.28 nN; 2.5 s: 0.65 ± 0.35 nN; 5 s: 0.70 ± 0.49 nN; 10 s: 0.74 ± 0.43 nN).

Dependence of BCAM/Lu-mediated RBC adhesion on contact time
To investigate the time dependence of cell adhesion formation in more detail, we varied the
contact time of RBCs with 50 µg/ml laminin substrates between 0.1 and 10 s and determined
the respective detachment forces. It should be noted that the maximal contact time that can be
achieved with our AFM system is 10 s. For each contact time interval, 5 cells were analyzed and
100 approach/retraction cycles were recorded per cell at each interval. For the 0.1 s contact
time, RBCs required forces of several hundred piconewtons for laminin detachment (Figure
9.4.2a). As the contact time increased to 10 s, we recorded a minor increase in the mean
detachment forces (Figure 9.4.2b), however the range of forces increased significantly, with a
maximal detachment force of 3.3 nN at 0.1 s and 13.7 nN at 10 s. Because the result is similar
across the different time scales, we opted to use the 0.1 s contact time for experimental
convenience. At higher time scales, the RBC had a greater probability to detach from the probe
prior to the completion of 100 approach/retraction cycles leading to experimental failure.
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Increases in SCFS detachment forces correlates with increases in total forces recorded
by SMFS on 1 µm2 membrane regions
To determine the relationship between single-molecule measurements and single-cell
measurements, we performed both assays using 5 cells from healthy human subjects (N = 3). In
contrast to SMFS experiments, which probe specific receptor-ligand adhesion events on a small
area on the cell membrane with high resolution, SCFS obtains the detachment force of cell
probes from a functionalized substrate, or another cell. The method of SCFS is more readily
comparable to flow adhesion assays, which measure the average adhesion of a large number of
RBCs to a functionalized-substrate under flow-induced shear stress. Further, the measurements
of SCFS are able to specifically quantify the detachment of cells from endothelial proteins found
in capillaries and blood vessels, giving substantial insight into cytoadhesion events in the body.

SMFS experiments probed 1 µm x 1 µm areas of the RBC surface with a lateral resolution of
31.25 nm, enabling us to measure single-rupture events. The details of the technique along with
the protocols we follow and the calibration tests are explained elsewhere [30, 300]. For the
SCFS assay, RBCs probed a laminin-functionalized substrate (50 µg/ml laminin solution
concentration) with a contact time of 0.1 s. For comparison of SMFS to SCFS, the resultant total
force associated with each 1 µm x 1 µm membrane area was calculated as the product of the
frequency of detected events and the mean detachment force. For example, an area with a
mean detachment force of 39.51 pN detected in 2.83% of sampled sites yields a total force of
1.15 nN, while an area with a mean detachment force of 46.98 pN detected in 3.52% of
sampled sites yields a total force of 1.69 nN. Resultant total forces measured on 1 µm x 1 µm
areas of the RBC ranged from 0.77 nN to 3.92 nN (Figure 9.4.3a). In contrast, detachment
forces obtained between single RBCs with a laminin substrate were lower, averaging 0.61 ±
0.27 nN and ranging from 0.24 nN to 1.38 nN (Figure 9.4.3a). The mean detachment force for
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an entire RBC corresponds to the simultaneous formation of approximately 15-20 active bonds
between BCAM/Lu molecules expressed on the RBC surface and laminin added to the
substrate. This was calculated by dividing the average single cell detachment force by the
average single-molecule detachment force, where the detachment force of one BCAM/Lu
receptor from laminin is taken to be 40.24 pN, as determined by fitting the Gaussian model to a
frequency (%) distribution of all SMFS measured detachment forces.

Since multiple cells (n = 5) were tested from each subject (N = 3), detachment forces could be
compared between subjects. The Pearson correlation test was used to determine the strength
of relationship between single-molecule and single-cell force spectroscopy assays (Figure
9.4.3b). We found that SMFS total force (1 µm x 1 µm area) correlated strongly with the whole
cell force obtained via SCFS (Pearson correlation test; r = 0.96, R2 = 0.93). Due to the fact that
SCFS measurements reflect the percentage of bonds that are currently active, as well as innate
cellular features, they can be used as an innovative tool to study RBC adhesion. However, it is
important to note that detachment of the cell from the substrate is a complicated process, and
the detachment force obtained is a result not only of receptor-ligand binding strength and spatial
distribution of receptors on the cell membrane but also of other factors such as membrane
fluctuations, cellular elasticity, and cell shape [130, 309-310].
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Figure 9.4.3. Correlation of single-cell measurements with traditional SMFS measurements. (a)
Plot of the mean detachment forces from SMFS and SCFS assays. Experiments were
performed on 5 cells from each human sample (N=3). SCFS experiments used single RBCs to
probe a laminin functionalized substrate (50 µg/ml) with a contact time of 0.1 s. SMFS
experiments probed BCAM/Lu receptors on 1 µm x 1 µm areas of the RBC surface with a
laminin-functionalized probe. The resultant total force for each area was calculated as the
product of the frequency of detected events and the mean detachment force. Error bars
represent SEM. (b) Correlation of the resultant total force on 1 µm x 1 µm areas of the RBC
surface obtained via SMFS with the mean detachment force obtained via SCFS measurements
(Pearson correlation test; r = 0.96, R2 = 0.93). Each plotted point represents 5 tested cells from
one healthy subject.

Increases in RBC compliance may allow the cell to spread, leading to an increased number of
ligand-receptor interactions and in effect, greater detachment forces measured via SCFS [138].
Because our experiments were conducted using RBCs from healthy subjects (N = 3, n = 5), the
samples had a similar Young’s modulus and we found that there was not a significant
correlation between the mean effective Young’s modulus of tested samples [30, 100] and the
mean detachment force of RBCs (Pearson correlation test; r = -0.62, R2 = 0.39).

cAMP-dependent modulation of red blood cell adhesion to laminin via BCAM/Lu
To establish the sensitivity of the assay in the detection of variations in the adhesion of
BCAM/Lu to laminin based primarily on the number of active receptors, we investigated
changes in the detachment force between single RBCs and the laminin substrate via
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pharmacologic modulation of the cAMP signaling pathway. Quantitative understanding of RBC
cytoadherence mediated by the second messenger cAMP is necessary to fully elucidate the
mechanism of RBC adhesion. Previous experimental approaches utilizing flow adhesion assays
have shown that the interaction between BCAM/Lu and laminin is mediated by cAMPdependent PKA [30, 83]. Stimulation of the β2-adrenergic receptor (β2-AR) [85-86] activates the
G-protein coupled receptor Gαs, which stimulates adenylyl cyclase (AC) [87]. AC then catalyzes
the conversion of adenosine triphosphate (ATP) to cAMP, resulting in PKA activation and
ensuing BCAM/Lu-laminin adhesion. In human RBCs, basal intracellular cAMP levels are
controlled through the activity of phosphodiesterases [224, 293], which limit not only the
signaling lifespan of cAMP but also the distance it can diffuse from its site of production [311].

First, we treated RBCs with forskolin (30μM, FSK), a strong AC activator that stimulates cAMP
production, subsequently activating PKA. Compared to untreated RBCs, forskolin-treated RBCs
exhibited significantly higher detachment forces shown by the shift in the frequency distribution
and bar graph (Figure 9.4.4a,b,e; p < 0.0001, one-way ANOVA with Tukey post hoc). To
quantify the effect of direct PKA inhibition on the detachment force of the RBC with laminin,
RBCs were treated with KT-5720 (1μM), a PKA inhibitor, which resulted in a significant
decrease in the detachment force from baseline measurements (Figure 9.4.4c; p < 0.01). PKA
is a key regulator of BCAM/Lu receptor activation on human RBCs. Based on the results
obtained in the presence of KT-5720 and FSK, PKA inhibitor and activator respectively, we
conjecture that RBCs maintain varying intracellular levels of tonic PKA [311-312]. We further
speculate that this tonic PKA is modulated by cAMP levels and must be raised for activation of
BCAM/Lu receptors to occur, resulting in elevated adhesion to subendothelial laminin. Indeed,
inhibition of PKA activity with KT-5720 was sufficient to reduce the number of active BCAM/Lu
receptors on the RBC surface, reflected by the significant decrease in detachment forces. This
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is suggestive of a tonic drive because even in the absence of PKA inhibitors and activators,
PKA exerts a sustained, steady-state activation of BCAM/Lu receptors. Finally, the physiologic
implication of cAMP-stimulated adhesion was studied by treating RBCs with epinephrine (1μM),
a hormone released during stress and strenuous exercise which is known to stimulate the β2AR. Treatment with epinephrine resulted in a significant increase in the detachment force as
compared to baseline (Figure 9.4.4d; p < 0.0005). These data demonstrate that the single-cell
AFM assay can detect differences in the detachment of whole RBCs from a laminin substrate in
response to pharmacologic modulation (Figure 9.4.4e). Because a single-cell technique was
used to measure 5 cells each from several human subjects (N=3), we also showed the
individual results of detachment forces for each subject. Figure 9.4.4f shows the mean
detachment force for each subject measured in each condition. Interpatient variations in
baseline measurements showed that the sustained steady-state activation of BCAM/Lu
receptors by PKA is not identical among human subjects.

It should be noted that previous experiments using flow adhesion assays did not detect
adhesion of non-stimulated normal RBCs to laminin [72-73] nor an increase in adhesion upon
FSK stimulation [72]. It is highly possible that flow adhesion assays, which measure the average
adhesion of a large number of erythrocytes to a functionalized-substrate under flow-induced
shear stress, are not sensitive enough to detect increases in the overall low adhesion of normal
RBCs.
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Figure 9.4.4. Single-cell force spectroscopy can clearly detect significant changes in RBC
adhesion to laminin substrates (50 µg/ml) following treatment with biochemical agents
modulating the cAMP-dependent pathway. (a) Frequency distribution of the mean detachment
force associated with healthy RBCs at baseline (N=3, n=15) shows a mean force of 0.61 ± 0.27
nN. (b) Measurement in FSK (30 µM) indicates a significant increase in the mean detachment
force to 1.15 ± 0.46 nN (p < 0.0001, one-way ANOVA with Tukey post hoc). Dotted distribution
represents frequency distribution of the mean detachment force measured at baseline. (c)
Measurement in KT-5720 (1 µM) indicates a significant decrease in the mean detachment force
to 0.37 ± 0.23 nN (p < 0.01). (d) The physiologic implication of cAMP-stimulated adhesion was
studied. Measurement in epinephrine (1 µM) indicates a significant increase in the mean
detachment force to 0.76 ± 0.35 nN (p < 0.0005). (e) Summary of mean detachment forces
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obtained for healthy RBCs from laminin substrates in the presence and absence of biochemical
agents known to modulate cAMP-dependent adhesion. (f) Variability in mean detachment force
amongst patient samples under different conditions.

9.5. Conclusion
In this work, SCFS was established as a method to quantify the strength and modulation of
adhesion of human RBCs to functionalized substrates. We first determined the appropriate
solution concentration of laminin to utilize for substrate functionalization via SMFS to determine
the density of protein adsorption to the substrate. Subsequently, single-cell experiments were
performed to measure variation in the detachment force associated with different laminin
concentrations. From these tests, we determined the 50 µg/ml solution concentration of laminin
to be most effective for our assay. Next, we probed laminin substrates with RBCs using various
contact times, with a minimum contact time 0.1 s, and a maximum contact time of 10 s. While
the mean detachment forces did not increase significantly, we observed an increase in the
range of measured detachment forces. At 10 s, there was an increased probability of
experimental failure resulting when the RBC would detach from the probe prior to the
completion of 100 approach/retract cycles. Therefore, we chose 0.1 s for experimental
convenience and for comparison between single-molecule and single-cell detachment forces.
We found a significant correlation between results from SMFS measurements probing BCAM/Lu
with a laminin-functionalized probe and SCFS measurements probing a laminin substrate with
an RBC probe. Finally, we established that SCFS can detect variations in the detachment force
of RBCs to laminin based primarily on the number of active BCAM/Lu receptors, which was
modulated via biochemicals affecting the cAMP-PKA pathway. This study shows new, important
implications for AFM-based SCFS measurements in understanding and evaluating the
pharmacologic response of adhesion receptors on RBCs. Further, this method can easily be
employed to measure the adhesive interactions of various cell types with functionalized
substrates or other cells.
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Chapter 10. Epilogue

The pathogenesis of vasculopathy in sickle cell disease is a multi-faceted biological process
resulting from red cell sickling, inflammation and adhesion biology, coagulation activation,
stasis, deficient bioavailability and excessive consumption of NO, excessive oxidation, and
reperfusion injury physiology [2]. VOEs account for much of the morbidity and mortality in SCD
and also with exercise-induced collapse and sudden death in SCT. The biomechanical
properties of increased erythrocyte stiffness and abnormal cytoadherence to endothelial
components were investigated to gain insight into the cascade of events involved in the
pathogenesis of complications in SCD and SCT. AFM is appropriate for measuring the
biomechanical and adhesive properties of living cells due to its high force sensitivity and ability
to measure local and overall properties of individual cells in physiological conditions. In
particular, the effective Young’s modulus was quantified for RBCs from healthy, SCT, and SCD
subjects, as well as RBC adhesive properties, defined by 1) the subcellular density and
distribution of adhesion receptors, and 2) the unbinding force associated with specific ligands.

Three-dimensional topographic images were recorded for human RBCs from healthy subjects,
SCT subjects, and SCD subjects using AFM. The characteristic biconcave shape was observed
for normal erythrocytes while SCT erythrocytes deviated from this morphology by means of a
decrease in the diameter and height, likely due to increased membrane stiffness and
dehydration. In contrast to normal and SCT RBCs, erythrocytes from patients with SCD
substantially deviated from the characteristic biconcave shape and possessed highly irregular
morphologies characterized by protrusions, elongation, bumps, and enlargement associated
with aggregation of HbS fibers.
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The biomechanical properties of human RBCs from healthy subjects, SCT subjects, and SCD
subjects were investigated. A systematic force-displacement curve analysis based on the Hertz
model was established to quantify the effective Young’s modulus of RBCs from human subjects
via AFM microindentation measurements. Consistent with the Hertz model, no adhesion was
observed between the indenter and the tested cell. It was determined that sickle RBCs possess
Young’s modulus values between 1-60 kPa depending on their degree of oxygenation and, we
conjecture, the percentage of HbS present in the RBCs. Both oxygenated and deoxygenated
samples of RBCs from patients with SCD maintained a bimodal distribution with peaks
representative of normal RBCs (

= 1.0 kPa ± 1.1 kPa) and SCT RBCs (

Significantly higher Young’s modulus values resulting in peaks at
sickle RBCs and

= 3.0 ± 2.7 kPa).

= 15 kPa for oxygenated

= 40 kPa for deoxygenated sickle RBCs were likely a result of the presence

of polymerized HbS. This significant increase in the Young’s modulus upon full deoxygenation
can present major problems in SCD vasculopathy because rigid RBCs have a greater
propensity to occlude the microvasculature, resulting in severe VOEs. Small Young’s modulus
values for both oxygenated and deoxygenated SCD erythrocytes are likely due to treatment with
the drug hydroxyurea, a variable in the obtained clinical samples. Hydroxyurea is the only
approved medication for the treatment of VOEs in SCD for adults which works by stimulating the
production of HbF and inhibits sickling by preventing effective contact between HbS molecules.

The AFM technique used to measure the stiffness of normal and pathological RBCs was then
employed in the study of RBCs from mice with SCD. In an effort to rectify the increased stiffness
of sickle RBCs, mice were fed a diet supplemented with DHA, an omega-3 fatty acid. To date,
studies of omega-3 fatty acids in human SCD showed a decrease in acute painful VOEs, but
have not carefully assessed the effect of DHA on sickle RBC structural and functional
characteristics. Although individuals with SCD are known to have increased daily pain and
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allodynia, effects of omega-3 fatty acid supplementation on chronic or neuropathic pain in SCD
have not been reported. Our findings indicate that DHA supplementation improves RBC
membrane flexibility measured via AFM and reduces irreversibly sickled cells in mice with SCD.
The increased RBC flexibility and decrease in irreversibly sickled RBCs found in this study at
steady state suggest that the RBCs in SCD DHA mice may be more resistant to acute sickling
events and resultant tissue injury, such as can be induced using hypoxia-reoxygenation in SCD
mice. Therefore, dietary supplementation with omega-3 fatty acids may provide a safe and
effective way to ameliorate pathologies associated with VOEs in human and murine SCD.

As previously mentioned, the abnormal cytoadherence of RBCs to the endothelium is thought to
be a chief contributor to the complicated biological processes causing the pathogenesis of
vasculopathy in SCD and SCT. It is known that the BCAM/Lu-laminin and ICAM-4-αvβ3 binding
complexes contribute to VOEs, yet the single-molecule characteristics of these adhesive
interactions were previously unknown for SCT and SCD erythrocytes. To establish the singlemolecule force spectroscopy technique which measures adhesive interactions, experiments
were performed using a functionalized laminin probe and a BCAM/Lu-coated gold substrate. In
wild-type and SCT RBCs, the magnitude of the BCAM/Lu-laminin binding complex (46 ± 6 pN
and 46 ± 10 pN, respectively) was found to be equal to the average rupture force of 50 ± 11 pN
recorded between a functionalized laminin probe and a BCAM/Lu-coated gold substrate.
Similarly, in wild-type RBCs and sickle cell trait RBCs, the magnitude of the ICAM-4-αvβ3
binding complex (46 ± 10 pN and 47 ± 10 pN, respectively) is nearly the same as the average
rupture force of 47 ± 15 pN recorded between a functionalized integrin αvβ3 probe and a ICAM4-coated gold substrate. Further, the observed increase in adhesive frequency, in conjunction
with the detected receptor aggregation into nanodomains, is significant evidence of the
contribution of epinephrine to enhancing BCAM/Lu-laminin and ICAM-4-αvβ3 adhesive
interactions. These findings suggest a mechano-adhesive role for epinephrine in the
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pathophysiology of VOEs related to collapse and sudden death in SCT individuals during
strenuous exercise.

The sensitivity of the SMFS system was validated in a neuronal system to quantitatively map SK
channels. Because the activation of adhesion receptors on RBCs and other cells can be
modulated by various biochemical stimuli, it was important to assure that the technique could
detect changes in the population of membrane components such as adhesion receptors or ion
channels. We showed that integration of single-molecule force spectroscopy with toxin
pharmacology allowed us to map the spatial organization and density of endogenous SK
channels in living neurons. By taking advantage of the nanometer resolution of single-molecule
AFM, we demonstrated that SK channels are highly concentrated on neuronal dendrites and are
organized on neuronal membranes as either groups of two or single entities. To establish the
technique’s sensitivity, forskolin was used to show that SK channel dendritic distribution is
dynamic and under the control of PKA.

SMFS was employed to investigate the effects of subcellular cAMP pathway targeting on the
activation of BCAM/Lu receptors at the single-molecule level on normal and SCD RBCs. In
SCD, cytoadherence of RBCs to endothelial and subendothelial matrix components is thought
to be a major contributor to and possibly the primary cause of VOEs. A determinant of clinical
phenotype in SCD is the adhesive properties of RBCs, defined by the subcellular density and
distribution of adhesion receptors, and the unbinding force associated with specific ligands.
Importantly, we demonstrate that AKAPs are essential for BCAM/Lu receptor activation, and
that the collective frequency of BCAM/Lu receptors, present on both the normal and SS-RBC
membrane, is critically dependent on the cAMP pathway. HU-treatment was also found to
reduce the ability for BCAM/Lu receptor stimulation by epinephrine suggesting that HU modifies
β2-AR signaling. We also measured that the unbinding force between BCAM/Lu and laminin in
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hydroxyurea-treated patients is lower than in untreated patients. The study shows new,
important implications for AFM cytoadhesion assays in evaluating the pharmacologic response
of adhesion receptors on RBCs.

To examine the relevance of results based on SMFS in the cytoadhesion of entire RBCs, SCFS
was established to measure the adhesion of whole cells with a functionalized substrate. We first
determined the appropriate solution concentration of laminin to utilize for substrate
functionalization by employing both SMFS and SCFS experiments. It was determined that the
50 µg/ml solution concentration of laminin is most effective for this assay. Laminin substrates
were then probed with RBCs using various contact times, ranging from 0.1 s to 10 s. While the
mean detachment forces did not increase significantly, we observed an increase in the range of
measured detachment forces with increased contact time. It was determined that elevated
overall cell adhesion measured via SCFS coincided with a rise in the resultant force measured
on 1µm2 areas of the RBC membrane via SMFS. To establish the sensitivity of the technique,
RBCs were treated with biochemicals affecting the cAMP-PKA pathway and we indeed found
that SCFS can detect variations in the detachment force of RBCs to laminin based primarily on
the number of active BCAM/Lu receptors. This study shows new, important implication for AFMbased SCFS measurements in understanding and evaluating the pharmacologic response of
adhesion receptors on RBCs.
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